Page last updated: 2024-08-22

angiotensin ii and Kidney Diseases

angiotensin ii has been researched along with Kidney Diseases in 587 studies

Research

Studies (587)

Timeframe	Studies, this research(%)	All Research%
pre-1990	154 (26.24)	18.7374
1990's	78 (13.29)	18.2507
2000's	180 (30.66)	29.6817
2010's	137 (23.34)	24.3611
2020's	38 (6.47)	2.80

Authors

Authors	Studies
Fang, H; Gao, F; Li, C; Wang, Y; Xue, K	1
Ali, FEM; Azouz, AA; Hersi, F; Hussein Elkelawy, AMM; Omar, HA	1
Jala, VR; Juin, SK; Majumder, S; Pushpakumar, S; Sen, U	1
Adjaye, J; Bohndorf, M; Erichsen, L; Rahman, MS; Thimm, C; Wruck, W	1
Cantrell, AC; Chen, JX; He, X; Williams, QA; Zeng, H	1
Chan, JSD; Chang, SY; Chenier, I; El-Mortada, MA; Ingelfinger, JR; Liao, MC; Lo, CS; Miyata, KN; Peng, J; Yamashita, M; Zhang, SL; Zhao, XP	1
Gan, L; Hu, X; Li, H; Li, X; Lu, Y; Meng, T; Peng, L; Tang, R; Wang, W; Xiao, C; Xiao, P; Zhou, Q	1
Dugas, CM; Franco, M; Katsurada, A; Navar, LG; Satou, R	1
Boekell, KL; Brown, BJ; Schlondorff, JS; Stotter, BR; Talbot, BE	1
Clahsen-van Groningen, MC; Cruz-López, EO; Danser, AHJ; Domenig, O; Foster, D; Garrelds, IM; Kasper, A; Nioi, P; Poglitsch, M; Ren, L; Rooney, T; Uijl, E; van Veghel, R; Zlatev, I	1
Chen, YH; Li, XT; Liang, LR; Liu, XY; Liu, Y; Miao, R; Song, JW; Zhang, MW; Zhang, ZZ; Zhong, JC	1
Du, C; He, MC; Poon, CC; Wang, NN; Wong, MS; Zhang, JL; Zhang, Y	1
Andrade, CAF; Colombari, DSA; Colombari, E; De Luca, LA; De Paula, PM; Lauar, MR; Menani, JV	1
Gómez, GI; Sáez, JC; Velarde, V	1
Hao, L; Li, X; Lyu, H; Wu, Q	1
Chen, Z; Ding, G; Fan, Y; Gao, Z; Hu, J; Huang, H; Shao, N; Wang, W; Yang, Y; Zhang, L; Zhu, W	1
Fu, D; Senouthai, S; Wang, J; You, Y	1
Han, C; Hu, H; Jiang, Y; Li, W; Liu, Y; Zhou, L	1
Barzaghi, F; Carletti, R; Castoldi, G; Colzani, M; di Gioia, CRT; Ippolito, S; Perseghin, G; Stella, A; Zerbini, G	1
Gao, W; Liu, C; Lu, G; Man, S; Wang, Y; Xiang, H; Yang, L	1
Chen, DR; Chen, HJ; Chen, XH; Gao, PJ; Kong, LR; Pan, XX; Ruan, CC; Wu, F	1
Fang, ZY; Jiang, WM; Mao, XJ; Zhang, SF	1
Chen, JX; He, X; Liu, B; Zeng, H; Zhao, Y	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Angelotti, ML; Corcoran, J; Fraser, D; Hendry, BM; Li, J; Noor, M; Papadimitriou, A; Piedagnel, R; Raby, K; Romagnani, P; Wilson, PD; Xu, Q	1
Chen, JX; Feng, X; He, X; Su, H; Zeng, H	1
Benhamou, M; Blank, U; Bratti, M; Charles, N; Daugas, E; El Ghoneimi, A; Montero-Hernández, JE; Vibhushan, S	1
Krishnan, S; Li, J; Mohandas, R; Raizada, MK; Richards, EM; Sharma, RK	1
Chen, P; Cheng, Q; Li, J; Liu, J; Lu, L; Miao, N; Ni, J; Wang, X; Wang, Y; Xie, H; Xu, D; Yin, F; Zhang, W; Zheng, P; Zhou, L; Zhou, Z	1
Feng, P; Huang, H; Kong, Y; Li, C; Li, S; Liang, B; Lin, Y; Qiu, M; Wang, W; Zhao, X; Zhu, Q	1
Abeyat, H; Behmanesh, MA; Poormoosavi, SM; Sangtarash, E	1
Chan, JSD; Chang, SY; Filep, JG; Ingelfinger, JR; Kretzler, M; Liao, MC; Lo, CS; Miyata, KN; Pang, Y; Peng, J; Zhang, SL; Zhao, S	1
Hu, C; Kohan, DE; Min Cho, J; Peterson, CS; Ramkumar, N; Stuart, D; Symons, JD; Wheatley, W	1
Dolinina, J; Öberg, CM; Rippe, A	1
Bi, X; Ding, W; Hu, C; Liu, Y; Zhang, Y	1
Benndorf, RA; Eckenstaler, R; Gekle, M; Sandori, J	1
Chen, W; Cong, C; Hu, Y; Tao, L; Wang, Y; Yuan, X	1
Alexander, B; Casarini, DE; Hassan, R; Leite, APO; Li, XC; Zheng, X; Zhuo, JL	1
Cui, Z; Fu, G; Gao, J; Li, X; Wang, M; Zhang, J; Zhang, Y	1
Castillo, A; Majid, DSA	1
Akita, K; Isobe, S; Isoda, K; Iwakura, Y; Minamino, T; Niida, T; Ohtomo, F; Sano, M; Sato-Okabayashi, Y; Shimada, K	1
Li, J; Ye, Y; Yu, WQ; Zhang, JH	1
Han, J; Huang, W; Li, W; Li, X; Liang, G; Lum, H; Shan, X; Xu, Z; Yu, W; Zou, C	1
Davidge, KN; Gonzalez, FJ; Katsurada, A; Khan, NS; Majid, DSA; Malik, KU; Navar, LG; Pingili, AK; Thirunavukkarasu, S	1
Itano, S; Kadoya, H; Kashihara, N; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A	1
Beheshti, F; Bideskan, AE; Hosseinian, S; Mohebbati, R; Motejadded, F; Rad, AK; Sadeghnia, H; Shafei, MN; Shahraki, S; Soukhtanloo, M	1
Lang, Y; Liu, Z; Shi, S; Wu, J; Xu, F; Yang, F; Yun, S; Zhang, M; Zhao, Y; Zhou, M; Zhou, X; Zhu, X	1
Bialkowska, AB; Gao, X; Gu, X; Guo, Y; He, JC; Jain, MK; Mallipattu, SK; Mei, C; Miller, T; Pace, J; Revelo, MP; Yang, VW	1
Bhattacharya, SK; Chen, Y; Lu, L; Sun, Y; Zhao, T; Zhao, W	1
Scholey, JW; Williams, VR	1
Chen, DQ; Chen, H; Chen, L; Liu, D; Wang, M; Wang, MC; Zhao, H; Zhao, YY	1
Li, H; Liang, J; Liu, L; Wang, Z; Wen, Y; Zhou, P	1
Scherer, PE; Zhu, Q	1
Cao, R; Chen, H; Guan, Y; Li, S; Liu, J; Su, W; Xu, H; Ye, S; Yu, J; Zhang, X; Zhou, Y; Zhu, C	1
Ding, G; Liang, W; Ma, Y; Yang, Q; Yang, Y; Zhang, L; Zhong, Z	1
Kobori, H; Nishiyama, A	1
Chen, DQ; Chen, H; Wang, MC; Yang, T; Yang, Y; Zhao, YY	1
Al-Shorbagy, MY; Ali, RM; El-Abhar, HS; Helmy, MW	1
Chen, WD; Gao, PJ; Han, WQ; Tang, XF; Wu, YJ; Xu, L	1
Booz, GW; Coffman, TM; Eguchi, S; Forrester, SJ; Kawai, T; Rizzo, V; Scalia, R; Sigmund, CD	1
Ebrahimzadeh Bideskan, A; Hosseinian, S; Khajavi Rad, A; Sadeghnia, HR; Samadi Noshahr, Z; Shafei, MN; Shahraki, S; Soukhtanloo, M	1
van Beusekom, CD; Zimmering, TM	1
Chen, PP; Cheng, Q; Liu, J; Lu, LM; Miao, NJ; Wang, B; Wang, XX; Wang, YZ; Xie, HY; Xu, D; Xue, H; Yin, F; Yin, JY; Zhang, W; Zhou, L; Zhou, ZL	1
Bi, X; Ding, W; Ling, L; Shen, Q	1
Llinas, MT; Martinez, CM; Moreno, JM; Oltra, L; Reverte, V; Salazar, FJ; Tapia, A	1
Batruch, I; Cardinal, H; Hébert, MJ; John, R; Jurisica, I; Kim, SJ; Konvalinka, A; Li, Y; Mohammed-Ali, Z; Reid, S; Tavares-Brum, A; Tokar, T; Yip, P	1
Ames, MK; Atkins, CE; Pitt, B	1
Bastacky, SI; Jackson, EK; Salah, E; Tofovic, SP	1
He, L; Ji, J; Tao, P	1
Huang, L; Khan, Z; Liang, G; Wang, J; Wang, Y; Xu, S; Xu, Z; Yu, W; Zou, C	1
Azushima, K; Haku, S; Haruhara, K; Ishigami, T; Kinguchi, S; Kobayashi, R; Minegishi, S; Ohki, K; Tamura, K; Uneda, K; Wakui, H; Yamaji, T; Yamashita, A	1
Okuliarova, M; Svitok, P; Varga, I; Zeman, M	1
Liu, ZF; Pang, DW; Wang, C; Wang, J; Xu, N; Zhang, ZL	1
Cheng, GJ; Hu, GY; Huang, L; Mei, WJ; Peng, ZZ; Qin, J; Tao, LJ; Xie, YY; Yuan, QJ; Yuan, XN	1
Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL	1
Danser, AH; Lu, X; Roksnoer, LC	1
Ayuzawa, N; Fujita, T; Ishizawa, K; Kawarazaki, W; Nagase, M; Takeuchi, M; Ueda, K; Yoshida, S	1
Ichikawa, I; Matsusaka, T; Niimura, F; Nishiyama, A; Pastan, I; Shintani, A	1
Benndorf, RA; Ehmke, H; Krebs, CF; Lange, S; Lehners, A; Meyer-Schwesinger, C; Niemann, G; Panzer, U; Paust, HJ; Rosendahl, A; Stahl, RA; Velden, J; Wenzel, UO	1
Čertíková Chábová, V; Červenka, L; Husková, Z; Kompanowska-Jezierska, E; Kramer, HJ; Kujal, P; Sadowski, J; Škaroupková, P; Tesař, V; Vaněčková, I; Vernerová, Z; Walkowska, A	1
Dursun, N; Kunduz Kindap, E; Ozdogan, K; Taskin, E	1
Ahmad, S; Ferrario, CM; Nagata, S; Varagic, J	1
Chen, HY; Feng, M; Huang, XR; Lan, HY; Li, YQ; Liu, GX; Meng, XM; Shi, YJ; Wei, LH; Zhang, Y	1
Cui, W; Fu, J; Maimaitiyiming, H; Norman, H; Qi, X; Wang, S; Wang, X; Zhou, Q	1
Gao, HM; Gao, YX; Kong, W; Li, G; Lu, JH; Yu, CA; Zheng, J	1
Gu, Y; Li, SZ; Zhang, LL	1
Ortiz-Melo, DI; Spurney, RF	1
Inoue, T; Ishii, N; Miyazaki, T; Nishiyama, A; Ohno, Y; Suzuki, H; Takenaka, T	1
Entman, ML; Jin, X; Wang, Y; Xia, Y; Yan, J	1
Jang, HS; Kim, JI; Noh, M; Park, KM; Rhee, MH	1
Fu, LJ; Huang, Y; Kong, YL; Liu, J; Lu, LM; Ni, J; Shao, DC; Shen, Y; Wang, Z; Xue, H; Yu, C; Zhang, W; Zhou, L	1
Arévalo, M; Docherty, NG; Eleno, N; Fuentes-Calvo, I; Grande, MT; López-Novoa, JM; Pérez-Barriocanal, F; Rodríguez-Peña, AB	1
Ahghari, P; Bakhshi, E; Esmaeili, P; Kadkhodaee, M; Ranjbaran, M; Sedaghat, Z; Seifi, B; Zahmatkesh, M	1
Chen, Y; Gu, W; Lin, ZC; Lu, Y; Ma, WG; Meng, FX; Shang, XZ; Tan, L; Wang, YN; Xu, YM	1
Choi, YK; Jeon, JH; Jung, GS; Jung, YA; Kim, HS; Kim, JG; Kim, MK; Lee, IK; Park, KG	1
Cao, H; Dai, C; Di, J; Fang, L; Jiang, L; Li, X; Wen, P; Yang, J; Zhou, Y	1
Jang, HS; Kim, J; Kim, JI; Park, JW; Park, KM	1
Yu, S	1
Gao, S; Guo, K; Huang, LL; Pan, C; Wang, HZ; Wang, XH; Yu, TT; Zhang, JY	1
Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Padda, R; Shi, Y; Zhang, SL	1
Adanur, S; Akpinar, E; Alkan, E; Bayir, Y; Cadirci, E; Ferah, I; Halici, Z; Karakus, E; Mercantepe, T; Polat, B; Ziypak, T	1
Ichikawa, I; Matsusaka, T; Miyazaki, Y; Niimura, F; Nishiyama, A; Okabe, M; Pastan, I; Yokoo, T	1
Estes, AM; Fang, XR; Gonzalez, FJ; Jennings, BL; Kanu, A; Malik, KU; Moore, JA; Pingili, AK	1
Gonzalez, AA; Prieto, MC	1
Cespedes, C; Cuevas, CA; Inestrosa, NC; Tapia-Rojas, C; Vio, CP	1
Navar, LG; Satou, R; Shao, W	1
Bonventre, JV; Fang, XR; Khan, NS; Malik, KU; Song, CY; Thirunavukkarasu, S	1
Cercek, B; Chyu, KY; Dimayuga, PC; Honjo, T; Lio, WM; Shah, PK; Trinidad, P; Yano, J; Zhao, X; Zhou, J	1
Chin, YE; Fu, L; Niu, Y; Wang, Y; Yu, C; Yu, Y	1
Arumugam, S; Karuppagounder, V; Krishnamurthy, P; Nakamura, M; Sreedhar, R; Suzuki, K; Thandavarayan, RA; Watanabe, K	1
Ding, G; Huang, S; Jia, Z; Sun, Y; Zhang, A; Zhang, Y	1
Azocar, A; Castro, PF; Chiong, M; Jalil, JE; Lavandero, S; Mendoza-Torres, E; Mondaca-Ruff, D; Ocaranza, MP; Oyarzún, A	1
Guo, J; Wong, PC; Zhang, A	1
Hu, J; Huang, Y; Liang, D; Liang, G; Peng, K; Qian, Y; Qiu, C; Skibba, M; Wang, Y; Xu, Z; Zhang, Y; Zou, C	1
Hernández-Fonseca, JP; Mosquera, J; Pedreañez, A; Peña, C; Viera, N	1
Bae, EH; Kim, CS; Kim, IJ; Kim, SW; Lee, J; Ma, SK	1
Kruzliak, P; Soucek, M; Suzuki, E; Takahashi, H; Uehara, Y; Wu, Y	1
Chen, S; Levi, M; Li, C; Lin, Y; Luo, R; Wang, F; Wang, W; Yang, T; Zheng, P	1
Fang, P; Geng, J; Li, Z; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Wang, Y; Zhang, Q	1
Gan, X; Lu, L; Miao, N; Shen, Y; Xu, D; Xu, J; Xue, H; Zhang, W; Zhou, L	1
Brand, DD; Gonzalez, FJ; Kara, M; Katsurada, A; Majid, DS; Malik, KU; Navar, LG; Pingili, AK; Thirunavukkarasu, S	1
Gan, XX; Lu, LM; Miao, NJ; Shen, Y; Xu, D; Xu, JL; Xue, H; Zhang, W; Zhou, L	1
Duerrschmid, C; Entman, ML; Haudek, SB; Mayr, M; Medrano, G; Taffet, GE; Wang, Y	1
Abd-Elrahman, KS; Boisvert, NC; Carter, A; Cron, GO; Ferguson, SS; He, Y; Holterman, CE; Hsu, KJ; Kennedy, CR; Thibodeau, JF	1
Cao, S; Fan, J; Li, H; Mao, H; Peng, X; Wang, Y; Xiong, L; Yu, X; Zhuang, S	1
Allen, TJ; Chow, BS	1
Kagami, S; Urushihara, M	1
Liu, B; Liu, H; Liu, Y; Lv, L; Ma, K; Tang, T; Wen, Y	1
Buckley, AF; Crowley, SD; Griffiths, R; Gunn, MD; Jeffs, AD; Kan, MJ; Karlovich, NS; Patel, MB; Rudemiller, NP; Zhang, JD	1
Baek, CH; Chang, JW; Kim, H; Lee, RB; Lee, SK; Yang, WS	1
Huang, J; Liu, X; Lu, L; Niu, Y; Wang, Y; Yu, C; Yu, Y; Zhao, L; Zhou, L	1
Danser, AH; de Bruyn, JH; Derkx, FH; Krop, M	1
Cartier, C; Carvajal, G; Egido, J; Esteban, V; Mezzano, SA; Ortiz, A; Rodrigues-Díez, R; Rodríguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Schiffrin, EL	1
Fisher, ND; Patel, TV; Williams, GH	1
Block, K; Eid, A; Gorin, Y; Griendling, KK; Lee, DY; Wittrant, Y	1
Daniel, C	1
Blantz, RC; Deng, A; Satriano, J; Singh, P; Tang, T; Thomson, SC; Wang, C	1
Chen, K; Cui, WY; Liu, GS; Long, CL; Pan, ZY; Qin, XC; Wang, H; Zhang, YF	1
Liu, XP; Pang, YJ; Sun, SJ; Sun, ZJ; Wang, YB; Zhao, TT; Zheng, M; Zhu, WW	1
Schindler, C	1
Gao, J; Li, Q; Liu, BC; Xu, LM	1
Brown, NJ; Fogo, AB; Fowler, SM; Kwak, ES; Lea, WB; Luther, JM; Ma, J; Wang, Z	1
Doller, A; Eberhardt, W; Gauer, S; Geiger, H; Pfeilschifter, J; Sobkowiak, E	1
Cao, C; Pallone, TL; Patzak, A; Persson, AE; Persson, PB; Sendeski, M	1
Budge, H; Fainberg, HP; Gardner, DS; Harvey, E; Sharkey, D; Symonds, ME; Wilson, V	1
Fukuda, K; Ieda, M; Kikuchi, E; Kosaka, T; Kozakai, N; Miyajima, A; Ohigashi, T; Oya, M; Uchida, Y	1
Berden, JH; Kramer, AB; Navis, G; Rops, AL; van den Hoven, MJ; van der Vlag, J; van Goor, H; Waanders, F	1
Boie, Y; Kennedy, BP; Melnyk, RA; Percival, MD; Tam, J	1
Duan, SB; Liu, FY; Peng, YM; Wang, P; Wang, YH; Xu, XQ; Zou, Q	1
Abdi, R; Azzi, J; Geara, AS; Jurewicz, M	1
Siragy, HM	3
Chang, YS; Chung, HW; Chung, S; Kim, HW; Lee, JH; Lim, JH; Park, CW; Shin, SJ; Youn, DY	1
Chung, AC; Huang, XR; Lan, HY; Yang, F	1
Hao, LY; Hao, XQ; Li, XH; Yang, DL; Yuan, ZB; Zhang, HG	1
Fogo, AB; Han, JY; Kon, V; Ma, LJ; Naito, T; Tang, Y; Yang, H; Zuo, Y	1
Bledsoe, G; Chao, J; Chao, L; Hagiwara, M; Liu, Y; Shen, B; Yang, ZR	1
Burns, KD; Dilauro, M; Genest, D; Robertson, SJ; Zimpelmann, J	1
Azegami, T; Hayashi, K; Ishiguro, K; Itoh, H; Sakamaki, Y; Sasamura, H	1
Kobori, H	1
Loriga, G	1
Bruneval, P; Campbell, DJ; Karam, H; Ménard, J; Mullins, JJ	1
Patzak, A; Persson, PB; Sendeski, M	1
Chung, AC; Hou, CC; Huang, XR; Lai, KN; Lan, HY; Yang, F	1
Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H	1
Ghee, JY; Han, DH; Kim, S; Kobori, H; Kuro-o, M; Ohashi, N; Piao, S; Song, JH; Yang, CW; Yoon, HE	1
Aizawa, Y; Arozal, W; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K	1
Burns, WC; Thomas, MC	1
Arribas, I; Bosch, RJ; Bover, J; Esbrit, P; Izquierdo, A; Ortega, A	1
Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Narita, T; Nishiyama, A; Ohshima, Y; Ryuzaki, M; Sakoda, M	1
Lee, HS	1
Kim, HJ; Rodríguez-Iturbe, B; Sato, T; Vaziri, ND	1
Abdulla, MH; Abdullah, NA; Johns, EJ; Khan, MA; Sattar, MA	1
Dai, Y; Kellems, RE; Wen, J; Xia, Y; Zhang, W; Zhang, Y	1
Dimarakis, I; Koumallos, N; Nteliopoulos, G; Paschalis, A; Yonan, N	1
Fanelli, C; Fernandes, BH; Fujihara, CK; Machado, FG; Malheiros, DM; Okabe, C; Zatz, R	1
Li, XC; Zhuo, JL	2
Nordquist, L; Palm, F	1
Bakker, M; Berden, JH; Bindels, RJ; de Boer, RA; Faul, C; Flesche, J; Hamming, I; Hoenderop, JG; Kistler, AD; Möller, CC; Navis, G; Nijenhuis, T; Reiser, J; Sloan, AJ; van der Vlag, J; van Goor, H; Wetzels, JF	1
Abbate, A; Dhaduk, R; Li, N; Li, PL; Van Tassell, BW; Wang, Z; Xia, M; Zhu, Q	1
Brazin, JA; Chen, J; Estephan, R; Felsen, D; Kameue, T; Maack, T; Mora, R; O'Connor, N; Poppas, DP; Reid, AC; Seshan, SV; Silver, RB; Veerappan, A	1
Eguchi, S; Fujigaki, Y; Hishida, A; Suzuki, H; Yamamoto, T	1
Bellini, G; Bernardi, S; Fabris, B; Fallo, F; Johnston, CI; Losurdo, P; Monticone, S; Thomas, MC; Tikellis, C; Toffoli, B; Veglio, F; Zennaro, C	1
Gonzalez, AA; Green, T; Mitchell, KD; Navar, LG	1
Barrick, CJ; Caron, KM; Dackor, RT; Lenhart, PM; Nagle, E	1
Kagami, S	1
Huang, XR; Lan, HY; Liu, Z	1
Balarini, CM; Baldo, MP; Casarini, DE; Meyrelles, SS; Nogueira, BV; Palomino, Z; Pereira, TM; Porto, ML; Vasquez, EC	1
Afonso, J; Albino-Teixeira, A; Carvalho, F; Fraga, S; Morato, M; Oliveira, S; Patinha, D; Sousa, T	1
Barrett, PQ; Guagliardo, NA; Hu, C; Rusin, CG; Tan, Z	1
Brown, NJ; Cohen, SE; Fogo, AB; Kim, HS; Luo, P; Luther, JM; Wang, Z	1
Fujii, N; Hamano, T; Hirata, M; Inoue, K; Isaka, Y; Kusunoki, Y; Matsui, I; Nakano, C; Nishiyama, A; Rakugi, H; Shimomura, A; Takabatake, Y; Tsubakihara, Y	1
Brem, AS	1
Mitsuyama, S	1
Chen, GC; Duan, SB; Liu, GL; Pan, P; Wang, P; Xu, XQ	1
Loria, AS; Pollock, DM; Pollock, JS; Yamamoto, T	1
Ohishi, M; Rakugi, H; Yamamoto, K	1
Chen, HY; Heuchel, RL; Huang, XR; Lan, HY; Li, YQ; Liu, GX; Shi, YJ; Wei, L	1
Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H	1
Mansoor, GA; Thavarajah, S	1
Devonald, MA; Karet, FE	1
Benigni, A; Donadoni, C; Fassi, A; Gagliardini, E; Lepre, MS; Remuzzi, A; Remuzzi, G; Sangalli, F	1
Fujihara, CK; Zatz, R	1
Aros, C; Remuzzi, G	1
Dechend, R; Fiebeler, A; Finckenberg, P; Haller, H; Hampich, F; Heidecke, H; Ju, X; Kreuzer, J; Luft, FC; Mervaala, E; Muller, DN; Park, JK; Shagdarsuren, E; Theuer, J; Viedt, C; Zenke, M	1
Doggrell, SA	1
Fakhry, I; Gehr, TW; Ghosh, S; Haas, M; Quigg, RJ; Schoolwerth, AC; Sica, D	1
Griendling, KK; Hanna, IR; Rocic, P; Szöcs, K; Taniyama, Y	1
Ahn, HJ; Bang, BK; Cha, JH; Jung, JY; Kim, J; Kim, WY; Kim, YS; Li, C; Yang, CW; Yoon, SA	1
Eisner, GM; Felder, RA; Jose, PA	1
Goto, A	1
Alebiosu, CO	1
Burnett, JC; Cataliotti, A; Chen, HH; Nordstrom, LJ; Redfield, MM	1
deS Senanayake, P; Gomos, JB; Kessler, SP; Rowe, TM; Scheidemantel, TS; Sen, GC	1
Egido, J; Gomez-Guerrero, C; Ruiz-Ortega, M; Suzuki, Y; Tomino, Y	1
Ardiles, L; Egido, J; Esteban, V; Justo, P; Mezzano, S; Ortiz, A; Ruiz-Ortega, M; Ruperez, M; Suzuki, Y	1
KAPLAN, NM; SILAH, JG	1
ITSKOVITZ, HD; MCGIFF, JC	1
Raij, L	2
Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR	1
Remuzzi, G; Schieppati, A	2
Cheng, ZJ; Finckenberg, P; Helkamaa, T; Lapatto, R; Louhelainen, M; Luft, FC; Männistö, P; Merasto, S; Mervaala, EM; Müller, DN; Rauhala, P; Reenilä, I	1
Arai, Y; Fukuzaki, A; Ishidoya, S; Kaneto, H; Nakagawa, H; Ogata, Y; Orikasa, S; Takeda, A	1
Cao, B; Feng, QH; Li, S; Li, XZ	1
Barbosa-Sicard, E; Dechend, R; Fiebeler, A; Haller, H; Honeck, H; Kaergel, E; Kirsch, T; Luft, FC; Markovic, M; Muller, DN; Park, JK; Rothe, M; Schunck, WH; Shagdarsuren, E; Theuer, J; Wellner, M	1
Banas, B; Fiebeler, A; Haller, H; Lindschau, C; Luft, FC; Mengel, M; Merkel, S; Muller, DN; Park, JK	1
Herrera-Acosta, J; Johnson, RJ; Long, DA; Price, KL	1
Wenzel, UO; Wolf, G	1
Agarwal, R; Campbell, RC; Warnock, DG	1
Benigni, A; Gagliardini, E; Remuzzi, G	1
Ruggenenti, P	1
de Nucci, G; Fujihara, CK; Gonçalves, AR; Malheiros, DM; Mattar, AL; Noronha, Ide L; Zatz, R	1
Blanco, J; Egido, J; Esteban, V; Kretzler, M; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Rupérez, M; Sugaya, T; Suzuki, Y	1
Iigaya, K; Kumagai, H; Onami, T; Saruta, T; Takimoto, C	1
Azizi, M; Ménard, J	1
Coyle, JD; Gardner, SF; White, CM	1
Calò, LA; Davis, PA; Pagnin, E; Pessina, AC; Sartori, M; Semplicini, A	1
Epstein, BJ	1
Ishizaka, N; Mori, I; Nagai, R; Noiri, E; Ohno, M; Saito, K; Sata, M	1
Campo, C; Ruilope, LM; Segura, J	1
Bertsche, T; Schulz, M	1
Ritz, E; Wolf, G	1
Meldrum, KK; Misseri, R	1
Burnier, M; Maillard, M; Meier, P	1
Itakura, A; Ito, T; Kikkawa, F; Kobayashi, H; Mitsui, T; Mizutani, S; Nomura, M; Nomura, S; Suzuki, M	1
Kobori, H; Nishiyama, A; Ozawa, Y; Suzaki, Y	1
Chan, LY; Choy, CB; Lai, KN; Leung, JC; Tang, SC	1
Al-Saadi, N; Dechend, R; Fiebeler, A; Hilfenhaus, G; Jeng, AY; Luft, FC; Maser-Gluth, C; Meiners, S; Muller, DN; Nussberger, J; Rong, S; Shagdarsuren, E; Webb, RL; Wellner, M	1
Adams, JW; Bernstein, KE; Frenzel, K; Fuchs, S; Li, P; Shen, XZ; Xiao, HD	1
Pool, JL	1
Fang, Y; He, L; Li, JN; Liu, P; Liu, ZQ; Wang, Y; Ye, F; Ye, T; Zheng, Y	1
Alili, R; Burtin, M; Friedlander, G; Lautrette, A; Lee, DC; Li, S; Sunnarborg, SW; Terzi, F	1
Liu, GS; Wang, H; Xue, H; Zhang, YL	1
Wolf, G	8
Barnes, JL; Faulkner, JL; Springer, F; Szcykalski, LM	1
Carvajal, G; Egido, J; Esteban, V; Rodríguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ	1
Blanco-Colio, LM; Egido, J; Esteban, V; Plaza, JJ; Rodríguez-Vita, J; Ruiz-Ortega, M; Rupérez, M; Sánchez-López, E	1
Gelosa, P; Gianella, A; Nobili, E; Sironi, L; Tremoli, E	1
Kida, Y	1
Hayashi, K; Homma, K; Kanda, T; Saruta, T; Sugano, N; Wakino, S	1
Cowley, AW; Ito, S; Mori, T	1
Gaedeke, J; Neumayer, HH; Peters, H	1
Catt, KJ; Shah, BH	1
Chen, J; Chen, JK; Harris, RC; Neilson, EG	1
Gillin, A; Harris, D; Johnson, D; Nicholls, K; Thomas, M	1
Backx, PH; Crackower, MA; Herzenberg, AM; Kassiri, Z; Khokha, R; Oudit, GY; Penninger, JM; Reich, H; Scholey, JW; Wong, D	1
Hirokoshi, K; Ichinose, K; Kitayama, H; Maeshima, Y; Makino, H; Sugiyama, H; Takazawa, Y; Wu, Y; Yamamoto, Y; Yamasaki, Y	1
Chappell, MC; Westwood, BM; Yamaleyeva, LM	1
Nickenig, G; Ostergren, J; Struijker-Boudier, H	1
Fujita, K; Funahashi, T; Hibuse, T; Hiuge, A; Kihara, S; Kumada, M; Kurata, A; Kuriyama, H; Maeda, N; Nishizawa, H; Ohashi, K; Okada, T; Shimomura, I; Sonoda, M; Yasui, A	1
Hostetter, TH; Rosenberg, ME	1
Cohn, JN	1
Al-Saadi, N; Dechend, R; Feldt, S; Fiebeler, A; Fischer, R; Gapeljuk, A; Gratze, P; Haller, H; Luft, FC; Madwed, JB; Meiners, S; Muller, DN; Park, JK; Schirdewan, A; Shagdarsuren, E; Wellner, M	1
Chatziantoniou, C; Dussaule, JC	1
Border, WA; Huang, Y; Noble, NA	1
Bravo, Y; Ferrebuz, A; Quiroz, Y; Rodríguez-Iturbe, B; Vaziri, ND	1
Dechend, R; Dietz, R; Gross, V; Henke, N; Luft, FC; Muller, DN; Obst, M; Park, JK; Qadri, F; Scheidereit, C; Schmidt-Ullrich, R; Wellner, M	1
Cooper, SA; Habibi, J; Lastra, G; Manrique, C; Sowers, JR; Stas, S; Wei, Y; Whaley-Connell, A	1
Chappell, MC; Gallagher, PE; Groban, L; Pendergrass, KD; Pirro, NT; Yamaleyeva, LM	1
Adrogue, HJ; Huang, XR; Lan, HY; Soltero, L; Wang, W; Zhang, P	1
Cohen, EP; Fish, BL; Li, XA; Moulder, JE; Sharma, M	1
Guzik, TJ; Harrison, DG	1
Sachse, A; Wolf, G	1
Boesen, EI; Hair, CD; Mintz, JD; Pollock, DM; Stepp, DW; Sullivan, JC	1
Kobori, H; Nangaku, M; Navar, LG; Nishiyama, A	1
Burrell, LM; Dean, RG	1
Müller, DN	1
Chou, JY; Mansfield, BC; Pan, CJ; Peng, WT; Ruef, RA; Starost, MF; Yiu, WH	1
Blantz, RC; Deng, A; Singh, P; Weir, MR	1
Sullivan, JC	1
Fujita, T; Nangaku, M	1
Batlle, D; González-Pacheco, FR; Wysocki, J	1
Liu, Y; Meng, QH; Wang, L; Zhu, S	1
Chander, PN; Chun, TY; Kim, JW; Pratt, JH; Stier, CT	1
Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M	1
Wilkinson, R	1
Limone, P; Molinatti, GM	1
Rösler, A	1
Beretta-Piccoli, C; Reubi, FC; Schiffl, H; Weidmann, P	1
Beretta-Piccoli, C; Cottier, C; Schiffl, H; Seiler, AJ; Weidmann, P; Ziegler, WH	1
Hummerich, W; Konrads, A; Meurer, KA; Vlaho, M	1
Bahlmann, J; Brod, J; Cachovan, M; Hubrich, W; Pretschner, D	1
Giese, J; Kappelgaard, AM; Lund, JO; Tønnesen, KH	1
Wilson, DR	1
Ekelund, L	1
Ayano, Y; Mutoh, S; Sakanashi, M; Ueda, S; Yano, S	1
Harris, RH; Schocken, DD; Yarger, WE	1
Harris, PJ	1
Harris, RC; Martinez-Maldonado, M	1
Ishidoya, S; Klahr, S; Morrissey, J	1
Border, WA; Ketteler, M; Noble, NA	1
Alcázar, R; Bustos, C; Egido, J; Gómez-Garre, D; González, E; González, S; Palacios, I; Plaza, JJ; Ruíz-Ortega, M	1
Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T	1
Fogo, A	1
Adams, MA; Bobik, A; Bohman, SO; Friberg, P; Gustafsson, H; Nilsson, H; Petersen, J; Sundelin, B; Wickman, A	1
Bakris, GL; Riley, DJ; Weir, M	1
Schlondorff, D	1
Cofán, F; Romero, R	1
Chao, J; Dipp, S; el-Dahr, SS; Gee, J; Hanss, BG; Vari, RC	1
Kopp, JB; Martínez-Maldonado, M; Montero, A; Pimentel, JL; Sundell, CL; Wang, S	1
Alpers, CE; Andoh, TF; Bennett, WM; Burdmann, EA; Couser, WG; Franceschini, N; Hugo, C; Pichler, RH; Shankland, SJ; Young, BA	1
Heidland, A; Ling, H; Paczek, L; Vamvakas, S	1
Greene, EL; Hostetter, TH; Kren, S	1
Dondi, M; Fanti, S; Monetti, N	1
Hymes, J; Ichikawa, I; Matsusaka, T	1
Krasnikova, TL	1
Hilgers, KF; Mann, JF	1
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD	1
Mohamed, EI; Remuzzi, A	1
Abe, K; Kanazawa, M; Kohzuki, M; Sato, T; Yasujima, M; Yoshida, K	1
Ichikawa, I; Matsusaka, T	1
Arai, Y; Asano, M; Honda, K; Inagaki, O; Kasai-Nakagawa, C; Takanashi, M; Takenaka, T; Takizawa, K; Tanaka, A; Uchida, W; Yatsu, T	1
Baldoncini, R; Bellini, C; De Angelis, C; Desideri, G; Ferri, C; Santucci, A	1
Border, WA; Noble, NA; Peters, H	1
Andoh, TF; Bennett, WM; Shihab, FS; Tanner, AM	1
Hostetter, TH; Ibrahim, HN; Rosenberg, ME	1
Wolf, G; Ziyadeh, FN	1
Border, WA; Noble, NA	3
Gouyon, JB; Guignard, JP; Huet, F	1
Aguilar, M; Andujar, M; Arrebola, F; del Moral, RG; García-Chicano, MJ; Gómez-Morales, M; Guillén, M; Masseroli, M; Nogales, FF; O'Valle, F; Olmo, A; Ramírez, C	1
Johnston, CI; Tikkanen, I	1
Bakris, GL; Tarif, N	1
Klahr, S; Morrissey, JJ	1
Anarat, A; Anarat, R; Duman, N; Kibar, M; Noyan, A	1
Klahr, S; Morrissey, J	1
Hayashi, S; Higaki, J; Kato, S; Kida, I; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Ogihara, T; Tomita, N; Yamamoto, K; Yo, Y	1
Dimitrov, Y; Hannedouche, T; Muller, S	1
Daemen, MJ; de Leeuw, PW; Geraedts, JP; Kroon, AA; Spiering, W; Vreugdenhil, HA	1
Cohen, EP; Fish, BL; Moulder, JE	1
Perico, N; Remuzzi, G	1
Benigni, A; Remuzzi, G	2
Gibbons, GH	1
Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K; Takenaka, T	1
Moreau, P	1
Fukamizu, A; Ishikawa, K; Kai, T; Kurooka, A; Murakami, K; Shimada, S; Sugimura, K; Takenaka, T	1
Stroth, U; Unger, T	1
McInnes, GT	1
Mann, JF	1
Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Sugimura, K	1
Foroncewicz, B; Mucha, K; Paczek, L	1
Ishimitsu, T; Matsuoka, H; Ono, H; Teranishi, M	1
Fogo, A; Hohenfellner, K; Kon, V	1
Buter, H; de Jong, PE; de Zeeuw, D; Navis, GY; Woittiez, AJ	1
Fogo, A; Ichikawa, I; Miyazaki, Y; Tsuchida, S	1
Cohen, EP; Datta, PK; Fish, BL; Lianos, EA; Moulder, JE	2
Cerullo, G; Colucci, M; Gesualdo, L; Grandaliano, G; Monno, R; Ranieri, E; Rossiello, MR; Schena, FP; Semeraro, N; Ursi, M	1
Inoshita, S; Ito, H; Kuwahara, M; Marumo, F; Nakashima, O; Sasaki, S; Tamamori, M; Terada, Y	1
Bennett, WM	1
Luft, FC	2
Stahl, RA; Wolf, G; Ziyadeh, FN	1
Derrien, A; Harada, S; Jarett, L; Smith, JA; Solow, BT	1
Peters, H; Ritz, E	1
Blantz, RC	1
Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Theuer, J	1
Iwao, H; Kim, S	1
Baroni, EA; Coimbra, TM; Costa, RS; da Silva, CG	1
Brenner, BM; Taal, MW	1
Ramires, FJ; Sun, Y; Zhang, J; Zhang, JQ	1
Inada, Y; Naka, T	1
Meyer, TW	1
Benck, U; Orth, SR; Ritz, E	1
Caridi, G; Ghiggeri, GM; Gusmano, R; Musante, L; Oleggini, R; Ravazzolo, R	1
Jones, EA; Shahed, A; Shoskes, DA	1
Henrich, WL; Weir, MR	1
Bianchetti, MG; Teuffel, O; von Vigier, RO; Zberg, PM	1
Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A	1
Adam, A; Blais, C; Loute, G	1
de La Sierra, A; Ruilope, LM	1
Deutsch, P; Ianosi-Irimie, M	1
Ji, H; Sandberg, K	1
Flack, JM	1
Antus, B; Mucsi, I; Rosivall, L	1
Berk, BC; Haendeler, J	1
Ardaillou, R; Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Tharaux, PL	1
Doyle, S; Kurtzberg, L; Ledbetter, S; Pratt, BM	1
Ichikawa, I; Katori, H; Matsusaka, T; Miyazaki, Y; Niimura, F	1
Łapiński, R	1
Johnson, RJ; Lombardi, DM; Saavedra, JM; Schwartz, SM; Vio, CP; Viswanathan, M	1
Benigni, A; Perico, N; Remuzzi, G	1
Cooper, ME; de Gasparo, M; Webb, RL	1
Ramahi, TM	1
Beshara, G; Ghali, R; Sabra, R; Serhal, H; Sharaf, LH; Zeinoun, N	1
Brunner, HR	1
Martínez-Maldonado, M	1
Epstein, M	2
Breu, V; Dechend, R; Dietz, R; Elger, M; Fiebeler, A; Ganten, D; Haller, H; Hampich, F; Heissmeyer, V; Luft, FC; Muller, DN; Park, JK; Pilz, B; Scheidereit, C; Schroer, K; Shagdarsuren, E; Theuer, J	1
Shestakova, MV	1
Hollenberg, NK	1
Gordon, KL; Hughes, J; Johnson, RJ; Kim, YG; Mazzali, M; Phillips, MI; Raleigh, JA; Ray, PE; Suga, SI; Vio, CP	1
Egido, J; Mezzano, SA; Ruiz-Ortega, M	1
Egido, J; Esteban, V; Lorenzo, O; Mezzano, S; Ruiz-Ortega, M; Rupérez, M	1
Border, WA; Gaedeke, J; Noble, NA; Peters, H	1
Galle, J; Quaschning, T	1
Cachat, F; Chevalier, RL	1
Gesualdo, L; Grandaliano, G; Schena, FP	1
Border, WA; Noble, N	1
Hostetter, TH; Ibrahim, HN; Juknevicius, I; Rosenberg, ME	1
de Zeeuw, D	1
Fujihara, CK; Noronha, IL; Zatz, R	1
Thurston, H	1
Dudley, J; Gardner, A; Johnston, A; McGraw, M	1
Border, WA; Noble, NA; Yu, L	1
Dodic, M; Moritz, KM; Wintour, EM	1
Gouyon, JB; Guignard, JP; Huet, F; Prévot, A; Semama, DS	1
Fervenza, FC; Rabkin, R	1
de Jong, PE; de Jong-van den Berg, LT; Donker, AJ; Statius van Eps, LW	1
Swales, JD	1
Sparks, JC; Susic, D	1
Maxwell, MH; Weidmann, P	1
Case, DB; Drayer, JI; Keim, HJ; Laragh, JH; Sealey, JE; Wallace, JM; Weber, MA; White, RP	1
Benoit, G	1
Mitch, WE; Zacur, HA	1
Epstien, M	1
Dunn, MJ; Hood, VL	1
Oelkers, W	1
Pal'tsev, MA; Serov, VV	1
Bönner, G; Helber, A; Hummerich, W; Meurer, KA; Moritz, G	1
Beevers, DG; Brown, JJ; Davies, DL; Ferriss, JB; Fraser, R; Lever, AF; Mason, P; Neville, AM; Robertson, JI	1
Seino, M	1
Haberland, GL	1
Novak, D; Weber, J	1
Reubi, F; Weidmann, P	1
Werning, C	1
Carpi, A; Donato, L; Palla, R; Puntoni, R	1
Thiele, KG	1
Berg, S; Spark, RF	1
During, R; Kyank, H; Neumayer, E	1
Batterman, B; Fitz, A; Stegman, MR	1
Hall, JE; Young, DB	1
Cottier, P	1
Peart, WS	1
Beevers, DG; Brown, JJ; Fraser, R; Lever, AF; Morton, JJ; Robertson, JI; Semple, PF; Tree, M	1
Materson, BJ; Perez-Stable, EC	1
Abe, K; Aoyagi, H; Irokawa, N; Memezawa, H; Yasujima, M	1
Lindop, G; Morton, JJ; Padfield, PL; Timbury, GC	1
Russell, SB	1
DeClue, JW; Guyton, AC; Hall, JE; Trippodo, N; Young, DB	1
Campbell, DJ; Skinner, SL	1
Ahmed, M; Nuttall, FQ; Priest, JN	1
Giese, J; Kappelgaard, AM; Nielsen, MD	1
Camargo, MJ; Campbell, WG; Laragh, JH; Mueller, FB; Sealey, JE; Timmermans, PB; von Lutterotti, N	1
Dunn, MJ	1
Masuyama, Y; Ueno, Y	1
Debusmann, ER; Grötsch, H; Irmisch, R; Jane, F; Lahn, W; Mora, J; Ocón-Pujadas, J	1
Bailey, RR; Swainson, CP; Walker, RJ	1
Edwards, CR; Padfield, PL	1
Eiskjaer, H; Jespersen, B; Pedersen, EB; Rasmussen, LM	1
Ichikawa, I; Kon, V	1
Kokko, JP	1
Bauer, JH; Reams, GP	1
Cobden, I; Record, CO; Shore, A; Wilkinson, R	1
Dunn, MJ; Scharschmidt, L; Simonson, M	1
Cade, R; Hawkins, R; Hood-Lewis, D; Mars, D; Peterson, J; Privette, M; Raulerson, D; Schlein, E; Vogel, S; Wagemaker, H	1
Arbeit, LA; Devarajan, P; Kaskel, FJ; Moore, LC; Partin, JS	1
Seyberth, HW	1
Dillon, MJ	1
Hänze, S; Pierach, CA; Stark, G	1
Berlyne, GM; Cooper, M; Janabi, K; Nilwarangkur, S	1
Del Greco, F; Roguska, J; Simon, NM	1
Carroll, R; Kovács, K; Tapp, E	1
Itskovitz, HD; Murphy, JJ; Schoenberg, HW	1
Creditor, MC; Loschky, UK	1
Aparicio, M; Martin-Dupont, C; Wone, C	1
Beilin, LJ; Crane, M; Nelson, DH; Schiffman, N	1
Georgescu, P; Nicolescu, D; Papadopol, S	1
Kawabe, K; Sokabe, H	1
de Sousa, RC; Godard, C; Mégevand, A; Muller, AF	1
Scheitlin, WA	1
Klapproth, HJ	1
Rulli, V; Tria, E	1
Klaus, D	1
Brodehl, J; Gellissen, K	1
Brackett, NC; Koppel, M; Nixon, WP; Randall, RE	1
Gomez, J; McCabe, RE; Zintel, HA	1
Altman, KA	1
Bourgoignie, J; Catanzaro, F; Perry, HM; Serirat, P	1
Gerasimova, EN; Markov, KhM; Pal, S	1
Gross, F	1
Czekala, Z; Kiecoń, I; Kokot, F; Kuska, J	1
Brown, H; Deleña, S; Fleischer, N; Graham, DY	1
Zosin, C	1
Fukuda, T; Honda, H; Kobayashi, H; Miyama, S; Tanaka, T	1
Markov, KhM	1
Edis, AJ; Shepherd, JT	1
Baldus, WP; Barnardo, DE; Strong, CG; Summerskill, WH	1
Barjon, P	1
Koletsky, S; Rivera-Velez, JM	1
Sims, EA	1
Ancona, E; Borsatti, A; Corsini, A; Lechi, A; Oselladore, D; Spina, GS	1
Bailey, JD; Balis, JU; Hartroft, P; Lynch, MJ; Sutherland, LE	1
Brown, JJ; Cost, WS; Desmit, EM; Fraser, R; Lever, AF; Robertson, JI	1
Grollman, A	1
Condorelli, M; Critelli, G; Peschle, C; Rengo, F; Santucci, A; Tallarida, G	1
Best, JB; Cain, MD; Catt, KJ; Coghlan, JP; Cran, E; Zimmet, PZ	1
Kaplan, NM	1
Beroniade, V; Cărnaru, S; Lugojan, R; Osiescu, J; P2AU6SESCU, E; Rădulescu, C	1
Hoobler, SW; Romero, JC	1
Janukowicz-Lorenz, H; Lorenz, J; Skóra, K	1
Arant, BS; Brackett, NC; Still, WJ; Young, RB	1
Hayden, J; Targett, MA	1
Aso, Y; Kawabe, K; Nakauchi, K; Takayasu, H	1
Fukuchi, S	1
Boyd, GW; Peart, WS	1
Bayard, F; Beitins, IZ; Cooke, CR; Kowarski, A; Migeon, CJ; Tiller, DJ; Walker, WG	1
Cottier, P; Reubi, F; Veyrat, R; Wettstein, R	1
Pulver, W; Schmid, HJ	1
Spitzer, A	1
Laragh, JH	1
Feldner, H; Giessauf, W; Kratochvil, K; Pogglitsch, H; Stöckl, G	1
Feldner, H; Giessauf, W; Oser, W; Pogglitsch, H; Stöckl, G	1
White, MG	1
Burmeister, H; Ruiz-Torres, A	1
Chkalova, IP; Paleeva, FM; Serebrovskaia, IuA; Uchitel', IA	1
Deilmann, W; Gross, F; Lamprecht, F; Ziegler, M	1
Baer, L; Brunner, HR; Buhler, FR; Laragh, JH; Sealey, JE; Vaughan, ED	1
Bernard, J; Fournier, A; Girard, J; Laval-Jeantet, M; Milliez, P; Plainfossé, MC; Safar, M; Weil, B	1
Kuhlmann, U; Schweikert, HU; Siegenthaler, W; Stadelmann, O; Stiel, D; Trübestein, GK; Werning, C	1
Feldman, BH; Fraley, EE	1
Ekelund, L; Göthlin, J; Lunderquist, A	1
Eisalo, A; Fyhrquist, F; Kala, R	1
Keane, PM; Smith, EK; Speed, JF; Viol, GW	1
Broyer, M; Godard, C; Royer, P; Vallotton, MB	1
Blosser, N; Corson, M; Jackson, GL; Tyler, D	1
Fourcade, JC; Guyton, AC; Navar, LG	1
Benderli, A; Better, OS; Chaimovitz, C; Levi, J; Oslander, L	1
Chaudhury, RR; Chhuttani, PN; Chugh, KS; Vohra, SK	1
Kincaid-Smith, P	1
Ferris, TF; Stein, JH	1
Aurell, M; Jonsson, S; Vikgren, P	1
Gantt, C; Grossman, A; Ramanathan, K	1
Speroff, L	1
Gabrilove, JL; Krakoff, LR; Modlinger, RS; Nicolis, GL	1
Erkelens, DW; Statius van Eps, LW	1
Baldini, G; Bani, E; Bottone, E; Macchia, PA	1
Cousins, MJ; Mazze, RI	1
Sarre, H	1
Berman, LB; Vertes, V	1
Goodfriend, TL; Heber, D; Uehling, D	1
Bernard, A; Deheneffe, J	1
Distler, A	1
Cristodorescu, R; Deutsch, G; Drugărin, D; Gavrilescu, M; Gavrilescu, S; Nubert, G; Pop, T; Streian, C	1
Momose, G; Nakada, T; Shigematsu, H; Tateno, Y; Yoshida, T	1
Jorgensen, H; Sundsfjord, JA	1
Basso, N; de la Riva, IJ	1
Corman, J; Ishikawa, M; Iwatsuki, S; Popovtzer, M; Starzl, TE	1

Reviews

189 review(s) available for angiotensin ii and Kidney Diseases

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Mast Cell Chymase and Kidney Disease. International journal of molecular sciences, 2020, Dec-30, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Biomarkers; Chymases; Disease Management; Disease Susceptibility; Humans; Kidney Diseases; Mast Cells; Molecular Targeted Therapy; Nephritis; Serine Proteinase Inhibitors	2020
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases. Clinical science (London, England : 1979), 2021, 01-15, Volume: 135, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Heart Diseases; Humans; Kidney Diseases; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2	2021
Angiotensin II receptor type 1 - An update on structure, expression and pathology. Biochemical pharmacology, 2021, Volume: 192 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Gene Expression; Humans; Kidney Diseases; Protein Structure, Secondary; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2021
Angiotensin-converting enzyme 2 and renal disease. Current opinion in nephrology and hypertension, 2018, Volume: 27, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus; Fibrosis; Humans; Inflammation; Kidney; Kidney Diseases; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2018
Immunologic and endocrine functions of adipose tissue: implications for kidney disease. Nature reviews. Nephrology, 2018, Volume: 14, Issue:2 Topics: Adipokines; Adiponectin; Adipose Tissue; AMP-Activated Protein Kinases; Angiotensin II; Angiotensinogen; Ceramidases; Diabetes Mellitus, Type 2; Humans; Inflammation; Kidney Diseases; Leptin; Macrophages; Obesity; Receptors, Adiponectin; Signal Transduction	2018
Independent regulation of renin-angiotensin-aldosterone system in the kidney. Clinical and experimental nephrology, 2018, Volume: 22, Issue:6 Topics: Angiotensin II; Angiotensinogen; Enzyme-Linked Immunosorbent Assay; Humans; Hypertension; Kidney; Kidney Diseases; Renin; Renin-Angiotensin System	2018
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology. Physiological reviews, 2018, 07-01, Volume: 98, Issue:3 Topics: Adipocytes; Angiotensin II; Animals; Blood Vessels; Brain; Heart Diseases; Humans; Inflammation; Kidney; Kidney Diseases; Receptors, Angiotensin; Signal Transduction	2018
The renin-angiotensin-aldosterone system and its suppression. Journal of veterinary internal medicine, 2019, Volume: 33, Issue:2 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Heart Failure; Hypertension; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System	2019
The intrarenal renin-angiotensin system: does it exist? Implications from a recent study in renal angiotensin-converting enzyme knockout mice. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:12 Topics: Angiotensin II; Animals; Hypertension; Kidney Diseases; Mice; Mice, Knockout; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2013
ACE2: angiotensin II/angiotensin-(1-7) balance in cardiac and renal injury. Current hypertension reports, 2014, Volume: 16, Issue:3 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Heart Diseases; Humans; Hypertension; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A	2014
Roles of collecting duct renin and (pro)renin receptor in hypertension: mini review. Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:4 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Humans; Hypertension; Kidney Diseases; Peptidyl-Dipeptidase A; Rats; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Vacuolar Proton-Translocating ATPases	2015
Role of stimulated intrarenal angiotensinogen in hypertension. Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:4 Topics: Angiotensin II; Angiotensinogen; Animals; Biological Transport; Humans; Hypertension; Kidney Diseases; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Sodium; Vasoconstriction	2015
Angiotensin receptor blockers: Focus on cardiac and renal injury. Trends in cardiovascular medicine, 2016, Volume: 26, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Drug Interactions; Drug Therapy, Combination; Heart; Heart Diseases; Humans; Kidney; Kidney Diseases; Myocardium; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Treatment Outcome	2016
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension. Therapeutic advances in cardiovascular disease, 2015, Volume: 9, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Mice; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Renin-Angiotensin System	2015
Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease. Clinical science (London, England : 1979), 2016, 08-01, Volume: 130, Issue:15 Topics: Angiotensin II; Animals; Cardiovascular Agents; Cardiovascular Diseases; Cardiovascular System; Humans; Kidney; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Signal Transduction	2016
Role of the intrarenal renin-angiotensin system in the progression of renal disease. Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:9 Topics: Angiotensin II; Angiotensinogen; Animals; Biomarkers; Disease Progression; Humans; Kidney; Kidney Diseases; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction	2017
The renin-angiotensin system: an old, newly discovered player in immunoregulation. Transplantation reviews (Orlando, Fla.), 2009, Volume: 23, Issue:3 Topics: Angiotensin II; Animals; Chemotaxis, Leukocyte; Dendritic Cells; Graft Rejection; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Killer Cells, Natural; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Primary Graft Dysfunction; Renin-Angiotensin System; T-Lymphocytes; Transforming Growth Factor beta1	2009
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection. Current hypertension reports, 2009, Volume: 11, Issue:4 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Arteriosclerosis; Humans; Hypertension; Kidney Diseases; Nitric Oxide; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Renin-Angiotensin System; Vasodilation	2009
[Intrarenal mechanisms of angiotensin II formation]. Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Biomarkers; Humans; Hypertension; Kidney; Kidney Diseases; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Serine Proteases	2010
Direct Renin inhibition: promising treatment in renoprotection? Recent patents on cardiovascular drug discovery, 2010, Volume: 5, Issue:2 Topics: Amides; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Fumarates; Humans; Kidney Diseases; Rats; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Treatment Outcome	2010
Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease. Cells, tissues, organs, 2011, Volume: 193, Issue:1-2 Topics: Angiotensin II; Animals; Epithelial-Mesenchymal Transition; Humans; Kidney Diseases; Renin-Angiotensin System	2011
A transgenic mouse model for studying the role of the parathyroid hormone-related protein system in renal injury. Journal of biomedicine & biotechnology, 2011, Volume: 2011 Topics: Acute Kidney Injury; Angiotensin II; Animals; Disease Models, Animal; Humans; Hypertrophy; Kidney Diseases; Mice; Mice, Transgenic; Parathyroid Hormone-Related Protein; Proteinuria	2011
Pathogenic role of TGF-β in the progression of podocyte diseases. Histology and histopathology, 2011, Volume: 26, Issue:1 Topics: Angiotensin II; Animals; Biomechanical Phenomena; Connective Tissue Growth Factor; Denys-Drash Syndrome; Diabetic Nephropathies; Glomerular Basement Membrane; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Kidney Diseases; Models, Biological; Paracrine Communication; Podocytes; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A	2011
Therapeutic interventions to renin-angiotensin-aldosterone system, and vascular redox state. Recent patents on cardiovascular drug discovery, 2011, Volume: 6, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; NADPH Oxidases; Oxidation-Reduction; Oxidative Stress; Patents as Topic; Reactive Oxygen Species; Renin-Angiotensin System	2011
New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides, 2011, Volume: 32, Issue:7 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cystinyl Aminopeptidase; Humans; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Transgenic; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Signal Transduction	2011
Renal oxidative stress, oxygenation, and hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 2011, Volume: 301, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Disease Progression; Fibrosis; Humans; Hypertension; Hypoxia; Kidney; Kidney Diseases; Oxidative Stress; Oxygen; Oxygen Consumption; Reactive Oxygen Species	2011
The complex interplay between cyclooxygenase-2 and angiotensin II in regulating kidney function. Current opinion in nephrology and hypertension, 2012, Volume: 21, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Hypertension; Kidney; Kidney Diseases; Renin-Angiotensin System; Signal Transduction	2012
Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clinical and experimental nephrology, 2012, Volume: 16, Issue:2 Topics: Angiotensin II; Animals; Disease Progression; Humans; Kidney Diseases; Kidney Glomerulus; Renin-Angiotensin System	2012
[Role of the renin-angiotensin system in the brain and cardiorenal system]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2012, Volume: 140, Issue:3 Topics: Angiotensin II; Animals; Brain Diseases; Cognition Disorders; Endothelium, Vascular; Heart Diseases; Humans; Kidney Diseases; Nitric Oxide Synthase Type III; Oxidative Stress; Renin-Angiotensin System; Stroke; Vascular Diseases	2012
Angiotensin (1-7) and other angiotensin peptides. Current pharmaceutical design, 2013, Volume: 19, Issue:17 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Glucose; Humans; Kidney Diseases; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled	2013
Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects? Current hypertension reports, 2002, Volume: 4, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Cardiovascular System; Diabetes Mellitus; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	2002
Targeting the renin-angiotensin system in patients with renal disease. Journal of the Royal Society of Medicine, 2002, Volume: 95, Issue:8 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Kidney Diseases; Proteinuria; Risk Factors; Vasoconstrictor Agents	2002
Mechanisms of progressive renal disease: role of angiotensin II, cyclooxygenase products and nitric oxide. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2002, Volume: 20, Issue:3 Topics: Angiotensin II; Animals; Endothelium, Vascular; Glomerular Mesangium; Humans; Inflammation; Kidney Diseases; Kidney Glomerulus; Nitric Oxide; Prostaglandin-Endoperoxide Synthases; Renin	2002
The renin-angiotensin system in progression, remission and regression of chronic nephropathies. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 2002, Volume: 20, Issue:3 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Proteins; Renin-Angiotensin System	2002
Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease? Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cough; Diabetes Complications; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Myocardial Infarction; Receptor, Angiotensin, Type 1	2002
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxidants & redox signaling, 2002, Volume: 4, Issue:6 Topics: Angiotensin II; Animals; Blood Vessels; Endothelium, Vascular; Humans; Kidney Diseases; Muscle, Smooth, Vascular; NADPH Oxidases; Oxidation-Reduction; Protein Kinases; Reactive Oxygen Species; Signal Transduction; Transcription Factors; Vascular Diseases	2002
Dopamine and the kidney: a role in hypertension? Current opinion in nephrology and hypertension, 2003, Volume: 12, Issue:2 Topics: Angiotensin II; Animals; Disease Models, Animal; Disease Progression; Dopamine; Female; Humans; Hypertension; Kidney Diseases; Male; Mice; Polymorphism, Genetic; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Dopamine; Renin-Angiotensin System; Sensitivity and Specificity; Sodium Chloride	2003
An update on 'progression promoters' in renal diseases. Journal of the National Medical Association, 2003, Volume: 95, Issue:1 Topics: Angiotensin II; Disease Progression; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Risk Factors	2003
Angiotensin II, the immune system and renal diseases: another road for RAS? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:8 Topics: Angiotensin II; Animals; Hypertension; Kidney Diseases; Killer Cells, Natural; Lymphokines; Renin-Angiotensin System	2003
[Pathophysiology and clinical implication of obstructive nephropathy]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2003, Volume: 94, Issue:7 Topics: Angiotensin II; Animals; Fibrosis; Humans; Hydronephrosis; Kidney Diseases; Kidney Tubules; Mice; Rats; Receptors, Angiotensin; Renal Circulation; Renin-Angiotensin System; Ureteral Obstruction	2003
Angiotensin II and cell cycle regulation. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Blood Vessels; Cardiovascular Diseases; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Size; Endothelins; G1 Phase; Heart; Humans; Hypertrophy; Kidney; Kidney Diseases; Myocardium	2004
Proteinuria and its consequences in renal disease. Acta paediatrica (Oslo, Norway : 1992). Supplement, 2003, Volume: 92, Issue:443 Topics: Angiotensin II; Chronic Disease; Disease Progression; Fabry Disease; Humans; Hyperlipidemias; Hypertension, Renal; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Chronic Disease; Disease Models, Animal; Humans; Hypertension; Infusion Pumps; Kidney Diseases; Oxidative Stress; Sodium Chloride, Dietary	2004
Changes in glomerular perm-selectivity induced by angiotensin II imply podocyte dysfunction and slit diaphragm protein rearrangement. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Cell Membrane Permeability; Epithelial Cells; Humans; Kidney Diseases; Kidney Glomerulus; Membrane Proteins; Urothelium	2004
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Seminars in nephrology, 2004, Volume: 24, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Chronic Disease; Drug Therapy, Combination; Humans; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Remission Induction	2004
[Organ protection by angiotensin II receptor blockers]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cognition Disorders; Heart Failure; Humans; Hypertension; Kidney Diseases; Losartan; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Proteins; Proteinuria; Randomized Controlled Trials as Topic; Stroke; Tetrazoles	2004
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. Circulation, 2004, Jun-01, Volume: 109, Issue:21 Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Diabetic Nephropathies; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Myocardial Infarction; Proteinuria; Rats; Renin-Angiotensin System; Ventricular Dysfunction, Left	2004
The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:10 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Kidney Diseases	2004
Influence of chronic kidney disease development and renin-angiotensin system inhibition on cardiovascular prognosis. Current medicinal chemistry. Cardiovascular and hematological agents, 2005, Volume: 3, Issue:1 Topics: Angiotensin II; Cardiovascular Diseases; Chronic Disease; Creatinine; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Prognosis; Renin-Angiotensin System; Risk Factors	2005
[Angiotensin receptor antagonists. A clinical-pharmacologic overview]. Medizinische Monatsschrift fur Pharmazeuten, 2005, Volume: 28, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Cardiac Output, Low; Diabetic Nephropathies; Humans; Kidney Diseases; Migraine Disorders; Myocardial Infarction	2005
Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney international, 2005, Volume: 67, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	2005
Mediators of fibrosis and apoptosis in obstructive uropathies. Current urology reports, 2005, Volume: 6, Issue:2 Topics: Angiotensin II; Apoptosis; Biomarkers; Female; Fibrosis; Humans; Kidney Diseases; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ureteral Obstruction	2005
The future of angiotensin II inhibition in cardiovascular medicine. Current drug targets. Cardiovascular & haematological disorders, 2005, Volume: 5, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Protease Inhibitors; Renin; Risk Factors	2005
The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Nephropathies; Glucose; Hemodynamics; Homeostasis; Humans; Hypertension; Kidney Diseases; Nitric Oxide; Renin-Angiotensin System	2005
Six truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of mice. Circulation research, 2005, Jun-10, Volume: 96, Issue:11 Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Kidney Diseases; Male; Mice; Mice, Knockout; Myocardium; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Testis	2005
The role of angiotensin II in hypertension and end-organ damage. International journal of clinical practice. Supplement, 2000, Issue:111 Topics: Angiotensin II; Animals; Arteriosclerosis; Coronary Disease; Diabetes Complications; Humans; Hypertension; Kidney Diseases	2000
[The renin-angiotensin-aldosterone system -- more complex as previously thought]. Medizinische Klinik (Munich, Germany : 1983), 2005, Aug-15, Volume: 100, Issue:8 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases	2005
"As time goes by": angiotensin II-mediated transactivation of the EGF receptor comes of age. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:10 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; ErbB Receptors; Humans; Kidney Diseases; Mice; Models, Biological; Renin-Angiotensin System; Transcriptional Activation	2005
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:1 Topics: Angiotensin II; Cytokines; Female; Fibrosis; Humans; Inflammation Mediators; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Prognosis; Receptor, Angiotensin, Type 2; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction	2006
Anti-inflammatory properties of drugs acting on the renin-angiotensin system. Drugs of today (Barcelona, Spain : 1998), 2005, Volume: 41, Issue:9 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cardiovascular Diseases; Humans; Kidney Diseases; Renin-Angiotensin System	2005
Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury. Journal of pharmacological sciences, 2006, Volume: 100, Issue:1 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Fibrosis; Glomerulosclerosis, Focal Segmental; Hypertension; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Microcirculation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; rho GTP-Binding Proteins; rho-Associated Kinases; Signal Transduction; Vasoconstrictor Agents	2006
Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. Journal of pharmacological sciences, 2006, Volume: 100, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aortic Valve Stenosis; Blood Pressure; Diffusion; Disease Models, Animal; Humans; Hypertension; Kidney Diseases; Kidney Medulla; Kidney Tubular Necrosis, Acute; Nitric Oxide; Oxidative Stress; Pressure; Rats; Rats, Inbred Dahl; Renal Circulation; Sodium Chloride, Dietary; Superoxides; Vasoconstrictor Agents	2006
Pharmacological management of renal fibrotic disease. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Disease Progression; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fibrosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Practice Guidelines as Topic; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Transforming Growth Factor beta	2006
TACE-dependent EGF receptor activation in angiotensin-II-induced kidney disease. Trends in pharmacological sciences, 2006, Volume: 27, Issue:5 Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Enzyme Activation; ErbB Receptors; Humans; Kidney Diseases; Mice	2006
Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7 Suppl 1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System	2006
Renal hemodynamics and permselectivity. Journal of the American Society of Nephrology : JASN, 1990, Volume: 1, Issue:5 Suppl 2 Topics: Angiotensin II; Animals; Diffusion; Disease Models, Animal; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Permeability; Pressure; Proteinuria; Rats	1990
Reversal of renal disease: is it enough to inhibit the action of angiotensin II? Cell death and differentiation, 2007, Volume: 14, Issue:7 Topics: Angiotensin II; Animals; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Extracellular Matrix Proteins; Fibrosis; Hepatocyte Growth Factor; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Transforming Growth Factor beta	2007
Functional renin receptors in renal mesangial cells. Current hypertension reports, 2007, Volume: 9, Issue:2 Topics: Angiotensin II; Animals; Humans; Kidney Diseases; Mesangial Cells; Mitogen-Activated Protein Kinases; Receptors, Cell Surface; Renin; Renin-Angiotensin System; Transforming Growth Factor beta; Vacuolar Proton-Translocating ATPases	2007
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Chronic Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hypertension; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kidney Diseases; Metabolic Syndrome; Mineralocorticoids; Muscle, Skeletal; Myocardium; Oxidative Stress; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Signal Transduction	2007
Angiotensin II-induced reactive oxygen species and the kidney. Journal of the American Society of Nephrology : JASN, 2007, Volume: 18, Issue:9 Topics: Angiotensin II; Animals; Humans; Kidney; Kidney Diseases; NADPH Oxidases; Reactive Oxygen Species	2007
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacological reviews, 2007, Volume: 59, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Chronic Disease; Disease Models, Animal; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Diseases; Receptors, Angiotensin; Renin; Renin-Angiotensin System	2007
ACE2 and diabetic complications. Current pharmaceutical design, 2007, Volume: 13, Issue:26 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Complications; Heart Diseases; Humans; Kidney Diseases; Peptidyl-Dipeptidase A	2007
Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:1 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; NF-kappa B; Signal Transduction	2008
The balance of angiotensin II and nitric oxide in kidney diseases. Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:1 Topics: Acute Kidney Injury; Angiotensin II; Animals; Humans; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide	2008
Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 294, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Estradiol; Female; Humans; Kidney; Kidney Diseases; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sex Factors; Signal Transduction; Treatment Outcome	2008
Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Kidney Diseases; Kidney Failure, Chronic; Microcirculation; Oxidative Stress; Renal Circulation; Renin-Angiotensin System	2008
Angiotensin-converting enzyme 2: possible role in hypertension and kidney disease. Current hypertension reports, 2008, Volume: 10, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Biological Assay; Humans; Hypertension; Kidney; Kidney Diseases; Peptidyl-Dipeptidase A; Renin-Angiotensin System	2008
Beta-blockers and renal function. Drugs, 1982, Volume: 23, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Dopamine; Glomerular Filtration Rate; Homeostasis; Humans; Kidney; Kidney Diseases; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renal Circulation	1982
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey]. Minerva medica, 1981, Mar-31, Volume: 72, Issue:12 Topics: Acromegaly; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Cushing Syndrome; Glycoproteins; Humans; Hyperaldosteronism; Hypertension; Kidney; Kidney Diseases; Prostaglandins; Receptors, Adrenergic; Receptors, Angiotensin; Renin; Sodium; Sympathetic Nervous System; Teprotide	1981
Pathophysiology of obstructive nephropathy. Kidney international, 1980, Volume: 18, Issue:3 Topics: Angiotensin II; Glomerular Filtration Rate; Humans; Hydrostatic Pressure; Kidney; Kidney Diseases; Nephrons; Phosphates; Potassium; Prostaglandins; Regional Blood Flow; Renin; Sodium; Ureteral Obstruction	1980
Angiotensin II-mediated renal injury. Mineral and electrolyte metabolism, 1995, Volume: 21, Issue:4-5 Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Kidney Diseases; Renin-Angiotensin System; Ureteral Obstruction	1995
Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995, Volume: 26, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Enalapril; Extracellular Matrix Proteins; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Macrophages; Monocytes; Rats; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Triazoles; Ureteral Obstruction	1995
Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annual review of physiology, 1995, Volume: 57 Topics: Angiotensin II; Animals; Glomerular Filtration Rate; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Diseases; Kidney Failure, Chronic; Renin-Angiotensin System; Transforming Growth Factor beta	1995
Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1994, Volume: 12, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Endothelins; Extracellular Matrix Proteins; Fibronectins; Humans; Kidney; Kidney Diseases; Sclerosis	1994
Internephron heterogeneity of growth factors and sclerosis. Kidney international. Supplement, 1994, Volume: 45 Topics: Angiotensin II; Animals; Glomerulosclerosis, Focal Segmental; Growth Substances; Humans; Hypertrophy; Kidney Diseases; Kidney Glomerulus; Nephrectomy; Nephrons; Platelet-Derived Growth Factor; Proteinuria; Puromycin Aminonucleoside; Rats	1994
Renal adaptation to the failing heart. Understanding the cascade of responses. Postgraduate medicine, 1994, Volume: 95, Issue:8 Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Endothelins; Heart Failure; Hemodynamics; Homeostasis; Humans; Kidney Diseases; Norepinephrine; Prostaglandins; Renal Circulation; Renin-Angiotensin System; Systole	1994
Regulating factors of renal tubular hypertrophy. The Clinical investigator, 1993, Volume: 71, Issue:10 Topics: Angiotensin II; Humans; Hypertrophy; Kidney Diseases; Kidney Tubules	1993
Cellular mechanisms of lipid injury in the glomerulus. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1993, Volume: 22, Issue:1 Topics: Angiotensin II; Animals; Cell Division; Cell Survival; Cytokines; Extracellular Matrix; Glomerular Mesangium; Glycosylation; Kidney Diseases; Kidney Glomerulus; Lipoproteins, LDL; Oxidation-Reduction; Prostaglandins; Protein Binding; Rats; Receptors, LDL; Thromboxanes	1993
[Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease]. Revista clinica espanola, 1993, Volume: 192, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Hypertension; Kidney; Kidney Diseases; Renin-Angiotensin System	1993
Impaired proteolytic activity as a potential cause of progressive renal disease. Mineral and electrolyte metabolism, 1996, Volume: 22, Issue:1-3 Topics: Acidosis; Ammonia; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Dietary Proteins; Endopeptidases; Glomerulonephritis; Humans; Hypertrophy; Inflammation; Insulin-Like Growth Factor I; Kidney; Kidney Diseases; Proteins; Transforming Growth Factor beta	1996
Angiotensin in progressive renal diseases: theory and practice. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Environment; Humans; Kidney Diseases; Models, Biological	1996
[Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy]. Klinicheskaia meditsina, 1996, Volume: 74, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Heart Failure; Humans; Hypertension; Hypertension, Renovascular; Imidazoles; Kidney Diseases; Losartan; Myocardial Infarction; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Time Factors	1996
Role of angiotensin II in glomerular injury: lessons from experimental and clinical studies. Kidney & blood pressure research, 1996, Volume: 19, Issue:5 Topics: Angiotensin II; Animals; Hemodynamics; Humans; Kidney Diseases; Kidney Glomerulus	1996
Impact of renin-angiotensin system blockade on structure and function of glomerular membrane components in animal models of kidney disease. Experimental nephrology, 1996, Volume: 4 Suppl 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Capillaries; Disease Models, Animal; Kidney Diseases; Kidney Glomerulus; Renin-Angiotensin System	1996
Biological functions of angiotensin and its receptors. Annual review of physiology, 1997, Volume: 59 Topics: Angiotensin II; Animals; Extracellular Matrix; Heart; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Receptors, Angiotensin	1997
Transforming growth factor-beta in human glomerular injury. Current opinion in nephrology and hypertension, 1997, Volume: 6, Issue:4 Topics: Angiotensin II; Animals; Decorin; Extracellular Matrix Proteins; Genetic Therapy; Humans; Kidney Diseases; Kidney Glomerulus; Proteoglycans; Transforming Growth Factor beta	1997
Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Hemodynamics; Kidney Diseases; Rats; Renin-Angiotensin System	1997
Renal tubular hypertrophy induced by angiotensin II. Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cells, Cultured; Disease Models, Animal; Disease Progression; Hypertrophy; Kidney Diseases; Kidney Tubules; Rats; Renin-Angiotensin System	1997
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target? Seminars in nephrology, 1997, Volume: 17, Issue:5 Topics: Angiotensin II; Animals; Disease Models, Animal; Fibrosis; Humans; Hypertension, Renal; Kidney Diseases; Transforming Growth Factor beta	1997
Comparison of renin-angiotensin to calcium channel blockade in renal disease. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Humans; Hypertension, Renovascular; Kidney Diseases; Renin-Angiotensin System	1997
Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Disease Progression; Humans; Kidney Diseases	1997
Angiotensin II and gene expression in the kidney. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:1 Topics: Angiotensin II; Animals; Gene Expression; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	1998
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Fibrinolysin; Fibrosis; Gene Transfer Techniques; Humans; Integrins; Kidney; Kidney Diseases; Transforming Growth Factor beta	1998
[Renal effects of AT1 angiotensin receptor antagonists (AT1ra)]. Presse medicale (Paris, France : 1983), 1997, Dec-20, Volume: 26, Issue:40 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Humans; Kidney; Kidney Diseases	1997
Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:5 Topics: Adjuvants, Immunologic; Angiotensin II; Animals; Cytokines; Disease Progression; Growth Substances; Hemodynamics; Humans; Kidney; Kidney Diseases	1998
[The relationship between genetic polymorphisms and disease, illustrated by the renin-angiotensin-aldosterone system and cardiovascular disease]. Nederlands tijdschrift voor geneeskunde, 1998, Jun-20, Volume: 142, Issue:25 Topics: Angiotensin II; Angiotensinogen; Cardiovascular Diseases; Chromosome Mapping; Female; Genetic Markers; Humans; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Point Mutation; Polymorphism, Genetic; Receptors, Angiotensin; Renin-Angiotensin System; Spondylitis, Ankylosing	1998
Angiotensin II receptor antagonists and treatment of hypertension and renal disease. Current opinion in nephrology and hypertension, 1998, Volume: 7, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hypertension; Kidney Diseases	1998
The pathophysiology of hypertension: the importance of angiotensin II in cardiovascular remodeling. American journal of hypertension, 1998, Volume: 11, Issue:11 Pt 2 Topics: Angiotensin II; Animals; Arteriosclerosis; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System	1998
Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms. Nephrologie, 1998, Volume: 19, Issue:7 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Growth Substances; Humans; Immunity; Kidney Diseases	1998
Endothelin in hypertension: a role for receptor antagonists? Cardiovascular research, 1998, Volume: 39, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Heart; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Rats; Vascular Diseases; Vasoconstrictor Agents	1998
The renin-angiotensin system and its receptors. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular Diseases; Cell Division; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System; Salts; Water	1999
Angiotensin II antagonism in clinical practice: experience with valsartan. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Age Factors; Angiotensin II; Antihypertensive Agents; Cardiovascular Diseases; Drug Synergism; Humans; Kidney Diseases; Racial Groups; Sex Factors; Tetrazoles; Valine; Valsartan	1999
Valsartan and the kidney: present and future. Journal of cardiovascular pharmacology, 1999, Volume: 33 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Humans; Hypertension; Kidney Diseases; Renal Insufficiency; Tetrazoles; Valine; Valsartan	1999
Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14 Suppl 1 Topics: Angiotensin II; Animals; Disease Progression; Humans; Kidney; Kidney Diseases	1999
[Mechanisms of action of angiotensin II]. Polskie Archiwum Medycyny Wewnetrznej, 1998, Volume: 100, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System; Transcription Factors	1998
Renin-angiotensin genes in renal development and the occurrence and progression of renal diseases. Seminars in nephrology, 1999, Volume: 19, Issue:2 Topics: Angiotensin II; Animals; Disease Progression; Female; Humans; Kidney; Kidney Diseases; Male; Mice; Renin-Angiotensin System	1999
Vasoactive factors and tubulointerstitial injury. Kidney & blood pressure research, 1999, Volume: 22, Issue:1-2 Topics: Angiotensin II; Animals; Eicosanoids; Endothelins; Humans; Kidney Diseases; Kidney Tubules; Natriuretic Agents; Receptors, Adrenergic; Transforming Growth Factor beta	1999
Drug-related renal dysfunction in the elderly. Geriatric nephrology and urology, 1999, Volume: 9, Issue:1 Topics: Aging; Aminoglycosides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Hormone Antagonists; Humans; Immunosuppressive Agents; Kidney Diseases	1999
Transforming growth factor beta-angiotensin II interaction: implications for cardiac and renal disease. Journal of molecular medicine (Berlin, Germany), 1999, Volume: 77, Issue:7 Topics: Angiotensin II; Heart Diseases; Humans; Kidney Diseases; Models, Biological; Signal Transduction; Transforming Growth Factor beta	1999
Dosing angiotensin II blockers--beyond blood pressure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Humans; Kidney Diseases	1999
Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacological reviews, 2000, Volume: 52, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Vessels; Cardiovascular Diseases; Heart; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin	2000
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney international, 2000, Volume: 57, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Drug Therapy, Combination; Humans; Kidney; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2000
[Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2000, Volume: 115, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Heart Failure; Humans; Kidney Diseases; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles	2000
Acute effects of cigarette smoking on renal hemodynamics. Contributions to nephrology, 2000, Volume: 130 Topics: Adrenergic Antagonists; Angiotensin II; Glomerulonephritis, IGA; Hemodynamics; Humans; Kidney; Kidney Diseases; Models, Biological; Renal Circulation; Risk Factors; Smoking	2000
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers. Current opinion in nephrology and hypertension, 2000, Volume: 9, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular Diseases; Hemodynamics; Humans; Hypertension; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Renin-Angiotensin System	2000
[Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors]. Nephrologie, 2000, Volume: 21, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Endothelium, Vascular; Humans; Hypertension, Renal; Kallikrein-Kinin System; Kidney; Kidney Diseases; Myocardium; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Receptors, Bradykinin; Vasomotor System	2000
Treatment of hypertension in diabetes mellitus. Current hypertension reports, 2000, Volume: 2, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors	2000
Kidney angiotensin receptors and their role in renal pathophysiology. Seminars in nephrology, 2000, Volume: 20, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Disease Models, Animal; Humans; Hypertension, Renovascular; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System	2000
Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta physiologica Hungarica, 2000, Volume: 87, Issue:1 Topics: Angiotensin II; Animals; Apoptosis; Cardiovascular Diseases; Cell Division; Humans; Kidney Diseases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; Signal Transduction	2000
Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regulatory peptides, 2000, Nov-24, Volume: 95, Issue:1-3 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Humans; Hypertension; Kidney Diseases; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Renin-Angiotensin System; Signal Transduction	2000
Endothelin, renal diseases, and hypertension. Advances in nephrology from the Necker Hospital, 2000, Volume: 30 Topics: Acute Kidney Injury; Angiotensin II; Animals; Endothelin-1; Endothelins; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Nitric Oxide	2000
Angiotensin II as a mediator of tubulointerstitial injury. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15 Suppl 6 Topics: Angiotensin II; Animals; Disease Progression; Kidney Diseases; Kidney Tubules	2000
[Renin-angiotensin system in kidney physiology and pathology]. Postepy higieny i medycyny doswiadczalnej, 2000, Volume: 54, Issue:5 Topics: Angiotensin II; Angiotensins; Humans; Kidney; Kidney Diseases; Receptors, Angiotensin; Reference Values; Renin-Angiotensin System	2000
Research on renal endothelin in proteinuric nephropathies dictates novel strategies to prevent progression. Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Progression; Endothelin Receptor Antagonists; Endothelins; Humans; Kidney; Kidney Diseases; Proteinuria	2001
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition? Cardiovascular drug reviews, 2001,Spring, Volume: 19, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Failure, Chronic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2001
Expanded role for ARBs in cardiovascular and renal disease? Recent observations have far-reaching implications. Postgraduate medicine, 2001, Volume: 109, Issue:4 Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Cardiovascular Diseases; Humans; Imidazoles; Irbesartan; Kidney Diseases; Losartan; Metabolic Clearance Rate; Patient Selection; Renin-Angiotensin System; Telmisartan; Tetrazoles; Thiophenes; Treatment Outcome; Valine; Valsartan	2001
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease. The American journal of cardiology, 2001, Apr-19, Volume: 87, Issue:8A Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Renin-Angiotensin System; Risk Factors	2001
Role of hypertension in the progression of chronic renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2001, Volume: 16 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Black or African American; Black People; Chronic Disease; Disease Progression; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Muscle, Smooth, Vascular; United States	2001
Aldosterone as a determinant of cardiovascular and renal dysfunction. Journal of the Royal Society of Medicine, 2001, Volume: 94, Issue:8 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Fibrosis; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Nitric Oxide; Potassium; Randomized Controlled Trials as Topic; Sodium; Spironolactone	2001
Angiotensin converting enzyme inhibition and the kidney. Current opinion in cardiology, 1988, Volume: 3, Issue:Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dogs; Humans; Hypertension; Hypertension, Renovascular; Kidney; Kidney Diseases; Renal Circulation; Renin-Angiotensin System; Sodium, Dietary	1988
Angiotensin II and renal fibrosis. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:3 Pt 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Fibrosis; Humans; Kidney; Kidney Diseases	2001
Angiotensin II, TGF-beta and renal fibrosis. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Disease Models, Animal; Fibrosis; Humans; Kidney; Kidney Diseases; Rats; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Transforming Growth Factor beta	2001
Angiotensin II and atherosclerosis: relevance for renal disease. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Arteriosclerosis; Biopsy, Needle; Humans; Kidney Diseases; Lipoproteins; Prognosis; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index	2001
Role of angiotensin II in chronic ureteral obstruction. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Chronic Disease; Humans; Kidney Diseases; Prognosis; Rats; Renin-Angiotensin System; Risk Assessment; Risk Factors; Ureteral Obstruction	2001
Angiotensin IV and renal diseases. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Humans; Kidney Diseases; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity	2001
Maximizing hemodynamic-independent effects of angiotensin II antagonists in fibrotic diseases. Seminars in nephrology, 2001, Volume: 21, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Fibrosis; Humans; Kidney Diseases; Liver Cirrhosis; Pulmonary Fibrosis; Renin-Angiotensin System; Transforming Growth Factor beta	2001
Aldosterone in progressive renal disease. Seminars in nephrology, 2001, Volume: 21, Issue:6 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperaldosteronism; Kidney Diseases; Rats; Rats, Inbred WF; Renal Insufficiency; Renin-Angiotensin System	2001
Proinflammatory effects of angiotensin II and endothelin: targets for progression of cardiovascular and renal diseases. Current opinion in nephrology and hypertension, 2002, Volume: 11, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Disease Progression; Endothelins; Humans; Inflammation; Kidney Diseases; Nitric Oxide; Receptor, Angiotensin, Type 1	2002
The inflammatory component in progressive renal disease--are interventions possible? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:3 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Fibrosis; Humans; Inflammation; Inflammation Mediators; Kidney Diseases; Models, Biological; Mycophenolic Acid; Nephritis; Renin-Angiotensin System; Transforming Growth Factor beta	2002
Dual angiotensin II blockade: a promise of enhanced renal protection? Journal of hypertension, 2002, Volume: 20, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Humans; Hypertension; Kidney Diseases; Proteinuria; Receptor, Angiotensin, Type 1; Tetrazoles	2002
Therapeutic strategies to halt renal fibrosis. Current opinion in pharmacology, 2002, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Enzyme Inhibitors; Fibrosis; Humans; Kidney; Kidney Diseases; Receptor, Angiotensin, Type 1	2002
The role of growth factors and ammonia in the genesis of hypokalemic nephropathy. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 2002, Volume: 12, Issue:3 Topics: Acid-Base Equilibrium; Ammonia; Angiotensin II; Growth Substances; Humans; Hypokalemia; Kidney Diseases; Potassium Deficiency	2002
The renin-angiotensin-aldosterone system in parenchymal kidney disease. Advances in nephrology from the Necker Hospital, 1975, Volume: 5 Topics: Acute Kidney Injury; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Blood Pressure; Heparin; Humans; Hypertension; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Nephrectomy; Posture; Potassium; Renal Dialysis; Renin; Sodium	1975
[Pure hypoaldosteronism in the adult]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1975, Volume: 20, Issue:2 Topics: Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Child; Glucocorticoids; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Kidney Diseases; Mineralocorticoids; Potassium; Renin	1975
Renal disease in pregnancy. The Medical clinics of North America, 1977, Volume: 61, Issue:1 Topics: Acute Kidney Injury; Angiotensin II; Anti-Bacterial Agents; Bacteriuria; Female; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Regional Blood Flow; Urologic Diseases; Uterus	1977
Deranged renal function in liver disease. Contributions to nephrology, 1977, Volume: 7 Topics: Angiotensin II; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Kidney; Kidney Diseases; Liver Cirrhosis; Liver Diseases; Oliguria; Prognosis; Renin; Sodium; Syndrome	1977
Prostaglandins and the kidney. The American journal of physiology, 1977, Volume: 233, Issue:3 Topics: Acute Kidney Injury; Angiotensin II; Animals; Anura; Chickens; Diuretics; Dogs; Erythropoiesis; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Medulla; Kidney Tubules; Prostaglandins; Rabbits; Rats; Regional Blood Flow; Renin; Sodium; Water	1977
[Pathophysiological aspects of the renin-angiotensin-aldosterone system]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43 Topics: Adrenal Insufficiency; Aldosterone; Angiotensin II; Bartter Syndrome; Contraceptives, Oral; Half-Life; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Renin	1977
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasis. Physiological reviews, 1978, Volume: 58, Issue:3 Topics: Acid-Base Equilibrium; Aldosterone; Angiotensin II; Animals; Blood Volume; Catecholamines; Diuresis; Dogs; Humans; Immersion; Kidney; Kidney Diseases; Liver Cirrhosis; Natriuresis; Parathyroid Hormone; Phosphates; Potassium; Primates; Prostaglandins; Renin; Temperature; Vasopressins; Water-Electrolyte Balance	1978
[Structural foundation for the functional connections of the endocrine apparatus and nervous system of the kidneys]. Arkhiv patologii, 1978, Volume: 40, Issue:11 Topics: Aldosterone; Angiotensin II; Endocrine Glands; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Cortex; Kidney Diseases; Kidney Medulla; Nephrons; Prostaglandins; Receptors, Adrenergic; Receptors, Cholinergic; Renin	1978
[Renal hypertension]. Schweizerische medizinische Wochenschrift, 1976, Dec-11, Volume: 106, Issue:50 Topics: Aldosterone; Angiotensin II; Diuretics; Furosemide; Glomerulonephritis; Humans; Hypercalcemia; Hypertension, Renal; Kidney; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Nephrectomy; Renal Artery Obstruction; Renin; Sodium	1976
[Pathophysiology of renal hypertension (author's transl)]. Der Radiologe, 1975, Volume: 15, Issue:4 Topics: Aldosterone; Angiotensin II; Arteriosclerosis; Blood Pressure; Catecholamines; Child; Extracellular Space; Glomerulonephritis; Hematoma; Hemodynamics; Humans; Hypertension, Malignant; Hypertension, Renal; Infarction; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Neoplasms; Male; Nephrectomy; Pulse; Renin; Sodium; Water-Electrolyte Balance	1975
The place of renin in the mechanism of hypertension in chronic renal disease. Clinical nephrology, 1975, Volume: 4, Issue:4 Topics: Angiotensin II; Animals; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Hypertension, Renal; Kidney Diseases; Kidney Neoplasms; Radioimmunoassay; Renal Artery Obstruction; Renin	1975
The clinical value of renin and angiotensin estimations. Kidney international. Supplement, 1975 Topics: Acute Kidney Injury; Addison Disease; Angiotensin II; Bartter Syndrome; Contraceptives, Oral; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Hypotension, Orthostatic; Kidney Diseases; Kidney Failure, Chronic; Kidney Neoplasms; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Renal Artery Obstruction; Renin	1975
The roles of angiotensin II and prostaglandins in the regulation of the glomerular filtration of albumin. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1990, Volume: 8, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Glomerulus; Prostaglandins; Rats; Urodynamics	1990
Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet (London, England), 1985, Jan-05, Volume: 1, Issue:8419 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Dipeptides; Drug Eruptions; Drug Interactions; Enalapril; Heart Failure; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Neutropenia; Proline; Taste Disorders	1985
Hormonal regulation of glomerular filtration. Annual review of medicine, 1985, Volume: 36 Topics: Angiotensin II; Animals; Dogs; Glomerular Filtration Rate; Hormones; Humans; In Vitro Techniques; Kidney Diseases; Kidney Glomerulus; Prostaglandins; Rabbits; Rats; Receptors, Cell Surface; Vasoconstrictor Agents; Vasodilator Agents	1985
Primary acquired hypoaldosteronism. Kidney international, 1985, Volume: 27, Issue:4 Topics: Absorption; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Biological Transport, Active; Desoxycorticosterone; Epinephrine; Female; Humans; Hyperkalemia; Hypotension; Kidney; Kidney Diseases; Middle Aged; Mineralocorticoids; Norepinephrine; Posture; Potassium; Protons; Renin; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfates	1985
Glomerular prostaglandins, angiotensin II, and nonsteroidal anti-inflammatory drugs. The American journal of medicine, 1986, Aug-25, Volume: 81, Issue:2B Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arginine Vasopressin; Humans; Kidney Diseases; Kidney Glomerulus; Prostaglandins	1986
[Activity of renin-angiotensin in normal and abnormal conditions]. Saishin igaku. Modern medicine, 1967, Volume: 22, Issue:5 Topics: Adrenal Gland Diseases; Aldosterone; Angiotensin II; Humans; Hypertension; Kidney; Kidney Diseases; Renin	1967
[Renal-vascular hypertension]. Ergebnisse der inneren Medizin und Kinderheilkunde, 1967, Volume: 26 Topics: Adolescent; Adult; Aged; Aneurysm; Angiotensin II; Animals; Aortic Diseases; Arteriovenous Fistula; Child; Embolism; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Radioisotope Renography; Renal Artery; Renal Artery Obstruction; Thrombosis; Vascular Diseases	1967
Hepatorenal syndrome. A review. The American journal of gastroenterology, 1968, Volume: 49, Issue:5 Topics: Angiotensin II; Body Fluids; Central Nervous System Diseases; Humans; Kidney; Kidney Diseases; Liver; Liver Cirrhosis; Liver Diseases; Renin; Urea; Vascular Resistance	1968
Control of aldosterone secretion by the renin-angiotensin system and by corticotropin. Advances in internal medicine, 1968, Volume: 14 Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertension; Hypopituitarism; Hypotension; In Vitro Techniques; Kidney Diseases; Pheochromocytoma; Pituitary Gland; Pituitary Hormones, Anterior; Potassium; Pregnancy; Renin; Serotonin; Sodium; Stress, Physiological; Stress, Psychological; Sympathetic Nervous System	1968
[Current status of nephrology]. Medicina interna, 1968, Volume: 20, Issue:12 Topics: Acute Kidney Injury; Angiotensin II; Anti-Bacterial Agents; Antilymphocyte Serum; Humans; Immunization, Passive; Immunosuppressive Agents; Indomethacin; Kidney Diseases; Kidney Transplantation; Lymphocytes; Renal Dialysis; Renin	1968
[Renovascular hypertension in pregnancy]. Naika. Internal medicine, 1969, Volume: 24, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Female; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Norepinephrine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Complications, Cardiovascular; Renin; Time Factors; Vasopressins	1969
[The renin--angiotensin--aldosterone system]. Kardiologiia, 1969, Volume: 9, Issue:9 Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Animals; Arteries; Blood Pressure; Blood Volume; Child; Corticosterone; Dogs; Glucocorticoids; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney; Kidney Diseases; Rats; Renin; Sheep; Sodium; Stimulation, Chemical; Tissue Extracts; Water-Electrolyte Balance	1969
Autonomic control of the peripheral vascular system. Archives of internal medicine, 1970, Volume: 125, Issue:4 Topics: Angiotensin II; Autonomic Nervous System; Blood Circulation; Blood Vessels; Carotid Sinus; Central Nervous System Diseases; Chromaffin System; Cushing Syndrome; Humans; Hyperaldosteronism; Hypotension; Hypotension, Orthostatic; Kidney Diseases; Parasympathetic Nervous System; Pheochromocytoma; Pressoreceptors; Renin; Sympathetic Nervous System; Synaptic Transmission; Vascular Resistance; Vasomotor System	1970
Pre-eclampsia and related complications of pregnancy. American journal of obstetrics and gynecology, 1970, May-01, Volume: 107, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Blood Coagulation Disorders; Catecholamines; Diagnosis, Differential; Estrogens; Female; Humans; Kidney Diseases; Placenta; Placenta Diseases; Pre-Eclampsia; Pregnancy; Renin; Serotonin; Uric Acid; Vasopressins; Water-Electrolyte Balance	1970
The renin-angiotensin system in clinical medicine. American heart journal, 1970, Volume: 80, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Endocrine System Diseases; Female; Glomerular Filtration Rate; Humans; Hypertension; Hypertension, Renal; Hypotension; Kidney; Kidney Diseases; Kidney Tubules; Pregnancy; Renin; Sodium; Sympathetic Nervous System	1970
The relationship between angiotensin and aldosterone. Advances in metabolic disorders, 1971, Volume: 5 Topics: Adrenal Gland Neoplasms; Aldosterone; Alkalosis; Angiotensin II; Animals; Humans; Hyperaldosteronism; Hypertension; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Metabolism, Inborn Errors; Mixed Function Oxygenases; Renin; Sodium	1971
Renal physiology. Impact of recent developments on clinical nephrology. Pediatric clinics of North America, 1971, Volume: 18, Issue:2 Topics: Acid-Base Equilibrium; Amino Acids; Aminohippuric Acids; Angiotensin II; Blood Pressure; Child; Child, Preschool; Chlorides; Glucose; Humans; Infant; Infant, Newborn; Kidney; Kidney Concentrating Ability; Kidney Diseases; Kidney Glomerulus; Natriuresis; Potassium; Renin; Sodium	1971
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. The American journal of medicine, 1972, Volume: 52, Issue:5 Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiotensin II; Contraceptives, Oral; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Hypokalemia; Kidney; Kidney Diseases; Potassium; Renin; Sodium	1972
Renal hypertension. The New England journal of medicine, 1972, Sep-14, Volume: 287, Issue:11 Topics: Adult; Angiotensin II; Blood Pressure; Humans; Hypertension, Renal; Ischemia; Kidney; Kidney Diseases; Middle Aged; Nephrectomy; Prostaglandins; Renal Artery Obstruction; Renin; Sodium; Water	1972
Coagulation and renal disease. Kidney international, 1972, Volume: 2, Issue:4 Topics: Acute Kidney Injury; Angiotensin II; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Disorders; Catecholamines; Disseminated Intravascular Coagulation; Female; Fibrin; Heparin; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Pre-Eclampsia; Pregnancy; Renin; Thrombosis; Uremia	1972
The physiology of renin. Archives of internal medicine, 1973, Volume: 131, Issue:6 Topics: Aldosterone; Angiotensin II; Edema; Extracellular Space; Female; Glomerular Filtration Rate; Humans; Hyperaldosteronism; Hypertension; Hypotension; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Kidney Failure, Chronic; Natriuresis; Potassium; Pregnancy; Pregnancy Complications; Pressoreceptors; Regional Blood Flow; Renal Artery Obstruction; Renin; Vasopressins	1973
Toxemia of pregnancy. Mechanism and therapeutic management. The American journal of cardiology, 1973, Sep-20, Volume: 32, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Dehydroepiandrosterone; Delivery, Obstetric; Edema; Female; Fetus; Humans; Ischemia; Kidney Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Nutritional Physiological Phenomena; Placenta; Pre-Eclampsia; Pregnancy; Prostaglandins; Renin; Uterus	1973
Anaesthesia, surgery and renal function: immediate and delayed effects. Anaesthesia and intensive care, 1973, Volume: 1, Issue:5 Topics: Aldosterone; Anesthesia, Inhalation; Anesthetics; Angiotensin II; Animals; Dose-Response Relationship, Drug; Epinephrine; Glomerular Filtration Rate; Homeostasis; Humans; Infusions, Parenteral; Kidney; Kidney Diseases; Methoxyflurane; Norepinephrine; Regional Blood Flow; Renin; Surgical Procedures, Operative; Vasopressins	1973
The pathophysiology of renin. Clinical symposia (Summit, N.J. : 1957), 1973, Volume: 25, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Kidney Tubules, Distal; Nephrectomy; Nephrosclerosis; Pressoreceptors; Renin; Sympathetic Nervous System	1973

Trials

10 trial(s) available for angiotensin ii and Kidney Diseases

Article	Year
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. American journal of physiology. Renal physiology, 2003, Volume: 284, Issue:5 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Kidney Diseases; Losartan; Receptor, Angiotensin, Type 1; Renal Circulation; Renin	2003
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:9 Topics: Administration, Inhalation; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Double-Blind Method; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Prospective Studies; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan	2008
Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness. European journal of clinical pharmacology, 1982, Volume: 23, Issue:3 Topics: Adult; Aged; Angiotensin II; Blood Pressure; Blood Volume; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Muzolimine; Norepinephrine; Pyrazoles; Renin; Renin-Angiotensin System; Sodium	1982
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 28, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow	1996
[ACE-inhibitors indicated even in non-diabetic nephropathy]. Der Internist, 1996, Volume: 37, Issue:10 Suppl A Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies	1996
Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function. European journal of clinical pharmacology, 1999, Volume: 54, Issue:12 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Prodrugs; Renin; Tetrazoles	1999
Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. European journal of pediatrics, 2000, Volume: 159, Issue:8 Topics: Adolescent; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Child; Child, Preschool; Chronic Disease; Female; Humans; Irbesartan; Kidney Diseases; Male; Proteinuria; Renin-Angiotensin System; Tetrazoles; Treatment Outcome	2000
Enalapril versus triple-drug therapy in the treatment of renovascular hypertension. Drugs, 1985, Volume: 30 Suppl 1 Topics: Angiotensin II; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension, Renovascular; Kidney Diseases; Male; Middle Aged; Random Allocation; Renal Circulation; Renin; Time Factors	1985
Hepatorenal syndrome. Studies of the effect of vascular volume and intraperitoneal pressure on renal and hepatic function. The American journal of medicine, 1987, Volume: 82, Issue:3 Topics: Angiotensin II; Ascites; Blood Transfusion; Blood Volume; Combined Modality Therapy; Female; Hepatorenal Syndrome; Humans; Kidney; Kidney Diseases; Liver; Male; Peritoneal Cavity; Peritoneovenous Shunt; Plasma; Pressure; Renin; Time Factors	1987

Other Studies

389 other study(ies) available for angiotensin ii and Kidney Diseases

Article	Year
Elevated reactivity of Apelin inhibited renal fibrosis induced by chronic intermittent hypoxia. Archives of biochemistry and biophysics, 2021, 10-30, Volume: 711 Topics: Angiotensin II; Animals; Apelin; Apelin Receptors; Cell Line; Fibrosis; Humans; Hypoxia; Inflammation; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Male; Nitrobenzoates; Oxidative Stress; Pyrans; Rats, Wistar	2021
Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways. Life sciences, 2022, Jan-01, Volume: 288 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Calcineurin Inhibitors; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Glutamate-Cysteine Ligase; Kidney Diseases; Male; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Superoxide Dismutase; Tacrolimus; Uric Acid; Xanthenes	2022
Toll-like receptor 4 mutation protects the kidney from Ang-II-induced hypertensive injury. Pharmacological research, 2022, Volume: 175 Topics: Angiotensin II; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Hypertension; Kidney; Kidney Diseases; Male; Mice, Inbred C3H; Mice, Mutant Strains; Microtubule-Associated Proteins; Mutation; NF-kappa B; Signal Transduction; Toll-Like Receptor 4	2022
Activation of the Renin-Angiotensin System Disrupts the Cytoskeletal Architecture of Human Urine-Derived Podocytes. Cells, 2022, 03-24, Volume: 11, Issue:7 Topics: Angiotensin II; Humans; Kidney; Kidney Diseases; Losartan; Podocytes; Renin-Angiotensin System	2022
TIGAR deficiency sensitizes angiotensin-II-induced renal fibrosis and glomerular injury. Physiological reports, 2022, Volume: 10, Issue:8 Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Blood Pressure; Female; Fibrosis; Glycolysis; Humans; Hypertension; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphoric Monoester Hydrolases	2022
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice. Clinical science (London, England : 1979), 2022, 05-27, Volume: 136, Issue:10 Topics: Angiotensin II; Animals; Cathepsin L; Glomerulosclerosis, Focal Segmental; Imidazoles; Kidney Diseases; Male; Mice; Mice, Knockout; Podocytes; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes	2022
Interleukin-22 exacerbates angiotensin II-induced hypertensive renal injury. International immunopharmacology, 2022, Volume: 109 Topics: Angiotensin II; Animals; Fibrosis; Humans; Hypertension; Inflammation; Interleukin-22; Interleukins; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL	2022
Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension. International journal of molecular sciences, 2022, Jul-12, Volume: 23, Issue:14 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Hypertension; Immunosuppression Therapy; Kidney; Kidney Diseases; Mycophenolic Acid; Proteinuria; Rats; Rats, Sprague-Dawley; RNA, Messenger	2022
Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models. PloS one, 2022, Volume: 17, Issue:8 Topics: Albuminuria; Angiotensin II; Animals; Disease Models, Animal; Gain of Function Mutation; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Diseases; Mice; Mutation; Podocytes; TRPC6 Cation Channel	2022
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes. British journal of pharmacology, 2023, Volume: 180, Issue:1 Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Humans; Hypertension; Kidney Diseases; Liver; Rats; Renin; Renin-Angiotensin System; RNA, Small Interfering; Valsartan	2023
Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15/Nrf2 signaling. Free radical biology & medicine, 2022, 11-20, Volume: 193, Issue:Pt 1 Topics: Angiotensin II; Animals; Ferroptosis; Fibrosis; Hypertension; Kidney; Kidney Diseases; Kruppel-Like Transcription Factors; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Sirtuins	2022
Structural characterization and protective effect against renal fibrosis of polysaccharide from Ligustrum lucidum Ait. Journal of ethnopharmacology, 2023, Feb-10, Volume: 302, Issue:Pt A Topics: Angiotensin II; Animals; Chemokine CCL5; Fibrosis; Kidney; Kidney Diseases; Ligustrum; Male; Mice; Polysaccharides; Ureteral Obstruction	2023
Chronic administration of catalase inhibitor attenuates hypertension in renovascular hypertensive rats. Life sciences, 2023, Apr-15, Volume: 319 Topics: Angiotensin II; Animals; Blood Pressure; Catalase; Hydrogen Peroxide; Hypertension; Hypertension, Renovascular; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger	2023
Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage. International journal of molecular sciences, 2019, Sep-07, Volume: 20, Issue:18 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Connexin 43; Creatinine; Disease Models, Animal; Gene Expression Regulation; Kidney Diseases; Male; Oxidative Stress; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Time Factors	2019
Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα. Journal of pharmacological sciences, 2019, Volume: 141, Issue:1 Topics: Angiotensin II; Cells, Cultured; Fibrosis; Fused Kidney; Gene Expression; Humans; Kidney; Kidney Diseases; MicroRNAs; Molecular Targeted Therapy; PPAR alpha; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1	2019
HIF-1α contributes to Ang II-induced inflammatory cytokine production in podocytes. BMC pharmacology & toxicology, 2019, 10-17, Volume: 20, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Cytokines; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Male; Podocytes; Rats, Wistar; RNA, Small Interfering	2019
Critical roles of PI3K/Akt/NF‑κB survival axis in angiotensin II‑induced podocyte injury. Molecular medicine reports, 2019, Volume: 20, Issue:6 Topics: Angiotensin II; Animals; Apoptosis; Caspase 9; Cell Line; Cell Survival; Disease Susceptibility; Kidney Diseases; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Podocytes; Proto-Oncogene Proteins c-akt; Signal Transduction	2019
MicroRNA-200c-3p inhibits proliferation and migration of renal artery endothelial cells by directly targeting ZEB2. Experimental cell research, 2020, 02-15, Volume: 387, Issue:2 Topics: Angiotensin II; Animals; Cell Line; Cell Movement; Cell Proliferation; Endothelial Cells; Hypertension; Kidney Diseases; MicroRNAs; Rats; Renal Artery; Up-Regulation; Zinc Finger E-box Binding Homeobox 2	2020
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension. American journal of nephrology, 2020, Volume: 51, Issue:2 Topics: Angiotensin II; Animals; Benzhydryl Compounds; Fibrosis; Glucosides; Hypertension; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors	2020
Antihypertensive and renal protective effect of Shunaoxin pill combined with captopril on spontaneous hypertension rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Captopril; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelin-1; Gene Expression Regulation; Hypertension; Kidney Diseases; Lipid Metabolism; Nitric Oxide; Nitric Oxide Synthase; Random Allocation; Rats; Rats, Inbred SHR	2020
T-cell senescence accelerates angiotensin II-induced target organ damage. Cardiovascular research, 2021, 01-01, Volume: 117, Issue:1 Topics: Adoptive Transfer; Angiotensin II; Animals; Aorta; Cardiovascular Diseases; Cell Line; Disease Models, Animal; Homeodomain Proteins; Humans; Hypertension; Immunosenescence; Inflammation Mediators; Interferon-gamma; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Oxidative Stress; Phenotype; Superoxides; T-Lymphocytes; Time Factors	2021
Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to Nicotinamide N-Methyltransferase (NNMT) expression. Journal of ethnopharmacology, 2020, Jun-12, Volume: 255 Topics: Acetylation; Angiotensin II; Animals; Cell Proliferation; Cortactin; Disease Models, Animal; DNA Methylation; Drugs, Chinese Herbal; Epigenesis, Genetic; Epithelial Cells; HEK293 Cells; Histones; Humans; Hypertension; Kidney; Kidney Diseases; Male; Nicotinamide N-Methyltransferase; Rats, Inbred SHR; Rats, Inbred WKY; S-Adenosylhomocysteine; Sirtuin 1	2020
Endothelial prolyl hydroxylase 2 is necessary for angiotensin II-mediated renal fibrosis and injury. American journal of physiology. Renal physiology, 2020, 08-01, Volume: 319, Issue:2 Topics: Angiotensin II; Animals; Endothelial Cells; Endothelium; Fibrosis; Hypoxia-Inducible Factor-Proline Dioxygenases; Kidney; Kidney Diseases; Mice; Mice, Knockout; Procollagen-Proline Dioxygenase; RNA, Small Interfering	2020
Collecting duct cells show differential retinoic acid responses to acute versus chronic kidney injury stimuli. Scientific reports, 2020, 10-07, Volume: 10, Issue:1 Topics: Acetylcholine; Albumins; Aldosterone; Angiotensin II; Animals; Calcitonin Gene-Related Peptide; Cell Line; Cisplatin; Endothelin-1; Female; Glucose; Humans; Kidney Diseases; Kidney Tubules, Collecting; Lipopolysaccharides; Mice; Mice, Transgenic; Receptors, Retinoic Acid; Tretinoin; Vasopressins	2020
SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis. Cells, 2020, 11-20, Volume: 9, Issue:11 Topics: Angiotensin II; Animals; Disease Models, Animal; Fibrosis; Humans; Hypertension; Kidney; Kidney Diseases; Mice; Sirtuin 3	2020
FoxM1 promotes Wnt/β-catenin pathway activation and renal fibrosis via transcriptionally regulating multi-Wnts expressions. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:4 Topics: Angiotensin II; Animals; Biomarkers; Cells, Cultured; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Fibrosis; Forkhead Box Protein M1; Gene Expression Regulation; Humans; Immunohistochemistry; Kidney Diseases; Kidney Tubules; Male; Mice; Wnt Proteins; Wnt Signaling Pathway	2021
Tubular Mas receptor mediates lipid-induced kidney injury. Cell death & disease, 2021, 01-21, Volume: 12, Issue:1 Topics: Angiotensin II; Animals; Autophagy; Cell Line; Diet, High-Fat; Endoplasmic Reticulum Stress; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled	2021
Evaluation of the Effect of Captopril and Losartan on Tacrolimus-induced Nephrotoxicity in Rats. Drug research, 2021, Volume: 71, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Creatinine; Epithelium; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Male; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Tacrolimus	2021
Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice. Clinical science (London, England : 1979), 2021, 04-16, Volume: 135, Issue:7 Topics: Adult; Angiotensin II; Animals; Cell Line; Female; Humans; Hypertension; Kidney Diseases; Male; Mice; Mice, Transgenic; Middle Aged; Renin-Angiotensin System; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2021
Loss of Soluble (Pro)renin Receptor Attenuates Angiotensin-II Induced Hypertension and Renal Injury. Circulation research, 2021, 06-25, Volume: 129, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension; Kidney; Kidney Diseases; Male; Mesenteric Arteries; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Prorenin Receptor; Proton-Translocating ATPases; Receptors, Cell Surface; Renin-Angiotensin System; Signal Transduction; Vasoconstriction; Vasodilation; Water-Electrolyte Balance	2021
Clemizole and La Physiological reports, 2021, Volume: 9, Issue:10 Topics: Angiotensin II; Animals; Benzimidazoles; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glomerular Filtration Rate; Heart Rate; Kidney Diseases; Kidney Glomerulus; Lanthanoid Series Elements; Male; Rats; Rats, Sprague-Dawley; Salts	2021
NLRP3 Deletion Attenuated Angiotensin II-Induced Renal Fibrosis by Improving Mitochondrial Dysfunction and Endoplasmic Reticulum Stress. Nephron, 2021, Volume: 145, Issue:5 Topics: Angiotensin II; Animals; Endoplasmic Reticulum Stress; Humans; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species	2021
Sinigrin attenuates angiotensin II‑induced kidney injury by inactivating nuclear factor‑κB and extracellular signal‑regulated kinase signaling International journal of molecular medicine, 2021, Volume: 48, Issue:2 Topics: Angiotensin II; Animals; Cell Line; Chemokine CCL2; Creatinine; Gene Expression Regulation; Glucosinolates; Humans; Inflammation; Kidney; Kidney Diseases; Malondialdehyde; MAP Kinase Signaling System; NF-kappa B; Oxidative Stress; Rats, Inbred SHR; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha	2021
Sex differences in angiotensin II-induced hypertension and kidney injury: role of AT1a receptors in the proximal tubule of the kidney. Clinical science (London, England : 1979), 2021, 08-13, Volume: 135, Issue:15 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterial Pressure; Disease Models, Animal; Female; Fibrosis; Hypertension; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Male; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sex Characteristics; Sex Factors; Signal Transduction	2021
Long Noncoding RNA Hypertension (Dallas, Tex. : 1979), 2021, Volume: 78, Issue:3 Topics: Angiotensin II; Cell Line; Fibrosis; Gene Expression Regulation; Humans; Kidney; Kidney Diseases; MicroRNAs; Receptors, Mineralocorticoid; RNA, Long Noncoding	2021
Angiotensin II-induced natriuresis is attenuated in knockout mice lacking the receptors for tumor necrosis factor-α. Physiological reports, 2021, Volume: 9, Issue:15 Topics: Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Hemodynamics; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Natriuresis; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Renal Circulation; Sodium	2021
Blocking of interleukin-1 suppresses angiotensin II-induced renal injury. Clinical science (London, England : 1979), 2021, 09-17, Volume: 135, Issue:17 Topics: Angiotensin II; Animals; Antibodies; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Fibrosis; Humans; Hypertension; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction	2021
rAAV9-mediated supplementation of miR-29b improve angiotensin-II induced renal fibrosis in mice. Molecular medicine (Cambridge, Mass.), 2021, 08-18, Volume: 27, Issue:1 Topics: Angiotensin II; Animals; Cell Line; Dependovirus; Disease Models, Animal; Fibrosis; Gene Expression; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Immunohistochemistry; Kidney Diseases; Male; Mice; MicroRNAs; Transduction, Genetic	2021
Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2). Scientific reports, 2017, 03-21, Volume: 7 Topics: Angiotensin II; Animals; Biopsy; Cytokines; Disease Models, Animal; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Inflammation Mediators; Kidney Diseases; Kidney Function Tests; Kidney Tubules; Lymphocyte Antigen 96; Mice; Mice, Knockout; NF-kappa B; Protein Binding; Signal Transduction; Toll-Like Receptor 4	2017
2-Methoxyestradiol Reduces Angiotensin II-Induced Hypertension and Renal Dysfunction in Ovariectomized Female and Intact Male Mice. Hypertension (Dallas, Tex. : 1979), 2017, Volume: 69, Issue:6 Topics: 2-Methoxyestradiol; Angiotensin II; Animals; Blood Pressure; Blood Pressure Determination; Cytochrome P-450 CYP1B1; Disease Models, Animal; Estradiol; Female; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ovariectomy; Random Allocation; Reactive Oxygen Species; Sensitivity and Specificity; Sex Factors	2017
Colchicine attenuates renal fibrosis in a murine unilateral ureteral obstruction model. Molecular medicine reports, 2017, Volume: 15, Issue:6 Topics: Angiotensin II; Animals; Biomarkers; Cell Line; Cell Movement; Cell Survival; Colchicine; Disease Models, Animal; Fibroblasts; Fibrosis; Immunohistochemistry; Kidney Diseases; Male; Mice; Rats; rhoA GTP-Binding Protein; Ureteral Obstruction	2017
Thymoquinone ameliorates renal damage in unilateral ureteral obstruction in rats. Pharmacological reports : PR, 2017, Volume: 69, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzoquinones; Biomarkers; Captopril; Chemokine CCL2; Gene Expression Regulation; Kidney; Kidney Diseases; Losartan; Male; Oxidative Stress; Rats; Rats, Wistar; Sulfhydryl Compounds; Ureteral Obstruction	2017
Angiotensin II induces calcium/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. Journal of molecular medicine (Berlin, Germany), 2017, Volume: 95, Issue:8 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcineurin; Calcium; Calcium Signaling; Cells, Cultured; Down-Regulation; Humans; Hypertension; Kidney Diseases; Kidney Glomerulus; Losartan; Male; Mice, Inbred C57BL; MicroRNAs; Podocytes	2017
The loss of Krüppel-like factor 15 in Foxd1 Kidney international, 2017, Volume: 92, Issue:5 Topics: Angiotensin II; Animals; beta Catenin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Fibrosis; Forkhead Transcription Factors; Gene Expression Regulation; Gene Knockdown Techniques; Kidney; Kidney Diseases; Kruppel-Like Transcription Factors; Male; Mice; Mice, Inbred C57BL; Myofibroblasts; Phosphorylation; RNA, Messenger; Stromal Cells; Transcription Factors; Wnt Signaling Pathway; Wnt1 Protein	2017
Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II. American journal of hypertension, 2017, Dec-08, Volume: 31, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Phenotype; Species Specificity; Transforming Growth Factor beta; Vasoconstrictor Agents	2017
Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2017, Dec-01, Volume: 36 Topics: Angiotensin II; Animals; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney Diseases; Mice; Phosphorylation; Podocytes; ras Proteins; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Smad2 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triterpenes; Up-Regulation; Wolfiporia	2017
Upregulation of Cabin1 During Injury to Renal Tubular Epithelial Cells in Rats. Iranian journal of kidney diseases, 2017, Volume: 11, Issue:6 Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Cadherins; Cell Line; Disease Models, Animal; Epithelial Cells; Fibrosis; Kidney Diseases; Kidney Tubules; Mitochondria; Mitochondrial Swelling; Nephrectomy; Rats, Sprague-Dawley; Smad Proteins; Time Factors; Up-Regulation	2017
Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3 Topics: Angiotensin II; Animals; Cytochrome P450 Family 4; Enzyme Induction; Fibrosis; Formamides; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Knockout; Morpholines	2018
Role of c-Abl and nephrin in podocyte cytoskeletal remodeling induced by angiotensin II. Cell death & disease, 2018, 02-07, Volume: 9, Issue:2 Topics: Adult; Angiotensin II; Animals; Binding Sites; Chlorocebus aethiops; COS Cells; Cytoskeleton; Female; Genes, abl; Humans; Kidney Diseases; Male; Membrane Proteins; Mice; Middle Aged; Phosphorylation; Podocytes; Proto-Oncogene Proteins c-abl; src Homology Domains; Young Adult	2018
Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2018, Mar-15, Volume: 42 Topics: Alisma; Angiotensin II; Animals; Cell Line; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Phosphatidylinositol 3-Kinases; Phosphorylation; ras Proteins; Rats; Smad3 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triterpenes; Wnt Signaling Pathway	2018
Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European journal of pharmacology, 2018, Jul-15, Volume: 831 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; beta Catenin; Cytoprotection; Disease Models, Animal; Hydroxycholecalciferols; Intercellular Adhesion Molecule-1; Interleukin-18; Kidney; Kidney Diseases; Male; Neutrophil Infiltration; NF-kappa B; Peptidyl-Dipeptidase A; Peroxidase; Pioglitazone; Rats, Sprague-Dawley; Reperfusion Injury; Thiazolidinediones; Time Factors; Transforming Growth Factor beta; Wnt Signaling Pathway; Wnt4 Protein	2018
Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition. The Journal of physiology, 2018, Volume: 596, Issue:16 Topics: Angiotensin II; Animals; Cells, Cultured; Epithelial-Mesenchymal Transition; Fibrosis; Hypertension, Renal; Kidney Diseases; Kidney Tubules, Proximal; Male; Membrane Microdomains; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta1	2018
Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction. Phytotherapy research : PTR, 2018, Volume: 32, Issue:11 Topics: Angiotensin II; Animals; Apoptosis; Captopril; Chemokine CCL2; Creatinine; Fibrosis; Inflammation; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Nigella sativa; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Urea; Ureteral Obstruction	2018
Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells. Journal of feline medicine and surgery, 2019, Volume: 21, Issue:8 Topics: Angiotensin II; Animals; Cat Diseases; Cats; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Kidney; Kidney Diseases; Transforming Growth Factor beta	2019
Caspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1. Acta pharmacologica Sinica, 2019, Volume: 40, Issue:6 Topics: Angiotensin II; Animals; Caspase 1; Caspase Inhibitors; Caspases; Caspases, Initiator; Coumarins; Enzyme Activation; Extracellular Matrix; Fibrosis; Gene Silencing; Interleukin-1beta; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Rats; RNA, Small Interfering; Ureteral Obstruction	2019
1,25-Dihydroxyvitamin D3 Attenuates Angiotensin II-Induced Renal Injury by Inhibiting Mitochondrial Dysfunction and Autophagy. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 51, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Calcitriol; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mitochondria; Vitamins	2018
Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high-fat diet. American journal of physiology. Renal physiology, 2019, 02-01, Volume: 316, Issue:2 Topics: Abdominal Fat; Adipokines; Adiposity; Age Factors; Albuminuria; Angiotensin II; Animals; Arterial Pressure; Diet, High-Fat; Disease Progression; Female; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Obesity; Rats, Sprague-Dawley; Sex Factors; Time Factors	2019
Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients. Transplantation, 2019, Volume: 103, Issue:6 Topics: ADP-ribosyl Cyclase; Adult; Angiotensin II; Antigens, CD; Biomarkers; Case-Control Studies; Female; Fibrosis; Glutamate-Ammonia Ligase; GPI-Linked Proteins; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Laminin; Male; Mass Spectrometry; Middle Aged; Predictive Value of Tests; rhoB GTP-Binding Protein; Thiolester Hydrolases; Thrombospondin 1; Treatment Outcome; Urinalysis	2019
2-Methoxyestradiol Attenuates Angiotensin II-Induced Hypertension, Cardiovascular Remodeling, and Renal Injury. Journal of cardiovascular pharmacology, 2019, Volume: 73, Issue:3 Topics: 2-Methoxyestradiol; Angiotensin II; Animals; Blood Pressure; Fibrosis; Glomerular Filtration Rate; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Kidney; Kidney Diseases; Male; Rats, Sprague-Dawley; Renin-Angiotensin System; Vascular Remodeling; Ventricular Function, Left; Ventricular Remodeling	2019
Kangxianling decoction prevents renal fibrosis in rats with 5/6 nephrectomy and inhibits Ang II-induced ECM production in glomerular mesangial cells. Journal of pharmacological sciences, 2019, Volume: 139, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Fibronectins; Fibrosis; Glomerular Mesangium; Kidney; Kidney Diseases; Male; MAP Kinase Signaling System; Mesangial Cells; Nephrectomy; Rats, Sprague-Dawley; Transforming Growth Factor beta; Up-Regulation	2019
Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction. British journal of pharmacology, 2019, Volume: 176, Issue:14 Topics: Aminosalicylic Acids; Angiotensin II; Animals; Benzenesulfonates; Cells, Cultured; Disease Models, Animal; Fibrosis; Humans; Hypertension, Renal; Infusions, Subcutaneous; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephritis; RNA, Small Interfering; STAT3 Transcription Factor; Toll-Like Receptor 4	2019
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice. Scientific reports, 2019, 04-17, Volume: 9, Issue:1 Topics: Angiotensin II; Animals; Drugs, Chinese Herbal; Fibrosis; Ghrelin; Inflammation; Kidney Diseases; Mice; Treatment Outcome	2019
Renal impairment induced by prenatal exposure to angiotensin II in male rat offspring. Experimental biology and medicine (Maywood, N.J.), 2019, Volume: 244, Issue:11 Topics: Angiotensin II; Animals; Cardiovascular System; Epithelial Cells; Female; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Macrophages; Male; Neutrophils; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; T-Lymphocytes, Cytotoxic	2019
A virus-induced kidney disease model based on organ-on-a-chip: Pathogenesis exploration of virus-related renal dysfunctions. Biomaterials, 2019, Volume: 219 Topics: Absorption, Physiological; Angiotensin II; Animals; Cell Polarity; Disease Models, Animal; Dogs; Herpesvirus 1, Suid; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Lab-On-A-Chip Devices; Madin Darby Canine Kidney Cells; Microfluidics; Sodium	2019
Fluorofenidone inhibits nicotinamide adeninedinucleotide phosphate oxidase via PI3K/Akt pathway in the pathogenesis of renal interstitial fibrosis. Nephrology (Carlton, Vic.), 2013, Volume: 18, Issue:10 Topics: Angiotensin II; Animals; Antioxidants; Cell Line; Class Ia Phosphatidylinositol 3-Kinase; Collagen Type I; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Fibrosis; Kidney Diseases; Kidney Tubules; Lipid Peroxidation; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridones; Rats; Rats, Sprague-Dawley; Signal Transduction; Transfection; Ureteral Obstruction	2013
Renin angiotensin system blockade ameliorates lead nephropathy. Biochemical and biophysical research communications, 2013, Aug-23, Volume: 438, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Gene Expression Regulation; Glomerular Filtration Rate; Kidney Diseases; Lead Poisoning; Losartan; Male; Peptidyl-Dipeptidase A; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Transforming Growth Factor beta	2013
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading. Clinical and experimental nephrology, 2014, Volume: 18, Issue:4 Topics: Albuminuria; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progression; Down-Regulation; Fumarates; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Ramipril; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors	2014
Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Kidney international, 2014, Volume: 85, Issue:5 Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antibodies, Monoclonal; Disease Models, Animal; Exotoxins; Genotype; Kidney Diseases; Kidney Tubules, Proximal; Liver; Membrane Proteins; Mice, Knockout; Phenotype; Podocytes; RNA, Messenger; Sodium; Time Factors; Up-Regulation	2014
Deficiency of the interleukin 17/23 axis accelerates renal injury in mice with deoxycorticosterone acetate+angiotensin ii-induced hypertension. Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Desoxycorticosterone Acetate; Hypertension; Interleukin-17; Kidney Diseases; Mice; Mice, Inbred C57BL; Signal Transduction	2014
Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats. Life sciences, 2014, Nov-24, Volume: 118, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Endothelin Receptor Antagonists; Endothelin-1; Kidney; Kidney Diseases; Nephrectomy; Protective Agents; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Endothelin A; Renin; Renin-Angiotensin System; Systole	2014
The restoration of kidney mitochondria function by inhibition of angiotensin-II production in rats with acute adriamycin-induced nephrotoxicity. Renal failure, 2014, Volume: 36, Issue:4 Topics: Adenosine Triphosphate; Amides; Angiotensin II; Animals; Captopril; Creatine Kinase; Doxorubicin; Fumarates; Kidney; Kidney Diseases; Male; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Renin-Angiotensin System	2014
Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension. Clinical science (London, England : 1979), 2014, Volume: 127, Issue:3 Topics: Angiotensin II; Animals; Disease Models, Animal; Gene Transfer Techniques; Genetic Therapy; Hypertension, Renal; Immunohistochemistry; Interleukin-1beta; Kidney; Kidney Diseases; Macrophages; Male; Mice; Mice, Inbred Strains; Nephritis; NF-kappa B; Real-Time Polymerase Chain Reaction; Signal Transduction; Smad7 Protein; Tumor Necrosis Factor-alpha	2014
Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis. American journal of physiology. Renal physiology, 2014, May-01, Volume: 306, Issue:9 Topics: Actins; Angiotensin II; Animals; Cadherins; Cells, Cultured; Culture Media, Conditioned; Cyclic GMP-Dependent Protein Kinase Type I; Cytokines; Disease Models, Animal; Fibrosis; Inflammation Mediators; Kidney Diseases; Kidney Tubules, Proximal; Macrophages; Male; Mice; Mice, Transgenic; Phosphodiesterase 5 Inhibitors; Phosphorylation; Piperazines; Purines; Signal Transduction; Sildenafil Citrate; Smad2 Protein; Sulfones; Time Factors; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction	2014
ADAMTS-7 expression increases in the early stage of angiotensin II-induced renal injury in elderly mice. Kidney & blood pressure research, 2013, Volume: 38, Issue:1 Topics: ADAM Proteins; ADAMTS7 Protein; Aging; Angiotensin II; Animals; Blood Pressure; HEK293 Cells; Humans; Inflammation; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Vasoconstrictor Agents	2013
[Changes of Ang II during renal injury induced by cisplatin]. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology, 2014, Volume: 30, Issue:1 Topics: Angiotensin II; Cisplatin; Humans; Kidney; Kidney Diseases	2014
Special deLIVERy: podocyte injury promotes renal angiotensin II generation from liver-derived angiotensinogen. Kidney international, 2014, Volume: 85, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Kidney Diseases; Kidney Tubules, Proximal; Liver; Podocytes	2014
Calcitriol supplementation improves endothelium-dependent vasodilation in rat hypertensive renal injury. Kidney & blood pressure research, 2014, Volume: 39, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcitriol; Dietary Supplements; Dinoprost; Disease Models, Animal; Endothelium, Vascular; Glucuronidase; Hypertension; Irbesartan; Kidney; Kidney Diseases; Klotho Proteins; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Tetrazoles; Vasodilation; Vitamins	2014
CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis. Arteriosclerosis, thrombosis, and vascular biology, 2014, Volume: 34, Issue:7 Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Bone Marrow Transplantation; Cytokines; Disease Models, Animal; Fibrosis; Green Fluorescent Proteins; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myofibroblasts; Receptors, CXCR; Receptors, CXCR6; Signal Transduction; T-Lymphocytes; Time Factors	2014
Regulator of G protein signaling 2 (RGS2) deficiency accelerates the progression of kidney fibrosis. Biochimica et biophysica acta, 2014, Volume: 1842, Issue:9 Topics: Angiotensin II; Animals; Blotting, Western; Cells, Cultured; Disease Progression; Female; Fibrosis; Humans; Immunoenzyme Techniques; Kidney Diseases; Mice; Mice, Knockout; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; RGS Proteins; RNA, Messenger; Ureteral Obstruction	2014
Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney. Acta pharmacologica Sinica, 2014, Volume: 35, Issue:8 Topics: Acetylation; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Phosphorylation; Rats; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes	2014
Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy. BioMed research international, 2014, Volume: 2014 Topics: Angiotensin II; Animals; Atorvastatin; Disease Models, Animal; Fibrosis; Heptanoic Acids; Humans; Kidney; Kidney Diseases; Mice; Monomeric GTP-Binding Proteins; Pyrroles; Receptor, Angiotensin, Type 1; Signal Transduction; Ureteral Obstruction	2014
Angiotensin II in paraventricular nucleus contributes to sympathoexcitation in renal ischemia-reperfusion injury by AT1 receptor and oxidative stress. The Journal of surgical research, 2015, Volume: 193, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; Losartan; Male; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats, Sprague-Dawley; Receptors, Angiotensin; Reperfusion Injury; Spin Labels; Sympathetic Nervous System	2015
[Effect of compound qingqin liquid on the expression levels of ang II and COX-2 mRNA transcription and protein expression in the renal tissue of uric acid nephropathy rats: an experimental study]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2014, Volume: 34, Issue:7 Topics: Angiotensin II; Animals; Cyclooxygenase 2; Disease Models, Animal; Drugs, Chinese Herbal; Kidney; Kidney Diseases; Male; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Uric Acid	2014
Clusterin/apolipoprotein J attenuates angiotensin II-induced renal fibrosis. PloS one, 2014, Volume: 9, Issue:8 Topics: Angiotensin II; Animals; Clusterin; Fibrosis; Humans; Kidney Diseases; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1	2014
Ets-1 targeted by microrna-221 regulates angiotensin II-induced renal fibroblast activation and fibrosis. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, Volume: 34, Issue:4 Topics: Angiotensin II; Animals; Cell Line; Cell Proliferation; Down-Regulation; Female; Fibroblasts; Fibronectins; Fibrosis; Gene Expression; Kidney; Kidney Diseases; Mice; Mice, Inbred BALB C; MicroRNAs; Proto-Oncogene Protein c-ets-1; Rats; Up-Regulation	2014
Angiotensin II removes kidney resistance conferred by ischemic preconditioning. BioMed research international, 2014, Volume: 2014 Topics: Angiotensin II; Animals; Creatinine; Fibrosis; Ischemic Preconditioning; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptor, Angiotensin, Type 1; Signal Transduction	2014
Role of nephrin in podocyte injury induced by angiotension II. Journal of receptor and signal transduction research, 2016, Volume: 36, Issue:1 Topics: Angiotensin II; Anti-Arrhythmia Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cells, Cultured; Humans; Kidney Diseases; Kidney Glomerulus; Losartan; Membrane Proteins; Podocytes; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vasoconstrictor Agents	2016
Benefical therapeutic effect of Chinese Herbal Xinji'erkang formula on hypertension-induced renal injury in the 2-kidney-1-clip hypertensive rats. African journal of traditional, complementary, and alternative medicines : AJTCAM, 2014, Volume: 11, Issue:5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Drugs, Chinese Herbal; Hypertension; Kidney; Kidney Diseases; Magnoliopsida; Male; Organ Size; Phytotherapy; Rats, Sprague-Dawley; Renal Artery; Surgical Instruments; Transforming Growth Factor beta1	2014
Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice. Clinical science (London, England : 1979), 2015, May-01, Volume: 128, Issue:10 Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Type 1; Fibrosis; Gene Expression Regulation; Histological Techniques; Hypertension; Immunohistochemistry; Injections, Subcutaneous; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled	2015
Renoprotective effect of aliskiren on renal ischemia/reperfusion injury in rats: electron microscopy and molecular study. Renal failure, 2015, Volume: 37, Issue:2 Topics: Amides; Angiotensin II; Animals; Antihypertensive Agents; Creatinine; Fumarates; Kidney; Kidney Diseases; Male; Malondialdehyde; Microscopy, Electron; Nitric Oxide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Renin; Reperfusion Injury; Superoxide Dismutase; Treatment Outcome	2015
Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury. American journal of physiology. Renal physiology, 2015, Apr-15, Volume: 308, Issue:8 Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antibodies, Monoclonal; Disease Models, Animal; Down-Regulation; Exotoxins; Female; Glomerular Filtration Rate; Humans; Interleukin-2 Receptor alpha Subunit; Kidney Diseases; Mice, Inbred C57BL; Mice, Transgenic; Podocytes; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Time Factors; Ureteral Obstruction	2015
Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice. American journal of physiology. Renal physiology, 2015, May-01, Volume: 308, Issue:9 Topics: Angiotensin II; Animals; Catalase; Cytochrome P-450 CYP1B1; Disease Models, Animal; Drinking; Estradiol; Female; Fibrosis; Genotype; Hypertension; Kidney; Kidney Diseases; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Natriuresis; Oxidative Stress; Phenotype; Renin-Angiotensin System; Sex Factors; Superoxide Dismutase; Superoxides; Tyrosine; Urination	2015
β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats. BioMed research international, 2015, Volume: 2015 Topics: Angiotensin II; Animals; beta Catenin; Blood Pressure; Cyclin D1; Fibrosis; Humans; Hypertension; Kidney; Kidney Diseases; Lisinopril; Proto-Oncogene Proteins c-myc; Pyrvinium Compounds; Rats; Signal Transduction	2015
Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension. American journal of hypertension, 2016, Volume: 29, Issue:2 Topics: Angiotensin II; Animals; Endothelins; Fibrosis; Group IV Phospholipases A2; Hypertension; Kidney; Kidney Diseases; Male; Mice; Renal Circulation; Vascular Resistance	2016
Immunization with an ApoB-100 Related Peptide Vaccine Attenuates Angiotensin-II Induced Hypertension and Renal Fibrosis in Mice. PloS one, 2015, Volume: 10, Issue:6 Topics: Angiotensin II; Animals; Apolipoprotein B-100; Blood Pressure; Cytokines; Disease Models, Animal; Fibrosis; Gene Expression; Hypertension; Immunization; Kidney Diseases; Lymphocyte Depletion; Male; Mice; Mice, Knockout; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Peptides; Reactive Oxygen Species; T-Lymphocyte Subsets; Vaccines, Subunit	2015
Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c. American journal of physiology. Renal physiology, 2015, Oct-01, Volume: 309, Issue:7 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type III; Computational Biology; Extracellular Matrix Proteins; Fibrosis; Gene Knockdown Techniques; Interleukin-6; Kidney; Kidney Diseases; Leukemia Inhibitory Factor; Mice; MicroRNAs; Nephritis, Interstitial; Rats; STAT3 Transcription Factor; Transfection; Ureteral Obstruction	2015
Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease. Scientific reports, 2015, Jul-24, Volume: 5 Topics: Angiotensin II; Animals; Dinoprostone; Electron Transport Complex I; Epithelial Sodium Channels; Gene Expression Regulation; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitochondria; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase Type II; Rotenone; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Ureteral Obstruction	2015
A hypothesis on the conflicting results of angiotensin converting enzyme inhibitor in the prevention of contrast-induced nephropathy. Medical hypotheses, 2015, Volume: 85, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Contrast Media; Humans; Hypoxia; Kidney Diseases; Practice Guidelines as Topic; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstriction; Vasodilation; Vasodilator Agents	2015
Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 356, Issue:1 Topics: Actins; Angiotensin II; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Collagen Type IV; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Knockdown Techniques; Kidney Diseases; MAP Kinase Signaling System; Mesangial Cells; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Rats; Renin-Angiotensin System; Repressor Proteins; RNA, Small Interfering; src-Family Kinases; Transforming Growth Factor beta	2016
Renal oxidative stress and renal CD8(+) T-cell infiltration in mercuric chloride-induced nephropathy in rats: role of angiotensin II. Journal of immunotoxicology, 2016, Volume: 13, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; CD8-Positive T-Lymphocytes; Enalapril; Glutathione; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Mercuric Chloride; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley	2016
Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats. PloS one, 2015, Volume: 10, Issue:11 Topics: Angiotensin I; Angiotensin II; Animals; Apoptosis; Cell Line; Kidney; Kidney Diseases; Male; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Transforming Growth Factor beta1	2015
Impaired response of regulator of Gαq signaling-2 mRNA to angiotensin II and hypertensive renal injury in Dahl salt-sensitive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2016, Volume: 39, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Dahl; RGS Proteins; Sodium, Dietary	2016
Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney. American journal of physiology. Renal physiology, 2016, Mar-01, Volume: 310, Issue:5 Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Glucose; Cell Line; Cell Survival; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fumarates; Gene Expression Regulation; Heat-Shock Proteins; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice, Inbred C57BL; Palmitic Acid; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Transcription Factor CHOP; Tunicamycin; Unfolded Protein Response; Valsartan	2016
Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy. Scientific reports, 2015, Dec-22, Volume: 5 Topics: Angiotensin II; Animals; Biomarkers; Cardiomyopathies; Cytokines; Denervation; Fibrosis; Heart Atria; Heart Ventricles; Inflammation Mediators; Isoproterenol; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats, Sprague-Dawley; Renin-Angiotensin System	2015
Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts. International journal of molecular sciences, 2016, Jan-22, Volume: 17, Issue:2 Topics: Angiotensin II; Animals; Disease Models, Animal; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Regulation; Kidney Diseases; MAP Kinase Signaling System; Metformin; Mice; Transforming Growth Factor beta; Ureteral Obstruction	2016
6β-Hydroxytestosterone, a Cytochrome P450 1B1-Testosterone-Metabolite, Mediates Angiotensin II-Induced Renal Dysfunction in Male Mice. Hypertension (Dallas, Tex. : 1979), 2016, Volume: 67, Issue:5 Topics: Analysis of Variance; Angiotensin II; Animals; Biopsy, Needle; Castration; Cytochrome P-450 CYP1B1; Disease Models, Animal; Hydroxytestosterones; Hypertension; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Male; Mice; Oxidative Stress; Random Allocation; Reactive Oxygen Species; Reference Values; Risk Factors; RNA, Messenger	2016
N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys. Acta pharmacologica Sinica, 2016, Volume: 37, Issue:5 Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Cell Line; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System; Ureteral Obstruction	2016
TNF/Ang-II synergy is obligate for fibroinflammatory pathology, but not for changes in cardiorenal function. Physiological reports, 2016, Volume: 4, Issue:8 Topics: Angiotensin II; Animals; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Fibrosis; Flow Cytometry; Heart; Heart Diseases; Inflammation; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Tumor Necrosis Factor, Type I; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha	2016
Vascular Smooth Muscle-Specific EP4 Receptor Deletion in Mice Exacerbates Angiotensin II-Induced Renal Injury. Antioxidants & redox signaling, 2016, 10-20, Volume: 25, Issue:12 Topics: Angiotensin II; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Kidney; Kidney Diseases; Mesenteric Arteries; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Prostaglandin E, EP4 Subtype; Renal Circulation	2016
Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis. Autophagy, 2016, Volume: 12, Issue:9 Topics: Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Collagen Type I; Epithelial Cells; Fibrosis; G2 Phase; Gene Deletion; Humans; Kidney; Kidney Diseases; Kidney Tubules; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Signal Transduction; Sirolimus	2016
NLRP3 inflammasome activation is involved in Ang II-induced kidney damage via mitochondrial dysfunction. Oncotarget, 2016, 08-23, Volume: 7, Issue:34 Topics: Angiotensin II; Animals; Cells, Cultured; Epithelial Cells; Kidney Diseases; Kidney Tubules; Mice; Mitochondria; NLR Family, Pyrin Domain-Containing 3 Protein; Organophosphorus Compounds; Piperidines; Reactive Oxygen Species; Receptor, Angiotensin, Type 1	2016
C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration. The American journal of pathology, 2016, Volume: 186, Issue:11 Topics: Angiotensin II; Animals; Blood Pressure; Chemokine CCL2; Chemokine CCL5; Essential Hypertension; Female; Fibrosis; Hypertension; Kidney; Kidney Diseases; Macrophages; Male; Mice; Mice, Knockout; Nephrectomy; Renin-Angiotensin System; T-Lymphocytes; Ureteral Obstruction	2016
Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin. International journal of molecular sciences, 2017, Jan-31, Volume: 18, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Epithelial Cells; Gene Expression; Heme Oxygenase-1; Kidney Diseases; Losartan; Mice; Sirtuin 1; Thioredoxins; Transforming Growth Factor beta; Tunicamycin	2017
β-Arrestin-biased AT1R stimulation promotes extracellular matrix synthesis in renal fibrosis. American journal of physiology. Renal physiology, 2017, 07-01, Volume: 313, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; beta-Arrestin 1; beta-Arrestin 2; Biphenyl Compounds; Cell Line; Collagen Type I; Disease Models, Animal; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Rats; Receptor, Angiotensin, Type 1; RNA Interference; Signal Transduction; Tetrazoles; Time Factors; Transfection; Ureteral Obstruction	2017
Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding? Frontiers in bioscience : a journal and virtual library, 2008, May-01, Volume: 13 Topics: Adenocarcinoma; Adult; Aged; Angiotensin I; Angiotensin II; Female; Humans; Kidney; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Postoperative Period; Protein Binding; Pyelonephritis; Renal Dialysis; Renin; Renin-Angiotensin System	2008
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. Kidney international, 2008, Volume: 74, Issue:5 Topics: Angiotensin II; Animals; Cell Differentiation; Cell Transdifferentiation; Cells, Cultured; Epithelial Cells; Fibrosis; Humans; Kidney; Kidney Diseases; Kidney Tubules; MAP Kinase Signaling System; Mesoderm; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2008
The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:2 Topics: Angiotensin II; Animals; Cardiovascular Diseases; Disease Models, Animal; Hypertension; Inflammation; Inflammation Mediators; Kidney Diseases; Mice; Mice, Knockout; Oxidative Stress	2008
Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients. Journal of hypertension, 2008, Volume: 26, Issue:7 Topics: Adult; Age Factors; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Captopril; Female; Genotype; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Renal Circulation; Renin-Angiotensin System; Vasoconstrictor Agents	2008
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. The Journal of biological chemistry, 2008, Aug-29, Volume: 283, Issue:35 Topics: 3-Phosphoinositide-Dependent Protein Kinases; Amino Acid Substitution; Angiotensin II; Animals; Cells, Cultured; Fibronectins; Fibrosis; Gene Expression Regulation; Glomerular Mesangium; Humans; Hypertrophy; Kidney Diseases; Mutation, Missense; NADPH Oxidase 4; NADPH Oxidases; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; RNA, Small Interfering; src-Family Kinases; Vasoconstrictor Agents	2008
Blocking of angiotensin II is more than blocking of transforming growth factor-beta. Kidney international, 2008, Volume: 74, Issue:5 Topics: Angiotensin II; Fibrosis; Humans; Kidney Diseases; Models, Biological; Signal Transduction; Smad Proteins; Transforming Growth Factor beta	2008
Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney international, 2009, Volume: 75, Issue:2 Topics: Angiotensin II; Animals; Captopril; Disease Models, Animal; Kidney Diseases; Losartan; Nitric Oxide Synthase; Oxygen Consumption; Rats; Sodium	2009
Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia. Journal of hypertension, 2008, Volume: 26, Issue:12 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Angiotensins; Animals; Cells, Cultured; Disease Models, Animal; Endothelin-1; Endothelium, Vascular; Hypertension; Hyperuricemia; KATP Channels; Kidney; Kidney Diseases; Male; Nitric Oxide; Oxonic Acid; Propylamines; Rats; Rats, Sprague-Dawley; Urate Oxidase; Uric Acid; Xanthine Oxidase	2008
Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways. Clinical and experimental pharmacology & physiology, 2009, Volume: 36, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Disease Models, Animal; Female; Glycation End Products, Advanced; Hypertension; Kidney Cortex; Kidney Diseases; Male; NADPH Oxidases; Oxidative Stress; Phosphorylation; Platelet-Derived Growth Factor; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Transcription Factor RelA; Transforming Growth Factor beta1; Vascular Cell Adhesion Molecule-1	2009
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. Therapeutic advances in cardiovascular disease, 2008, Volume: 2, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan	2008
Albumin caused the increasing production of angiotensin II due to the dysregulation of ACE/ACE2 expression in HK2 cells. Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 403, Issue:1-2 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cattle; Cell Line; Culture Media, Conditioned; Gene Expression Regulation; Humans; Kidney Diseases; Kidney Tubules; Microscopy, Electron, Transmission; Peptidyl-Dipeptidase A; Proteinuria; RNA, Messenger; Serum Albumin, Bovine	2009
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney international, 2009, Volume: 75, Issue:9 Topics: Angiotensin II; Animals; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fibrosis; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Rats; Sodium Chloride, Dietary; Spironolactone	2009
Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. The American journal of pathology, 2009, Volume: 174, Issue:4 Topics: Angiotensin II; Animals; Antigens, Surface; Cyclooxygenase 2; ELAV Proteins; ELAV-Like Protein 1; Electrophoretic Mobility Shift Assay; Fibrosis; Fluorescent Antibody Technique; Gene Expression Regulation; Humans; Hypertension; Immunohistochemistry; Immunoprecipitation; Kidney Diseases; Male; Plasminogen Activator Inhibitor 1; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA-Binding Proteins; RNA, Messenger	2009
Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology, 2009, Volume: 251, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Contrast Media; Endothelium, Vascular; Kidney Diseases; Kidney Medulla; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Circulation; Risk; Triiodobenzoic Acids; Vasoconstriction	2009
Impact of early onset obesity and hypertension on the unfolded protein response in renal tissues of juvenile sheep. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:6 Topics: Analysis of Variance; Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Male; Nitric Oxide; Obesity; Proteins; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Sheep; Statistics, Nonparametric; Tissue Culture Techniques	2009
Renal damage inhibited in mice lacking angiotensinogen gene subjected to unilateral ureteral obstruction. Urology, 2009, Volume: 74, Issue:4 Topics: Angiotensin II; Angiotensinogen; Animals; Female; Fibrosis; Kidney Diseases; Mice; Mice, Inbred C57BL; Ureteral Obstruction	2009
Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:9 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Base Sequence; Cell Line; DNA Primers; Doxorubicin; Gene Expression Regulation, Enzymologic; Glucuronidase; Kidney Diseases; Kidney Glomerulus; Male; Podocytes; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Spironolactone	2009
Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production. American journal of nephrology, 2009, Volume: 30, Issue:3 Topics: Angiotensin II; Cells, Cultured; Child; Female; Humans; Kidney Diseases; Male; Mesangial Cells; Middle Aged; Renin; Signal Transduction	2009
The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Acta radiologica (Stockholm, Sweden : 1987), 2009, Volume: 50, Issue:7 Topics: Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Caspase 3; Contrast Media; Creatinine; Diatrizoate; In Situ Nick-End Labeling; Iohexol; Kidney Diseases; Osmolar Concentration; Random Allocation; Rats; Rats, Sprague-Dawley; Telmisartan	2009
Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2009, Volume: 32, Issue:10 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dietary Fats; Fenofibrate; Glycated Hemoglobin; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Lipid Metabolism; Male; Oxidative Stress; PPAR alpha; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2009
Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:4 Topics: Angiotensin II; Animals; Cell Line; Collagen Type I; Connective Tissue Growth Factor; Disease Models, Animal; Epithelial Cells; Hypertension; Kidney Diseases; Kidney Tubules; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Up-Regulation	2009
Prenatal exposure to lipopolysaccharide alters the intrarenal renin-angiotensin system and renal damage in offspring rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2010, Volume: 33, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Creatine; Electrophoretic Mobility Shift Assay; Female; Immunohistochemistry; Kidney Diseases; Kidney Function Tests; Kidney Glomerulus; Lipopolysaccharides; NF-kappa B; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Proteinuria; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Thiocarbamates	2010
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Apoptosis; Blood Pressure; Cell Proliferation; Cells, Cultured; Chronic Disease; Collagen; Disease Models, Animal; Fibrinolysin; Fibrosis; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nephrectomy; Phosphorylation; Plasminogen Activator Inhibitor 1; Podocytes; Proteinuria; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Time Factors	2010
Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:4 Topics: Angiotensin II; Animals; Antibodies; Cell Line; Humans; Kidney Diseases; Kidney Tubules, Proximal; Male; Metalloproteases; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred WF; Reactive Oxygen Species; Tissue Inhibitor of Metalloproteinase-2; Tissue Kallikreins; Transforming Growth Factor beta	2010
Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:6 Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Glomerular Filtration Rate; Hematocrit; Imidazoles; Infusion Pumps; Injections, Subcutaneous; Inulin; Kidney; Kidney Diseases; Leucine; Losartan; Male; Mice; Nephrectomy; Organ Size; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Time Factors	2010
Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. Kidney international, 2010, Volume: 78, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Random Allocation; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Tetrazoles; Time Factors	2010
Increased dietary NaCl potentiates the effects of elevated prorenin levels on blood pressure and organ disease. Journal of hypertension, 2010, Volume: 28, Issue:7 Topics: Angiotensin II; Angiotensins; Animals; Blood Pressure; Cardiomegaly; Chymosin; Enzyme Precursors; Fibrosis; Hypertension; Kidney Diseases; Male; Random Allocation; Rats; Rats, Transgenic; Renin; Retrospective Studies; Sodium Chloride, Dietary	2010
Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents. Investigative radiology, 2010, Volume: 45, Issue:8 Topics: Analysis of Variance; Angiotensin II; Animals; Contrast Media; Diatrizoate; Humans; Iohexol; Ioxaglic Acid; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Triiodobenzoic Acids; Vasoconstriction	2010
Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition. The Journal of pathology, 2010, Volume: 221, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Epithelium; Genetic Therapy; Kidney Diseases; Kidney Tubules; Male; Mesoderm; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Smad Proteins, Receptor-Regulated; Smad2 Protein; Smad3 Protein; Smad7 Protein; Ubiquitin	2010
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney international, 2010, Volume: 78, Issue:11 Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography	2010
Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Angiotensin II; Animals; Blotting, Western; Chronic Disease; Cyclosporine; Deoxyguanosine; Disease Models, Animal; Glucuronidase; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Klotho Proteins; Male; Mice; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Up-Regulation; Vasoconstrictor Agents	2011
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. Toxicology, 2011, Jan-11, Volume: 279, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antioxidants; Benzimidazoles; Benzoates; Daunorubicin; Gene Expression Regulation; Kidney; Kidney Diseases; Kidney Function Tests; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Telmisartan	2011
Involvement of activated prorenin in the pathogenesis of slowly progressive nephropathy in the non-clipped kidney of two kidney, one-clip hypertension. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:3 Topics: Angiotensin II; Animals; Disease Progression; Hypertension, Renovascular; Kidney Diseases; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Renin; Transforming Growth Factor beta	2011
Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. The Journal of pharmacology and experimental therapeutics, 2011, Volume: 337, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Glomerulosclerosis, Focal Segmental; Hypertension; Imidazoles; Kidney; Kidney Diseases; Male; NF-E2 Transcription Factor; NF-kappa B; Oxidative Stress; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Tetrazoles; Thiobarbituric Acid Reactive Substances	2011
Evidence for the role of α1A-adrenoceptor subtype in the control of renal haemodynamics in fructose-fed Sprague-Dawley rat. European journal of nutrition, 2011, Volume: 50, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Animals; Fructose; Hemodynamics; Hypertension; Kidney; Kidney Diseases; Male; Methoxamine; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Vasoconstriction; Vasoconstrictor Agents	2011
A2B adenosine receptor-mediated induction of IL-6 promotes CKD. Journal of the American Society of Nephrology : JASN, 2011, Volume: 22, Issue:5 Topics: Adenosine Deaminase; Angiotensin II; Animals; Chronic Disease; Collagen; Fibrosis; Humans; Interleukin-6; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2B; Signal Transduction; Ureteral Obstruction	2011
Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American journal of physiology. Renal physiology, 2011, Volume: 301, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Blood Pressure; Chronic Disease; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Female; Hydrochlorothiazide; Kidney; Kidney Diseases; Lactation; Losartan; Male; Nephrons; Rats; Rats, Inbred Strains	2011
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. The American journal of pathology, 2011, Volume: 179, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcineurin; Calcium; Doxorubicin; Feedback, Physiological; Gene Expression Regulation; HEK293 Cells; Humans; Kidney Diseases; Mice; Models, Biological; NFATC Transcription Factors; Podocytes; Proteinuria; Rats; Renin; RNA, Messenger; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel	2011
Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 58, Issue:4 Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Gene Expression Regulation; Gene Silencing; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Endothelial Growth Factor A	2011
Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. American journal of physiology. Renal physiology, 2012, Jan-01, Volume: 302, Issue:1 Topics: Angiotensin II; Animals; Cell Degranulation; Fibrosis; Humans; In Vitro Techniques; Kidney; Kidney Diseases; Losartan; Male; Mast Cells; Mice; Rats; Renin; Renin-Angiotensin System; Ureteral Obstruction	2012
Comparison of ROCK and EGFR activation pathways in the progression of glomerular injuries in AngII-infused rats. Renal failure, 2011, Volume: 33, Issue:10 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Disease Progression; ErbB Receptors; Gefitinib; Kidney Diseases; Kidney Glomerulus; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; rho-Associated Kinases; Signal Transduction	2011
High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2012, Volume: 27, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Disease Models, Animal; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrectomy; Oxidative Stress; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin-Angiotensin System; Sodium Chloride, Dietary	2012
Loss of receptor activity-modifying protein 3 exacerbates cardiac hypertrophy and transition to heart failure in a sex-dependent manner. Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1 Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Female; Gene Expression; Gene Expression Profiling; Gene Knockout Techniques; Genetic Association Studies; Heart Failure; Hypertension; Hypertrophy, Right Ventricular; Kidney Diseases; Male; Mice; Mice, Knockout; Phenotype; Proto-Oncogene Proteins c-akt; Receptor Activity-Modifying Protein 3; Renin; Sex Factors	2012
Smad3 mediates ANG II-induced hypertensive kidney disease in mice. American journal of physiology. Renal physiology, 2012, Apr-15, Volume: 302, Issue:8 Topics: Actins; Albuminuria; Angiotensin II; Animals; Chemokine CCL2; Collagen Type I; Collagen Type IV; Creatinine; Female; Fibronectins; Fibrosis; Hypertension; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Ubiquitin-Protein Ligases	2012
Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2012, Volume: 29, Issue:1-2 Topics: Angiotensin I; Angiotensin II; Animals; Granulocyte Colony-Stimulating Factor; Hemodynamics; Hypertension, Renovascular; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL	2012
Role of H(2)O(2) in hypertension, renin-angiotensin system activation and renal medullary disfunction caused by angiotensin II. British journal of pharmacology, 2012, Volume: 166, Issue:8 Topics: Angiotensin II; Angiotensinogen; Animals; Biomarkers; Catalase; Gene Expression Regulation; Hydrogen Peroxide; Hypertension; Kidney Diseases; Kidney Medulla; Male; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System	2012
Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. The Journal of clinical investigation, 2012, Volume: 122, Issue:6 Topics: Angiotensin II; Animals; Biological Clocks; Calcium; Calcium Channels; Cardiovascular Diseases; Kidney Diseases; Male; Membrane Potentials; Mice; Potassium; Zona Glomerulosa	2012
Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Kidney international, 2012, Volume: 82, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Aorta; Biomarkers; Blood Pressure; Cytochrome P-450 CYP11B2; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Diseases; Inflammation; Kidney Diseases; Kidney Glomerulus; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Myocardium; Receptors, Mineralocorticoid; Renin-Angiotensin System; Sodium Chloride, Dietary; Spironolactone; Time Factors; Vascular Diseases	2012
Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3. Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:12 Topics: Angiotensin II; Animals; Base Sequence; Calcitriol; Cell Line; Extracellular Matrix Proteins; Fibrosis; Immunohistochemistry; Kidney Diseases; Kidney Tubules; Male; Molecular Sequence Data; Phosphoprotein Phosphatases; Phosphorylation; Protective Agents; Protein Phosphatase 2C; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Calcitriol; Renin; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction	2012
Targeting activated mineralocorticoid receptor: Occam's razor revisited. Kidney international, 2012, Volume: 82, Issue:6 Topics: Aldosterone; Angiotensin II; Animals; Heart Diseases; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Spironolactone; Vascular Diseases	2012
Aged rats are susceptible to nephrotoxicity induced by iodinated contrast media. Renal failure, 2013, Volume: 35, Issue:1 Topics: Aging; Angiotensin II; Animals; Contrast Media; Diatrizoate Meglumine; Disease Models, Animal; Kidney; Kidney Diseases; Male; Malondialdehyde; NADP; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Superoxide Dismutase	2013
Early life stress induces renal dysfunction in adult male rats but not female rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2013, Jan-15, Volume: 304, Issue:2 Topics: Age Factors; Aging; Angiotensin II; Animals; Anxiety, Separation; Arterial Pressure; Blood Pressure Monitoring, Ambulatory; Creatinine; Disease Models, Animal; Estradiol; Female; Hypertension; Kidney; Kidney Diseases; Male; Maternal Deprivation; Orchiectomy; Proteinuria; Rats; Rats, Inbred WKY; Sex Factors; Stress, Psychological; Telemetry; Testosterone	2013
Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice. PloS one, 2013, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Fibrosis; Gene Expression Regulation; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Mice; Mice, Knockout; MicroRNAs; NF-kappa B; Proteinuria; Signal Transduction; Smad3 Protein; Smad7 Protein; Sp1 Transcription Factor; Transforming Growth Factor beta	2013
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney international, 2002, Volume: 62, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cyclosporine; Disease Models, Animal; Enalapril; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Losartan; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors	2002
Effect of angiotensin II antagonism on the regression of kidney disease in the rat. Kidney international, 2002, Volume: 62, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Collagen Type III; Disease Progression; Kidney Diseases; Kidney Glomerulus; Lisinopril; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Valine; Valsartan	2002
Immunosuppressive treatment protects against angiotensin II-induced renal damage. The American journal of pathology, 2002, Volume: 161, Issue:5 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antigens, CD; B7-2 Antigen; Blood Pressure; Dendritic Cells; Dexamethasone; Etanercept; Histocompatibility Antigens Class II; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Kinetics; Macrophage Migration-Inhibitory Factors; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mycophenolic Acid; NADPH Dehydrogenase; NADPH Oxidases; NF-kappa B; Phosphoproteins; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Renin; T-Lymphocytes	2002
The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury. The American journal of the medical sciences, 2002, Volume: 324, Issue:6 Topics: Angiotensin II; Animals; Cholesterol; Diet; Humans; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Sclerosis	2002
Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy. Transplantation, 2003, Feb-15, Volume: 75, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Body Weight; Chronic Disease; Cyclosporine; Drug Synergism; Fibrosis; Gene Expression; Immunosuppressive Agents; Kidney; Kidney Diseases; Losartan; Macrophages; Male; Mycophenolic Acid; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Transforming Growth Factor beta; Transforming Growth Factor beta1	2003
Dual blockade of renin-angiotensin system. Kidney international, 2003, Volume: 63, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Kidney Diseases; Proteinuria; Renin-Angiotensin System	2003
Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme. The Journal of biological chemistry, 2003, Jun-06, Volume: 278, Issue:23 Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Endothelium, Vascular; Female; Gene Expression Regulation, Enzymologic; Infertility, Male; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Peptidyl-Dipeptidase A; Pregnancy; Transgenes	2003
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. Kidney international. Supplement, 2003, Issue:86 Topics: Angiotensin II; Animals; Folic Acid; Immunohistochemistry; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Up-Regulation	2003
THE EFFECT OF ANGIOTENSIN II ON THE BLOOD PRESSURE IN HUMANS WITH HYPERTENSIVE DISEASE. The Journal of clinical investigation, 1964, Volume: 43 Topics: Acidosis; Angiotensin II; Angiotensins; Aortic Coarctation; Biomedical Research; Blood Pressure; Glomerulonephritis; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Infusions, Parenteral; Kidney; Kidney Diseases; Liver Cirrhosis; Norepinephrine; Pharmacology; Sodium Chloride	1964
LOSS OF THE RENAL VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN II DURING RENAL ISCHEMIA. The Journal of clinical investigation, 1964, Volume: 43 Topics: Angiotensin II; Angiotensins; Atropine; Blood Flow Velocity; Blood Pressure Determination; Denervation; Dogs; Epinephrine; Ischemia; Kidney; Kidney Diseases; Norepinephrine; Pharmacology; Regional Blood Flow; Research; Sympathomimetics; Vasoconstrictor Agents; Vasomotor System	1964
End-organ susceptibility as a determinant of renal disease in hypertension. Kidney international, 2003, Volume: 64, Issue:5 Topics: Aged; Angiotensin II; Animals; Disease Models, Animal; Disease Susceptibility; Female; Humans; Hypertension, Renal; Kidney Diseases; Middle Aged; Nitric Oxide; Rats; Rats, Inbred Dahl; Rats, Inbred SHR	2003
Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Circulation, 2003, Nov-18, Volume: 108, Issue:20 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Coronary Artery Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mineralocorticoid Receptor Antagonists; Myocardium; NG-Nitroarginine Methyl Ester; Plasminogen Activator Inhibitor 1; Proteinuria; Sodium, Dietary; Spironolactone	2003
The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises. Kidney international, 2003, Volume: 64, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Clinical Trials as Topic; Disease Progression; Glomerular Filtration Rate; Humans; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Proteinuria	2003
Entacapone protects from angiotensin II-induced inflammation and renal injury. Journal of hypertension, 2003, Volume: 21, Issue:12 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cardiomegaly; Catechol O-Methyltransferase; Catechols; Creatinine; Dinoprost; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Hypertension; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Diseases; Leukocytes; Male; Models, Cardiovascular; Nitriles; Norepinephrine; Rats; Rats, Sprague-Dawley; RNA, Messenger	2003
[Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; Blood Urea Nitrogen; Collagen Type IV; Creatinine; Disease Models, Animal; Doxorubicin; Fibronectins; Growth Hormone; Immunohistochemistry; Irbesartan; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley; Serum Albumin; Tetrazoles; Transforming Growth Factor beta; Triglycerides	2003
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. The American journal of pathology, 2004, Volume: 164, Issue:2 Topics: 8,11,14-Eicosatrienoic Acid; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Arachidonic Acid; Blotting, Western; Chromatography, Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fenofibrate; Humans; Hypertension; Hypolipidemic Agents; Immunohistochemistry; Kidney; Kidney Diseases; Mass Spectrometry; NF-kappa B; Polymerase Chain Reaction; Rats; Receptors, Cytoplasmic and Nuclear; Renin; Transcription Factors; Vasoconstrictor Agents	2004
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 43, Issue:2 Topics: Adolescent; Adult; Aged; Angiotensin II; Animals; Axl Receptor Tyrosine Kinase; Cells, Cultured; Child; Female; Glomerular Mesangium; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Male; Mice; Middle Aged; Muscle, Smooth, Vascular; NADPH Oxidases; Oncogene Proteins; Proto-Oncogene Proteins; Rats; Receptor Protein-Tyrosine Kinases; Signal Transduction	2004
How does angiotensin II cause renal injury? Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Disease Progression; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Kidney Glomerulus; Models, Biological; Peptidyl-Dipeptidase A; Rats; Renal Circulation; Renal Insufficiency; Renin-Angiotensin System; Vasoconstriction	2004
Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. American journal of physiology. Renal physiology, 2004, Volume: 286, Issue:5 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cyclooxygenase 2; Drug Therapy, Combination; Flurbiprofen; Hypertension, Renal; Immunohistochemistry; Isoenzymes; Kidney; Kidney Diseases; Losartan; Male; Nephrectomy; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1	2004
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:6 Topics: Angiotensin II; Animals; Disease Progression; Gene Expression Regulation; Genotype; Immunohistochemistry; Inflammation; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA; Time Factors; Up-Regulation; Ureteral Obstruction	2004
Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling. Journal of hypertension, 2004, Volume: 22, Issue:10 Topics: Adult; Angiotensin II; Bartter Syndrome; Case-Control Studies; Female; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Protein Serine-Threonine Kinases; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Syndrome	2004
Comment: renal protective effects of angiotensin receptor blockers. The Annals of pharmacotherapy, 2004, Volume: 38, Issue:12 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Kidney Diseases	2004
Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin II-treated and untreated rats. Nephron. Physiology, 2004, Volume: 98, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Ferritins; Heme Oxygenase (Decyclizing); Iron; Iron Overload; Iron-Dextran Complex; Kidney; Kidney Diseases; Male; Proteinuria; Rats; Rats, Sprague-Dawley	2004
Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats. American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 1 Topics: Angiotensin II; Animals; Blood Pressure; Disease Progression; Dose-Response Relationship, Drug; Glomerulosclerosis, Focal Segmental; Glutamyl Aminopeptidase; Hyalin; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Inbred Dahl; Severity of Illness Index; Sodium Chloride, Dietary; Staining and Labeling	2005
Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Hypertension; Kidney Diseases; Male; Rats; Rats, Inbred SHR	2005
Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:8 Topics: Angiotensin II; Apoptosis; Cells, Cultured; Culture Media, Conditioned; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Epithelial Cells; Gene Expression Regulation; Glomerulonephritis, IGA; Humans; Imidazoles; Immunoblotting; Immunoglobulin A; Immunohistochemistry; Inflammation; Interleukin-6; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Kinetics; Losartan; MAP Kinase Signaling System; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Poly(ADP-ribose) Polymerases; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Recombinant Proteins; Renin-Angiotensin System; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation	2005
Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. Circulation, 2005, Jun-14, Volume: 111, Issue:23 Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Fibrosis; Heart Diseases; Humans; Inflammation; Kidney Diseases; Losartan; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Renin	2005
[Effects of high salt diet on blood pressure, renal morphology and osteopontin expression in Sprague-Dawley rat with Ang II-induced renal injury]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:7 Topics: Angiotensin II; Animals; Blood Pressure; Kidney; Kidney Diseases; Male; Osteopontin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium Chloride, Dietary; Transforming Growth Factor beta1	2005
Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nature medicine, 2005, Volume: 11, Issue:8 Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Blotting, Western; DNA Primers; ErbB Receptors; Fluorescent Antibody Technique; Hydroxamic Acids; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Mice; Mice, Transgenic; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tumor Necrosis Factor-alpha	2005
A new ATP-sensitive potassium channel opener protects the kidney from hypertensive damage in spontaneously hypertensive rats. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; ATP-Binding Cassette Transporters; Benzazepines; Endothelin-1; Extracellular Matrix; Hemodynamics; Hypertension; Immunohistochemistry; KATP Channels; Kidney; Kidney Diseases; Kidney Function Tests; Potassium Channels, Inwardly Rectifying; Propylamines; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. The American journal of pathology, 2005, Volume: 167, Issue:5 Topics: Actins; Angiotensin II; Animals; Atrophy; Crotalid Venoms; Disease Models, Animal; Epithelial Cells; Extracellular Matrix; Fibroblasts; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Male; Microscopy, Electron; Microscopy, Fluorescence; Myocytes, Smooth Muscle; Rats; Sodium-Potassium-Exchanging ATPase	2005
Effect of FTY720 on chronic cyclosporine nephropathy in rats. Transplantation, 2005, Nov-15, Volume: 80, Issue:9 Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1	2005
The Rho-kinase pathway regulates angiotensin II-induced renal damage. Kidney international. Supplement, 2005, Issue:99 Topics: Amides; Angiotensin II; Animals; Blotting, Western; Chemokine CCL2; Connective Tissue Growth Factor; Enzyme Inhibitors; Female; Gene Expression Regulation; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; NF-kappa B; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Rho Factor; rho-Associated Kinases; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation	2005
Apolipoprotein E and progression of chronic kidney disease. JAMA, 2006, Jan-04, Volume: 295, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Apolipoproteins E; Chronic Disease; Disease Progression; Humans; Kidney Diseases; Risk Factors	2006
Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy. Journal of the American Society of Nephrology : JASN, 2006, Volume: 17, Issue:6 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cell Cycle Proteins; DNA, Complementary; Enzyme Inhibitors; Epithelial Cells; ErbB Receptors; Gene Expression Regulation; Hypertrophy; Kidney Diseases; Models, Biological; Phosphoproteins; Ribosomal Protein S6; Swine; Transcriptional Activation; Transforming Growth Factor beta1	2006
The CARI guidelines. Prevention of progression of kidney disease. Nephrology (Carlton, Vic.), 2006, Volume: 11 Suppl 1 Topics: Acidosis; Adult; Analgesics; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Child; Cyclosporine; Diabetic Nephropathies; Diet, Protein-Restricted; Exercise; Female; Fish Oils; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hyperuricemia; Kidney Diseases; Kidney Failure, Chronic; Phosphates; Pregnancy; Pregnancy Complications; Proteinuria; Renal Artery Obstruction; Smoking Cessation; Tonsillectomy	2006
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. The American journal of pathology, 2006, Volume: 168, Issue:6 Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Collagen; Disease Models, Animal; Female; Fibronectins; Glomerulosclerosis, Focal Segmental; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A	2006
Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. American journal of hypertension, 2006, Volume: 19, Issue:7 Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Infusions, Parenteral; Kidney Diseases; Kidney Tubules; Macrophages; Male; Monocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, TIE-2; Vascular Endothelial Growth Factor A	2006
Estrogen and salt sensitivity in the female mRen(2). Lewis rat. American journal of physiology. Regulatory, integrative and comparative physiology, 2006, Volume: 291, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Estrogens; Female; Gene Expression Regulation; Heart Rate; Hypertension; Kidney Diseases; Ovariectomy; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary	2006
Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney international, 2006, Volume: 70, Issue:10 Topics: Adiponectin; Adipose Tissue; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atherosclerosis; Cells, Cultured; Female; Gene Expression Regulation; Imidazoles; Kidney Diseases; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oxidative Stress; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; Serum Amyloid A Protein; Signal Transduction; Tetrazoles; Tumor Necrosis Factor-alpha	2006
What is the role of angiotensin-receptor blockade in cardiovascular protection? American heart journal, 2006, Volume: 152, Issue:5 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Diseases; Pilot Projects; Renin-Angiotensin System; Research Design; Vascular Diseases; Ventricular Remodeling	2006
p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Cardiovascular Diseases; Disease Models, Animal; Kidney Diseases; Male; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin	2007
Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Creatinine; Hypertension; Immunosuppressive Agents; Inflammation; Kidney Diseases; Lead; Lymphocytes; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Superoxides; Transcription Factor RelA	2007
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circulation research, 2007, Aug-03, Volume: 101, Issue:3 Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Cardiovascular; Nephritis; NF-kappa B; NF-KappaB Inhibitor alpha; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Receptor, TIE-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2007
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2. Lewis rat. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Aging; Angiotensin I; Angiotensin II; Animals; Animals, Congenic; Blood Pressure; C-Reactive Protein; Cell Adhesion Molecules; Disease Models, Animal; Female; Fibrosis; Hypertension; Hypertrophy; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Membrane Proteins; Ovariectomy; Peptide Fragments; Proteinuria; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; RNA, Messenger; Sodium Chloride, Dietary	2007
Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Kidney; Kidney Diseases; Male; Nephritis; NF-kappa B; Potassium; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Smad7 Protein; Sodium; Transforming Growth Factor beta	2007
Role of the angiotensin II type-2 receptor in radiation nephropathy. Translational research : the journal of laboratory and clinical medicine, 2007, Volume: 150, Issue:2 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Cell Line; Humans; Imidazoles; Kidney Diseases; Male; Mice; Pyridines; Radiation Injuries, Experimental; Rats; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors	2007
Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease? Circulation research, 2007, Aug-03, Volume: 101, Issue:3 Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Endothelium, Vascular; Fibrosis; Gemfibrozil; Humans; Hypertension; I-kappa B Proteins; Inflammation; Kidney Diseases; Mice; Models, Cardiovascular; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Sodium Chloride, Dietary	2007
Obesity augments vasoconstrictor reactivity to angiotensin II in the renal circulation of the Zucker rat. American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Diet, Sodium-Restricted; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Insulin Resistance; Kidney Diseases; Mesenteric Artery, Superior; Norepinephrine; Obesity; Prediabetic State; Rats; Rats, Zucker; Renal Artery; Renal Circulation; Renin; Renin-Angiotensin System; Vasoconstriction; Vasoconstrictor Agents	2007
Spotlight on renin. Mechanisms of hypertension-induced target organ damage. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2007, Volume: 8, Issue:3 Topics: Angiotensin II; Animals; Blood Vessels; Death, Sudden; Heart Diseases; Humans; Hypertension; Immune System; Kidney; Kidney Diseases; NF-kappa B; Prorenin Receptor; Receptors, Cell Surface; Renin; Renin-Angiotensin System	2007
Angiotensin AT1 and AT2 receptors--the battle for health and disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11 Topics: Angiotensin II; Humans; Kidney Diseases; Kidney Failure, Chronic; Kidney Glomerulus; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values; Renal Circulation	2007
Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney international, 2008, Volume: 73, Issue:6 Topics: Angiotensin II; Angiotensinogen; Angiotensins; Animals; Connective Tissue Growth Factor; Extracellular Matrix; Fibrosis; Glucose-6-Phosphatase; Glycogen Storage Disease Type I; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Diseases; Mice; Mice, Mutant Strains; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta1	2008
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:2 Topics: Adrenalectomy; Aldosterone; Angiotensin II; Animals; Fibrosis; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred SHR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Smad2 Protein; Smad7 Protein; Transforming Growth Factor beta	2008
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. American journal of physiology. Renal physiology, 2008, Volume: 295, Issue:2 Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents	2008
The natural history of salt-wasting disorders of adrenal and renal origin. The Journal of clinical endocrinology and metabolism, 1984, Volume: 59, Issue:4 Topics: 18-Hydroxycorticosterone; Adolescent; Adrenal Insufficiency; Adult; Aging; Aldosterone; Angiotensin II; Desoxycorticosterone; Dexamethasone; Female; Humans; Hydrocortisone; Infant; Infant, Newborn; Kidney Diseases; Kidney Tubules; Male; Potassium; Renin; Sodium Chloride; Water-Electrolyte Imbalance	1984
Plasma catecholamines and cardiovascular response in mild renal failure. Contributions to nephrology, 1984, Volume: 41 Topics: Adult; Aged; Aldosterone; Angiotensin II; Catecholamines; Chronic Disease; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney Diseases; Male; Middle Aged; Renal Circulation; Renin; Sodium	1984
Effects of furosemide and orthostasis on active and inactive renin in normal and anephric man. European journal of clinical investigation, 1981, Volume: 11, Issue:2 Suppl 1 Topics: Adult; Angiotensin II; Child; Female; Furosemide; Humans; Kidney Diseases; Male; Nephrectomy; Posture; Renal Dialysis; Renin	1981
Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease. Nephron, 1980, Volume: 25, Issue:4 Topics: Adult; Angiotensin II; Blood Pressure; Chronic Disease; Female; Forearm; Heart Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Regional Blood Flow; Renin; Saralasin; Vascular Resistance	1980
Rate of angiotensin II generation within the human pulmonary vascular bed. Scandinavian journal of clinical and laboratory investigation, 1980, Volume: 40, Issue:5 Topics: Angiotensin II; Female; Humans; Hypertension; Kidney Diseases; Male; Pulmonary Circulation; Renin	1980
Pharmacoangiography of the kidney: an overview. Urologic radiology, 1980, Volume: 2, Issue:1 Topics: Acetylcholine; Adolescent; Adult; Angiotensin II; Animals; Contrast Media; Dogs; Epinephrine; Humans; Kidney Diseases; Male; Radiography; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins	1980
Changes in vascular reactivity in rats with experimental renal insufficiency. Archives internationales de pharmacodynamie et de therapie, 1981, Volume: 253, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Rats; Rats, Inbred Strains; Sodium	1981
Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function. The Journal of clinical investigation, 1980, Volume: 65, Issue:2 Topics: Angiotensin II; Animals; Imidazoles; Indomethacin; Kidney Diseases; Male; Prostaglandins; Rats; Renin; Thromboxanes; Ureteral Obstruction; Vasoconstriction	1980
[The regulation of proximal tubule function]. Fiziologicheskii zhurnal imeni I.M. Sechenova, 1994, Volume: 80, Issue:7 Topics: Absorption; Angiotensin II; Animals; Atrial Natriuretic Factor; Biological Transport; Endothelins; Humans; Kidney Diseases; Kidney Tubules, Proximal; Norepinephrine; Sodium	1994
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1994, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Desoxycorticosterone; Enalapril; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Wistar; Renin; RNA, Messenger; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta	1994
Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism. Kidney international, 1994, Volume: 45, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Pressure; Body Fluids; Body Weight; Electrolytes; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Renin-Angiotensin System	1994
Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy. The American journal of physiology, 1993, Volume: 264, Issue:5 Pt 2 Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Gene Expression; Imidazoles; Kallikreins; Kidney; Kidney Diseases; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ureteral Obstruction	1993
Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney international, 1995, Volume: 48, Issue:4 Topics: Angiotensin II; Animals; Biphenyl Compounds; Gene Expression; Imidazoles; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Tissue Distribution; Transforming Growth Factor beta; Ureteral Obstruction	1995
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. Journal of the American Society of Nephrology : JASN, 1995, Volume: 6, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Cyclosporine; Cytokines; Immunohistochemistry; Kidney; Kidney Diseases; Male; Osteopontin; Rats; Rats, Sprague-Dawley; Sialoglycoproteins	1995
Role of aldosterone in the remnant kidney model in the rat. The Journal of clinical investigation, 1996, Aug-15, Volume: 98, Issue:4 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles	1996
Bartter's syndrome: renal scintigraphic appearance after captopril administration. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:10 Topics: Adult; Angiotensin II; Captopril; Female; Humans; Hypokalemia; Kidney; Kidney Diseases; Radioisotope Renography; Renin; Syndrome	1996
Do kinins mediate cardioprotective and renoprotective effects of cilazapril in spontaneously hypertensive rats with renal ablation? Clinical and experimental pharmacology & physiology. Supplement, 1995, Volume: 22, Issue:1 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cilazapril; Heart Diseases; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Kinins; Nephrectomy; Organ Size; Rats; Rats, Inbred SHR	1995
Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs. European journal of pharmacology, 1997, Mar-12, Volume: 322, Issue:1 Topics: Anesthesia; Angiotensin II; Animals; Benzazepines; Dogs; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; Female; Hemodynamics; Infusions, Intravenous; Isoquinolines; Kidney; Kidney Diseases; Kidney Function Tests; Male; Platelet Activating Factor; Receptors, Dopamine D1; Renal Circulation; Tetrahydroisoquinolines; Vasodilator Agents	1997
Elevated albumin excretion in nonmodulating essential hypertensive patients. Nephron, 1997, Volume: 76, Issue:3 Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Drug Resistance; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Phenotype; Renin; Risk Factors; Sodium, Dietary	1997
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney international, 1997, Volume: 52, Issue:3 Topics: Angiotensin II; Animals; Blotting, Northern; Cyclosporine; Extracellular Matrix Proteins; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta	1997
Prevention of hypoxemia-induced renal dysfunction by perindoprilat in the rabbit. Life sciences, 1997, Volume: 61, Issue:22 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbon Dioxide; Glomerular Filtration Rate; Hypoxia; Indoles; Kidney Diseases; Oxygen; Partial Pressure; Rabbits; Renal Circulation; Vasoconstriction	1997
Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits. The American journal of pathology, 1997, Volume: 151, Issue:6 Topics: Angiotensin II; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Chronic Disease; Creatinine; Cyclosporine; Gene Expression Regulation; Immunoenzyme Techniques; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Urea	1997
Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney international. Supplement, 1997, Volume: 63 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Nucleus; Female; Immunohistochemistry; Kidney Diseases; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ureteral Obstruction	1997
The role of endothelin in radiocontrast nephropathy. International urology and nephrology, 1997, Volume: 29, Issue:5 Topics: Angiotensin II; Animals; Blood Urea Nitrogen; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Disease Models, Animal; Drug Combinations; Endothelins; Infusions, Intravenous; Iodine; Kidney; Kidney Diseases; Male; Nephrectomy; Radioimmunoassay; Radioisotopes; Random Allocation; Rats; Rats, Wistar; Reference Values	1997
[Value of angiotensin II-antagonists in kidney diseases and hypertension. Symposium on the occasion of the 102nd Session of the German Society of Internal Medicine, Wiesbaden, 14 April 1996]. Deutsche medizinische Wochenschrift (1946), 1996, Volume: 121, Issue:51 Suppl S Topics: Angiotensin II; Antihypertensive Agents; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Vasodilator Agents	1996
Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney international, 1998, Volume: 53, Issue:1 Topics: Angiotensin II; Animals; Cell Communication; Cells, Cultured; Hepatocyte Growth Factor; Kidney; Kidney Diseases; Rats; Rats, Sprague-Dawley; Recombinant Proteins	1998
Brief pharmacological intervention in experimental radiation nephropathy. Radiation research, 1998, Volume: 150, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Enzyme Inhibitors; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Radiation Injuries, Experimental; Rats; Whole-Body Irradiation	1998
Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:11 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Endothelin Receptor Antagonists; Endothelin-1; Humans; Kidney Diseases	1998
Enhanced angiotensin II stimulates renal disorders in transgenic Tsukuba hypertensive mice. Blood pressure, 1998, Volume: 7, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Gene Expression; Humans; Hypertension; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Renin-Angiotensin System	1998
Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice. Journal of hypertension, 1998, Volume: 16, Issue:12 Pt 2 Topics: Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Catecholamines; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Mice, Transgenic; Renin	1998
Renin-angiotensin system stimulates cardiac and renal disorders in Tsukuba hypertensive mice. Clinical and experimental pharmacology & physiology, 1999, Volume: 26, Issue:3 Topics: Angiotensin II; Angiotensinogen; Animals; Blood Pressure; Cardiomegaly; Humans; Hydralazine; Hypertension; Kidney Diseases; Lisinopril; Mice; Mice, Inbred C57BL; Renin; Renin-Angiotensin System; Survival Rate	1999
Insertion/deletion angiotensin converting enzyme gene polymorphism affects the microvascular structure of the kidney in patients with nondiabetic renal disease. Journal of hypertension, 1999, Volume: 17, Issue:3 Topics: Adult; Angiotensin I; Angiotensin II; Biopsy; Disease Progression; DNA; DNA Primers; Female; Follow-Up Studies; Gene Deletion; Genotype; Humans; Kidney Diseases; Kidney Medulla; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Renal Artery; Renin	1999
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. Kidney international, 1999, Volume: 55, Issue:5 Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Newborn; Apoptosis; Cell Division; Disease Models, Animal; Epidermal Growth Factor; Gene Expression Regulation, Developmental; In Situ Hybridization; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Kidney Diseases; Kidney Medulla; Kidney Pelvis; Macrophages; Mice; Mice, Knockout; Muscle, Smooth; Peptidyl-Dipeptidase A; Platelet-Derived Growth Factor; Pressure; RNA, Messenger; Transforming Growth Factor beta; Ureter; Ureteral Obstruction	1999
TGF-beta 1 production in radiation nephropathy: role of angiotensin II. International journal of radiation biology, 1999, Volume: 75, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Female; Imidazoles; Kidney Diseases; Kidney Glomerulus; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains; Tetrazoles; Transforming Growth Factor beta	1999
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney international, 1999, Volume: 56, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Blotting, Northern; Cell Division; Cell Line, Transformed; Epithelial Cells; Fibrosis; Gene Expression; Humans; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Peptides; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator	1999
Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells. Kidney international, 1999, Volume: 56, Issue:2 Topics: Adenoviridae; Angiotensin II; Animals; beta-Galactosidase; Carrier Proteins; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Size; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Genetic Vectors; Hypertrophy; Kidney Diseases; LLC-PK1 Cells; Microtubule-Associated Proteins; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Swine; Tritium; Tumor Suppressor Proteins; Vasoconstrictor Agents	1999
Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells. Journal of molecular medicine (Berlin, Germany), 1999, Volume: 77, Issue:7 Topics: Angiotensin II; Animals; Binding, Competitive; Blotting, Northern; Blotting, Western; Cell Line; Fibrosis; Fluorescent Antibody Technique; Genes, Reporter; Humans; Kidney Diseases; Kidney Tubules, Proximal; Kinetics; Mice; Receptors, Transforming Growth Factor beta; Transfection	1999
Angiotensin II inhibits insulin-induced egr-1 expression in mesangial cells. Archives of biochemistry and biophysics, 1999, Oct-15, Volume: 370, Issue:2 Topics: Angiotensin II; Animals; Cells, Cultured; Culture Media, Serum-Free; DNA-Binding Proteins; Early Growth Response Protein 1; Gene Expression; Genes, fos; Glomerular Mesangium; Immediate-Early Proteins; Insulin; Insulin Receptor Substrate Proteins; Kidney Diseases; MAP Kinase Signaling System; Mice; Phosphoproteins; Receptor, Insulin; Signal Transduction; Transcription Factors; Zinc Fingers	1999
Why are some people more receptive to angiotension II? Kidney international, 1999, Volume: 56, Issue:6 Topics: Angiotensin II; Animals; Humans; Kidney Diseases; Renin-Angiotensin System	1999
NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Chemokine CCL2; Coronary Circulation; Coronary Disease; DNA; Gene Expression; Humans; Hypertension; Intercellular Adhesion Molecule-1; Kidney Diseases; Male; NF-kappa B; Nitric Oxide Synthase; Protein Binding; Pyrrolidines; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; RNA, Messenger; Thiocarbamates; Transcription Factor AP-1; Vasculitis	2000
Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta. Nephron, 2000, Volume: 84, Issue:3 Topics: Angiotensin II; Animals; Blood Pressure; Creatinine; Doxorubicin; Endothelins; Female; Fibronectins; Heparin; Immunohistochemistry; Kidney Diseases; Kidney Glomerulus; Proteinuria; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta	2000
Effect of maximal reduction of angiotensin in renal fibrosis: bad news-good news from a pediatric mouse. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Disease Models, Animal; Fibrosis; Kidney Diseases; Mice; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System; Transforming Growth Factor beta; Ureteral Obstruction	2000
Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Transforming Growth Factor beta	2000
Why we block angiotensin II. Kidney international, 2000, Volume: 58, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Kidney Diseases; Oxidative Stress	2000
A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II. Kidney international, 2000, Volume: 58, Issue:2 Topics: Angiotensin II; Animals; Base Sequence; Cells, Cultured; Collagen; Extracellular Matrix Proteins; Fibrosis; Gene Expression; Genetic Complementation Test; Heart Diseases; Kidney Diseases; Molecular Sequence Data; Muscle Fibers, Skeletal; Mutagenesis, Site-Directed; Myocardium; Plasmids; Promoter Regions, Genetic; Proteinuria; Rats; RNA, Messenger; Transcription Factors; Transfection; Vasoconstrictor Agents	2000
Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology, 2000, Aug-01, Volume: 56, Issue:2 Topics: Angiotensin II; Animals; Apoptosis; Chemokines; Curcumin; Disease Models, Animal; Flavonoids; Gene Expression; Kidney Diseases; Male; Nephritis; Quercetin; Rats; Rats, Sprague-Dawley; Ureteral Obstruction	2000
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity. Pediatric nephrology (Berlin, Germany), 2000, Volume: 14, Issue:10-11 Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water	2000
AT(1) and AT(2) receptors in the kidney: role in disease and treatment. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Absorption; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Arterioles; Body Water; Bradykinin; Cell Differentiation; Cell Division; Collagen; Cyclic GMP; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Nitric Oxide; Receptors, Angiotensin; Renin-Angiotensin System; Sodium; Vasoconstriction; Vasodilation	2000
Renin-angiotensin system inhibitors as antihypertrophic agents. Die Pharmazie, 2000, Volume: 55, Issue:8 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System	2000
Minimizing the progression of kidney disease. Introduction. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetic Angiopathies; Disease Progression; Diuretics; Humans; Hypertension; Kidney Diseases; Kidney Failure, Chronic; Patient Care Planning; Renin-Angiotensin System	2000
Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. Kidney international, 2000, Volume: 58, Issue:6 Topics: Angiotensin II; Animals; Corrosion Casting; Endothelin-1; Fibrosis; Glomerular Filtration Rate; Humans; Hypoxia; Ischemia; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Procollagen; Recombinant Proteins; Transforming Growth Factor beta; Transforming Growth Factor beta2; Vasoconstriction	2000
Angiotensin II as a player in fibrosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15 Suppl 6 Topics: Angiotensin II; Animals; Kidney Diseases; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2000
How renal cytokines and growth factors contribute to renal disease progression. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 37, Issue:1 Suppl 2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Disease Progression; Glomerular Filtration Rate; Growth Substances; Humans; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Proteinuria; Rats	2001
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron, 2001, Volume: 87, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carotid Artery Injuries; Catheterization; Kidney Diseases; Losartan; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents	2001
Induction of heme oxygenase 1 in radiation nephropathy: role of angiotensin II. Radiation research, 2001, Volume: 155, Issue:5 Topics: Angiotensin II; Animals; Blood Pressure; Enzyme Induction; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Imidazoles; Kidney; Kidney Diseases; Rats; Tetrazoles; Transforming Growth Factor beta	2001
Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity. Pharmacology & toxicology, 2001, Volume: 88, Issue:4 Topics: Amphotericin B; Angiotensin II; Animals; Antifungal Agents; Arginine; Candida albicans; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Combinations; Endothelins; Glomerular Filtration Rate; Imidazoles; In Vitro Techniques; Injections, Intravenous; Kidney Diseases; Liposomes; Male; Nitric Oxide; Nitroso Compounds; Oligopeptides; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrazoles	2001
Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2001, Volume: 15, Issue:10 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Aspirin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Gene Expression; Heart Diseases; Humans; I-kappa B Kinase; Kidney; Kidney Diseases; Macrophages; Monocytes; Myocarditis; Myocardium; Nephritis; NF-kappa B; Protein Serine-Threonine Kinases; Rats; Renin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1	2001
[Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:6 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diabetes Complications; Diuretics; Follow-Up Studies; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Failure, Chronic; Multicenter Studies as Topic; Prognosis; Risk Factors; Time Factors	2001
Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity. American journal of physiology. Renal physiology, 2001, Volume: 281, Issue:4 Topics: Angiotensin II; Animals; Endothelium, Vascular; Hypertension, Renal; Hypokalemia; Hypoxia; Kallikreins; Kidney Diseases; Male; Osteopontin; Potassium, Dietary; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sialoglycoproteins; Sodium Chloride, Dietary; Vasoconstriction	2001
Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contributions to nephrology, 2001, Issue:135 Topics: Angiotensin II; Animals; Humans; Inflammation Mediators; Kidney Diseases; Mice; Rats; Renin-Angiotensin System; Sensitivity and Specificity	2001
Can angiotensin II be used for renoprotection? Kidney international, 2002, Volume: 61, Issue:3 Topics: Angiotensin II; Animals; Kidney; Kidney Diseases	2002
The deletion polymorphism of the ACE gene is not an independent risk factor for renal scarring in children with vesico-ureteric reflux. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:4 Topics: Adolescent; Alleles; Angiotensin II; Child; Child, Preschool; Cicatrix; Female; Gene Deletion; Genotype; Humans; Infant; Kidney Diseases; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Risk Factors; Vesico-Ureteral Reflux	2002
Fetal uninephrectomy leads to postnatal hypertension and compromised renal function. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:6 Topics: Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Female; Fetus; Glomerular Filtration Rate; Hormones; Hypertension; Kidney Diseases; Kinetics; Nephrectomy; Renin; Sheep; Sodium Chloride; Urea	2002
Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit. Life sciences, 2002, Jul-05, Volume: 71, Issue:7 Topics: Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Gas Analysis; Hypoxia; Indoles; Inulin; Kidney Diseases; Kidney Function Tests; Male; Rabbits; Renal Circulation; Theophylline; Vasoconstrictor Agents; Vasodilator Agents	2002
The role of prostaglandins and renin in sickle-cell nephropathy. A hypothesis. The Netherlands journal of medicine, 1978, Volume: 21, Issue:2 Topics: Adolescent; Adult; Anemia, Sickle Cell; Angiotensin II; Humans; Hydrogen-Ion Concentration; Kidney Concentrating Ability; Kidney Diseases; Kidney Medulla; Male; Prostaglandins; Renin; Sodium	1978
On the inappropriate in hypertension research. Lancet (London, England), 1977, Oct-01, Volume: 2, Issue:8040 Topics: Angiotensin II; Animals; Blood Pressure; Diet; Diet, Sodium-Restricted; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Diseases; Models, Biological; Natriuresis; Paraneoplastic Endocrine Syndromes; Rats; Renin; Research; Sodium; Terminology as Topic; Vasopressins	1977
Differentiation of nephrotensin from the renin angiotensin system. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1975, Volume: 148, Issue:4 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies; Atropine; Biological Assay; Blood Pressure; Carbon Tetrachloride Poisoning; Hypertension, Renal; Kidney Diseases; Male; Mercury; Nephrectomy; Norepinephrine; Pentolinium Tartrate; Peptides; Rats; Renin; Spironolactone; Teprotide; Vasoconstrictor Agents	1975
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. The American journal of medicine, 1976, Volume: 61, Issue:5 Topics: Adolescent; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Oligopeptides; Renin; Saralasin; Sodium; Teprotide	1976
[Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43 Topics: Angiotensin II; Blood Pressure; Humans; Hyperplasia; Hypertension, Renal; Kidney; Kidney Diseases; Regional Blood Flow; Renal Artery Obstruction; Renal Veins; Renin; Saralasin	1977
Clinical, biochemical and pathological features of low-renin ("primary") hyperaldosteronism. American heart journal, 1978, Volume: 95, Issue:3 Topics: 18-Hydroxydesoxycorticosterone; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aging; Angiotensin II; Angiotensinogen; Carbon Dioxide; Corticosterone; Desoxycorticosterone; Female; Humans; Hyperaldosteronism; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Potassium; Renin; Sodium; Urea; Vascular Diseases	1978
[Studies of urinary kallikrein in patients with various types of hypertension (relationship to renin-angiotension-aldosterone system (author's transl)]. Nihon Jinzo Gakkai shi, 1978, Volume: 20, Issue:8 Topics: Adult; Aldosterone; Angiotensin II; Female; Humans; Hypertension; Kallikreins; Kidney Diseases; Male; Middle Aged; Radioimmunoassay; Renin	1978
[Tissue hormones of the healthy and diseased kidney. The renin-angiotensin system, kallikrein-kinin system, prostaglandins]. Die Medizinische Welt, 1978, Nov-24, Volume: 29, Issue:47 Topics: Angiotensin II; Humans; Kallikreins; Kidney; Kidney Diseases; Kinins; Prostaglandins; Renin	1978
Renal occlusion phlebography: applicability of the balloon catheters. Cardiovascular radiology, 1978, Oct-31, Volume: 1, Issue:4 Topics: Adenocarcinoma; Angiotensin II; Humans; Kidney Diseases; Kidney Neoplasms; Phlebography; Pyelonephritis; Renal Artery; Renal Veins; Retroperitoneal Neoplasms; Thrombosis	1978
[Pathogenesis and therapy of edematous diseases. 1. Pathogenesis of edematous diseases]. Fortschritte der Medizin, 1977, Jul-14, Volume: 95, Issue:26 Topics: Aldosterone; Angiotensin II; Ascites; Capillary Permeability; Catecholamines; Edema; Edema, Cardiac; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Kidney Diseases; Liver Diseases; Lymph; Renin; Serum Albumin	1977
Angiotensin II metabolism and blood pressure in chronic renal disease. Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association, 1976, Volume: 12 Topics: Angiotensin II; Blood Pressure; Cardiac Output; Humans; Kidney Diseases; Vascular Resistance	1976
[Kideny and hepato-biliary diseases]. Deutsche medizinische Wochenschrift (1946), 1976, Jul-23, Volume: 101, Issue:30 Topics: Abdomen; Acidosis; Acute Kidney Injury; Aldosterone; Angiotensin II; Biliary Tract Diseases; Glomerular Filtration Rate; Hepatic Encephalopathy; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Liver Cirrhosis; Liver Diseases; Natriuresis; Pressure; Renin; Water	1976
Renal trauma and hypertension: the role of renin. Archives of internal medicine, 1976, Volume: 136, Issue:10 Topics: Adult; Angiotensin II; Female; Hematoma; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Male; Middle Aged; Nephrectomy; Renal Artery Obstruction; Renin; Thrombosis	1976
[A critical review of hypothetical causes of EPH-gestosis]. Zentralblatt fur Gynakologie, 1976, Volume: 98, Issue:18 Topics: Aldosterone; Angiotensin II; Animals; Biogenic Amines; Blood Volume; Body Fluids; Edema; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypertension; Immunity; Kidney Diseases; Nutritional Physiological Phenomena; Placenta; Pre-Eclampsia; Pregnancy; Prostaglandins; Proteinuria; Renin; Uterus; Vasoconstrictor Agents	1976
Hypertension and renal diseases. The Journal of the American Association of Nephrology Nurses & Technicians, 1975, Volume: 2, Issue:2 Topics: Aldosterone; Angiotensin II; Antihypertensive Agents; Humans; Hypertension; Hypertension, Malignant; Kidney Diseases; Renin	1975
Overall circulatory control in hypertension. Australian and New Zealand journal of medicine, 1976, Volume: 6 suppl 2 Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Output; Diuresis; Feedback; Hemodynamics; Homeostasis; Humans; Hypertension; Kidney Diseases; Renin; Sympathetic Nervous System; Vascular Resistance	1976
Workup of the newly discovered hypertensive patient. Postgraduate medicine, 1975, Volume: 57, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Cardiac Output; Cerebrovascular Disorders; Contraceptives, Oral; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Mass Screening; Medical History Taking; Middle Aged; Pheochromocytoma; Renin; United States; Uremia; Urography; Vascular Diseases	1975
Circulating renin in essential hypertension: an evaluation of its significance in the Japanese population. American heart journal, 1975, Volume: 89, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Angiotensin II; Asian People; Child; Female; Humans; Hypertension; Japan; Kidney; Kidney Diseases; Male; Middle Aged; Prognosis; Radioimmunoassay; Renin; Retinal Diseases; Sex Factors; Veins	1975
Lithium induced nephrogenic diabetes insipidus: changes in plasma vasopressin and angiotensin II. Clinical nephrology, 1975, Volume: 3, Issue:6 Topics: Adult; Angiotensin II; Arginine Vasopressin; Diabetes Insipidus; Humans; Kidney Diseases; Kidney Tubules, Distal; Lithium; Male; Osmolar Concentration; Vasopressins	1975
The mechanism of action of mercuric chloride on the isolated perfused rat kidney. European journal of clinical investigation, 1975, Jul-29, Volume: 5, Issue:4 Topics: Angiotensin II; Animals; Bradykinin; Chlorides; Kidney Diseases; Male; Mannitol; Mercury; Mercury Poisoning; Phentolamine; Propranolol; Rats; Tachyphylaxis; Vascular Resistance	1975
Fluid balance, renal function, and blood pressure. Clinical nephrology, 1975, Volume: 4, Issue:4 Topics: Angiotensin II; Blood Pressure; Body Fluids; Cardiac Output; Glomerular Filtration Rate; Homeostasis; Humans; Hypertension; Hypertension, Renal; Kidney; Kidney Diseases; Renin; Vascular Resistance; Vasomotor System; Water-Electrolyte Balance	1975
Measurement of renin concenration in human plasma using 125i-labelled sheep renin substrate. Clinica chimica acta; international journal of clinical chemistry, 1975, Dec-15, Volume: 65, Issue:3 Topics: Angiotensin II; Angiotensinogen; Biological Assay; Charcoal; Humans; Iodine Radioisotopes; Kidney Diseases; Kinetics; Nephrectomy; Renin	1975
Pathologic hypofunction of the renin-angiotensin-aldosterone system. Postgraduate medicine, 1976, Volume: 59, Issue:2 Topics: Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Diagnosis, Differential; Female; Humans; Hyperkalemia; Hyponatremia; Hypotension, Orthostatic; Kidney Diseases; Male; Middle Aged; Mineralocorticoids; Renin	1976
Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clinica chimica acta; international journal of clinical chemistry, 1976, Mar-15, Volume: 67, Issue:3 Topics: Adult; Angiotensin II; Chromatography, Ion Exchange; Humans; Hypertension; Kidney Diseases; Middle Aged; Radioimmunoassay; Renin; Time Factors	1976
Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. Journal of hypertension, 1992, Volume: 10, Issue:9 Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cerebrovascular Disorders; Hypertension; Imidazoles; Kidney Diseases; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium, Dietary; Survival Analysis; Tetrazoles	1992
[Plasma angiotensin II assay and the clinical significance]. Nihon rinsho. Japanese journal of clinical medicine, 1990, Volume: 48 Suppl Topics: Angiotensin II; Chromatography, High Pressure Liquid; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Hypertension, Renal; Kidney Diseases; Radioimmunoassay; Specimen Handling	1990
Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function. Journal of cardiovascular pharmacology, 1989, Volume: 13 Suppl 3 Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Creatinine; Female; Heart Rate; Humans; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Time Factors	1989
Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease. The American journal of medicine, 1989, Dec-26, Volume: 87, Issue:6B Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cilazapril; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Pyridazines; Renal Circulation; Renin	1989
Sustained release verapamil in renal hypertension. European journal of clinical pharmacology, 1988, Volume: 33, Issue:6 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Delayed-Action Preparations; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Verapamil	1988
Captopril in the hepatorenal syndrome. Journal of clinical gastroenterology, 1985, Volume: 7, Issue:4 Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Creatinine; Female; Humans; Iodine Radioisotopes; Kidney Diseases; Liver Diseases; Male; Middle Aged; Radioimmunoassay; Renin; Sodium; Syndrome	1985
Angiotensin, ACE inhibition and the kidney. Venice, Italy, September 1985. Proceedings. Kidney international. Supplement, 1987, Volume: 20 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Kidney; Kidney Diseases	1987
Cyclosporine nephrotoxicity: sodium excretion, autoregulation, and angiotensin II. The American journal of physiology, 1987, Volume: 252, Issue:4 Pt 2 Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Cyclosporins; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Kidney; Kidney Diseases; Kidney Tubules; Male; Rats; Regional Blood Flow; Renin; Saralasin; Sodium; Time Factors	1987
[The significance of renal prostaglandins for kidney function in early childhood]. Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1987, Volume: 135, Issue:4 Topics: Angiotensin II; Aspirin; Child, Preschool; Creatinine; Ductus Arteriosus, Patent; Glomerular Filtration Rate; Humans; Indomethacin; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Kidney Function Tests; Oliguria; Prostaglandins; Prostaglandins E; Renal Circulation; Renin-Angiotensin System; Vasopressins; Water-Electrolyte Balance	1987
Renin and hypertension in childhood. Archives of disease in childhood, 1974, Volume: 49, Issue:11 Topics: Aldosterone; Alpha-Globulins; Angiotensin II; Child; Child, Preschool; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney Diseases; Kidney Neoplasms; Nephrectomy; Radioimmunoassay; Renal Artery Obstruction; Renin; Sodium	1974
[Bartter syndrome. Vascular angiotensin II resistance with juxtaglomerular cellular hyperplasia and hyperaldosteronism]. Deutsche medizinische Wochenschrift (1946), 1965, Nov-12, Volume: 90, Issue:46 Topics: Adult; Angiotensin II; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Kidney Diseases; Potassium; Spironolactone	1965
Nocturnal nephrogenic diabetes insipidus. The Quarterly journal of medicine, 1965, Volume: 34, Issue:136 Topics: Angiotensin II; Diabetes Insipidus; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Hypertension, Malignant; In Vitro Techniques; Kidney Diseases; Male; Middle Aged; Natriuresis; Periodicity; Polyuria; Renin; Vasopressins	1965
Angiotensin II infusion in renal disease with hypertension. The American journal of the medical sciences, 1966, Volume: 251, Issue:3 Topics: Adolescent; Adult; Angiotensin II; Female; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Potassium; Sodium; Water	1966
Renal lesions induced by the simultaneous administration of angiotensin and hexadimethrine bromide. Experientia, 1965, Aug-15, Volume: 21, Issue:8 Topics: Angiotensin II; Animals; Female; Kidney Diseases; Quaternary Ammonium Compounds; Rats	1965
Differential renal function studies of the effects of angiotensin in normotensive and hypertensive patients. The American journal of the medical sciences, 1967, Volume: 253, Issue:2 Topics: Adult; Angiotensin II; Diuresis; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Natriuresis; Sodium	1967
Plasma renin activity in hypertension. The American journal of medicine, 1967, Volume: 43, Issue:3 Topics: Adult; Aged; Angiotensin II; Animals; Black or African American; Blood Pressure; Female; Humans; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Rats; Renin; Tissue Extracts; White People	1967
[Nephrology]. Journal de medecine de Bordeaux et du Sud-Ouest, 1966, Volume: 143, Issue:10 Topics: Adult; Angiotensin II; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Pregnancy; Proteinuria; Renin; Transplantation, Homologous	1966
Hypokalaemic alkalosis and hyperplasia of the juxtaglomerular apparatus without hypertension or oedema. British medical journal, 1967, Nov-11, Volume: 4, Issue:5575 Topics: Adolescent; Alkalosis; Angiotensin II; Blood Pressure; Extracellular Space; Humans; Hyperaldosteronism; Hyperplasia; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Renin; Sodium; Spironolactone	1967
[Angiotensin resistance test in arterial hypertension of renal origin. Limitations and indications]. Medicina interna, 1967, Volume: 19, Issue:8 Topics: Adolescent; Adult; Angiotensin II; Diagnosis, Differential; Female; Humans; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Renal Artery Obstruction	1967
[Study of aldosterone metabolism in a case of congenital nephrogenic diabetes insipidus]. Pediatric research, 1968, Volume: 2, Issue:1 Topics: Aldosterone; Angiotensin II; Diabetes Insipidus; Diet, Sodium-Restricted; Humans; Hydrochlorothiazide; Kidney Concentrating Ability; Kidney Diseases; Kidney Function Tests; Male; Potassium; Sodium	1968
Problems of correct interpretation of radioisotope renograms: experimental observations and clinical experiences. The Journal of urology, 1968, Volume: 99, Issue:2 Topics: Adult; Aminohippuric Acids; Angiotensin II; Animals; Dogs; Humans; Kidney Diseases; Mannitol; Middle Aged; Posture; Radioisotope Renography	1968
[Experimental hypertension]. Recenti progressi in medicina, 1966, Volume: 41, Issue:4 Topics: Angiotensin II; Animals; Endocrine System Diseases; Hyperaldosteronism; Hypernatremia; Hypertension; Hypertension, Renal; Hyperthyroidism; Kidney Diseases; Renin	1966
[Comparative studies on the blood pressure effect of alpha- and beta-Angiotensin II in intravenous infusions]. Klinische Wochenschrift, 1966, Sep-01, Volume: 44, Issue:17 Topics: Adrenal Gland Diseases; Angiotensin II; Biliary Tract Diseases; Blood Pressure; Humans; Hypertension; Infusions, Parenteral; Kidney Diseases; Liver Diseases	1966
[The influence of angiotensin II on the tubular phosphate back resorption in humans. A contribution on the method of action of angiotensin]. Klinische Wochenschrift, 1966, Oct-15, Volume: 44, Issue:20 Topics: Angiotensin II; Child; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Tubules; Metabolic Clearance Rate; Phosphates	1966
Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome). The American journal of medicine, 1968, Volume: 44, Issue:5 Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Aldosterone; Ammonium Chloride; Angiotensin II; Bicarbonates; Body Height; Body Weight; Catecholamines; Child; Chlorides; Diet; Female; Glucose Tolerance Test; Humans; Hyperaldosteronism; Hyperplasia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Function Tests; Metyrapone; Microscopy, Electron; Muscles; Norepinephrine; Pituitary-Adrenal Function Tests; Potassium; Renin; Serum Albumin; Sodium; Spironolactone; Triamterene; Water-Electrolyte Balance	1968
The effect of transient renal anoxia and portacaval transposition on canine arterial blood pressure. Surgery, gynecology & obstetrics, 1968, Volume: 126, Issue:6 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomyopathies; Dogs; Hypertension; Hypoxia; Kidney; Kidney Diseases; Organ Size; Portacaval Shunt, Surgical; Portal Vein; Radiography; Renal Artery	1968
Angiotensin-infusion test. Correlation with renin activity in peripheral venous blood. Archives of internal medicine, 1968, Volume: 122, Issue:1 Topics: Adult; Angiotensin II; Chronic Disease; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Male; Renin; Veins	1968
[Effect of unilateral injuries of the kidneys on the blood pressure level and urinary excretion of aldosterone in the rat]. Kardiologiia, 1967, Volume: 7, Issue:12 Topics: Aldosterone; Angiotensin II; Animals; Arteries; Blood Pressure; Constriction; Hypertension, Renal; Ischemia; Kidney; Kidney Diseases; Methods; Rats; Time Factors	1967
Studies of plasma renin activity in patients with hypertension. Polish medical journal, 1968, Volume: 7, Issue:6 Topics: Adult; Aldosterone; Angiotensin II; Diagnosis, Differential; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Posture; Renin	1968
Chronic laxative-induced hyperaldosteronism and hypokalemia simulating Bartter's syndrome. Annals of internal medicine, 1969, Volume: 70, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Blood Volume Determination; Body Weight; Calcium; Cathartics; Chronic Disease; Diagnosis, Differential; Female; Hematocrit; Humans; Hyperaldosteronism; Hypokalemia; Insulin; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Middle Aged; Plasma Volume; Posture; Potassium; Renin; Sodium; Substance-Related Disorders	1969
Renal function, renin activity and endogenous vasoactive substances in cirrhosis. The American journal of digestive diseases, 1970, Volume: 15, Issue:5 Topics: Alcoholism; Angiotensin II; Ascites; Catecholamines; Dopamine; Glomerular Filtration Rate; Humans; Hydroxyindoleacetic Acid; Kidney; Kidney Diseases; Liver Cirrhosis; Male; Plasma; Regional Blood Flow; Renin; Serotonin	1970
[Renin-angiotensin system in pathology]. Les Cahiers du College de medecine des hopitaux de Paris, 1968, Volume: 9, Issue:1 Topics: Adrenal Gland Diseases; Angiotensin II; Chronic Disease; Edema; Female; Humans; Hypertension; Hyponatremia; Kidney Diseases; Male; Pregnancy; Renin	1968
Factors determining the success or failure of nephrectomy in experimental renal hypertension. The Journal of laboratory and clinical medicine, 1970, Volume: 76, Issue:1 Topics: Angiotensin II; Animals; Biological Assay; Blood Pressure; Hypertension, Renal; Kidney Diseases; Nephrectomy; Rats; Renal Veins; Renin; Time Factors; Vasoconstrictor Agents	1970
[Changes of the pressoactive substance extractable from both kidneys of rats with hypertension induced by complete ligation of the aorta between the renal arteries]. Chirurgia e patologia sperimentale, 1968, Volume: 6 Topics: Angiotensin II; Animals; Hyperplasia; Hypertension, Renal; Ischemia; Kidney; Kidney Diseases; Rats; Renin	1968
Bartter's syndrome. A report of four cases, including three in one sibship, with comparative histologic evaluation of the juxtaglomerular apparatuses and glomeruli. Acta paediatrica Scandinavica. Supplement, 1970, Volume: 201 Topics: Alkalosis; Angiotensin II; Blood Pressure; Carbon Dioxide; Cerebrospinal Fluid Proteins; Electrolytes; Female; Glycosuria; Humans; Hydrogen-Ion Concentration; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Infant; Infant, Newborn; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Magnesium; Male; Microscopy; Microscopy, Electron; Phosphorus; Proteinuria; Specific Gravity; Spironolactone	1970
An unusual type of hypokalaemic alkalosis with a disturbance of renin and aldosterone. Acta endocrinologica, 1970, Volume: 64, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Albumins; Aldosterone; Alkalosis; Angiotensin II; Creatinine; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Kidney Diseases; Male; Potassium; Renin; Spironolactone; Triamterene	1970
Pressor activity of circulating blood after focal infarction of the kidney in the rat. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1970, Volume: 134, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Blood Specimen Collection; Centrifugation; Hypertension, Renal; Infarction; Kidney; Kidney Diseases; Rats; Renin	1970
[On the possible intervention of natriuretic factors of adrenal origin in conditions of deficiency of renal plasmatic flow]. Bollettino della Societa italiana di biologia sperimentale, 1970, Mar-31, Volume: 46, Issue:6 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Diuresis; Dogs; Ischemia; Kidney Diseases; Natriuresis; Renin	1970
Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension. Circulation research, 1970, Volume: 27 Topics: Angiotensin II; Arteries; Blood Pressure; Chlorothiazide; Chromatography, Paper; Contraceptives, Oral; Female; Humans; Hypertension; Hypertension, Renal; Immunoassay; Iodine Isotopes; Kidney Diseases; Male; Posture; Renin; Sodium; Veins	1970
Secondary aldosteronism: with observations on the definition of hypokalemia. American journal of clinical pathology, 1970, Volume: 54, Issue:3 Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Blood Volume; Edema; Estrogens; Female; Glycyrrhiza; Humans; Hyperaldosteronism; Hypertension, Renal; Hypokalemia; Kidney Diseases; Kidney Tubules; Male; Plants, Medicinal; Potassium; Pregnancy; Renin; Sodium	1970
Effects of angiotensin on the function and metabolism of the ischemic kidney. Archives internationales de pharmacodynamie et de therapie, 1970, Volume: 186, Issue:1 Topics: Aminohippuric Acids; Angiotensin II; Animals; Biological Transport, Active; Calcium; Creatinine; Dogs; Female; Humans; Hypertension, Renal; Ischemia; Kidney; Kidney Diseases; Male; Natriuresis; Potassium; Sodium; Water-Electrolyte Balance	1970
Intravenous infusion of angiotensin after surgical treatment of arterial hypertension. Polish medical journal, 1970, Volume: 9, Issue:4 Topics: Angiotensin II; Blood Pressure; Endarterectomy; Humans; Hypertension; Hypertension, Renal; Injections, Intravenous; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Nephrectomy; Posture; Renal Artery Obstruction; Renin; Stress, Physiological	1970
Case studies of siblings with juxtaglomerular hyperplasia and secondary aldosteronism associated with severe azotemia and renal rickets--Bartter's syndrome or disease? Pediatrics, 1970, Volume: 46, Issue:3 Topics: Aldosterone; Alkalosis; Angiotensin II; Bone Diseases; Child; Child, Preschool; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Glomerulus; Male; Spironolactone; Triamterene; Valine	1970
Central components of the renin-angiotensin system. British journal of pharmacology, 1971, Volume: 41, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Cats; Cervical Vertebrae; Cordotomy; Female; Heart Rate; Hexamethonium Compounds; Ischemia; Kidney; Kidney Diseases; Male; Rats; Renin; Spinal Cord; Stellate Ganglion; Thoracic Vertebrae; Vagotomy	1971
A case of Bartter's syndrome with surgical treatment followed for four years. The Journal of clinical endocrinology and metabolism, 1971, Volume: 32, Issue:6 Topics: Adrenalectomy; Adult; Alkalosis; Angiotensin II; Epinephrine; Follow-Up Studies; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Renin	1971
The role of aldosterone in pathogenesis of arterial hypertension. Japanese circulation journal, 1971, Volume: 35, Issue:5 Topics: Addison Disease; Aldosterone; Angiotensin II; Animals; Arteries; Cushing Syndrome; Fundus Oculi; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Pheochromocytoma; Rats	1971
The regulation of aldosterone secretion in anephric man. The Journal of clinical investigation, 1971, Volume: 50, Issue:8 Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Body Weight; Diet; Female; Heparin; Homeostasis; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Nephrectomy; Posture; Potassium; Radioimmunoassay; Renal Dialysis; Renin; Sodium	1971
[Importance of Kaplan's hypertension testing the etiologic diagnosis of hypertension]. Helvetica medica acta. Supplementum, 1966, May-15, Volume: 46 Topics: Angiography; Angiotensin II; Chronic Disease; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal; Kidney Diseases; Methods; Renal Artery Obstruction; Renin	1966
[Angiotensin resistence and hyperaldosteronism with normal blood pressure]. Helvetica medica acta. Supplementum, 1967, May-28, Volume: 47 Topics: Adult; Alkalosis; Angiotensin II; Blood Pressure; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases	1967
Curable renal hypertension--renin, marker or cause? JAMA, 1971, Nov-01, Volume: 218, Issue:5 Topics: Angiotensin II; Blood Pressure; Humans; Hypertension, Renal; Kidney Diseases; Kidney Function Tests; Renin	1971
[Effect differences between angiotensin II and noradrenalin in reference to diuresis, sodium and potassium excretion in healthy persons and patients with kidney diseases]. Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1970, Volume: 51, Issue:7 Topics: Angiotensin II; Blood Pressure; Chronic Disease; Depression, Chemical; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Natriuresis; Norepinephrine; Potassium; Pregnancy; Pregnancy Complications; Pyelonephritis; Stimulation, Chemical	1970
[Changes in kidney function values under angiotensin effect in various kidney diseases]. Wiener klinische Wochenschrift, 1969, Mar-07, Volume: 81, Issue:10 Topics: Adolescent; Adult; Angiotensin II; Diagnosis, Differential; Female; Glomerulonephritis; Humans; Hypertension, Renal; Inulin; Kidney; Kidney Diseases; Kidney Function Tests; Lupus Erythematosus, Systemic; Male; Middle Aged; Pyelonephritis	1969
Bartter's syndrome. A manifestation of renal tubular defects. Archives of internal medicine, 1972, Volume: 129, Issue:1 Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Bicarbonates; Chlorides; Diet Therapy; Diet, Sodium-Restricted; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Renin; Sodium; Sodium Chloride	1972
[Angiotensin resistance. Critical remarks on the so called Bartter syndrome]. Klinische Wochenschrift, 1971, Dec-01, Volume: 49, Issue:23 Topics: Adult; Aged; Alkalosis; Angiotensin II; Blood Pressure; Blood Pressure Determination; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Norepinephrine; Photometry; Potassium; Potassium Chloride	1971
[Renin activity, angiotensinogen levels and plasma angiotensinase activity in patients with hypertensive diseases of the kidneys]. Kardiologiia, 1971, Volume: 11, Issue:8 Topics: Amyloidosis; Angiotensin II; Chronic Disease; Congenital Abnormalities; Endopeptidases; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Nephrectomy; Pyelonephritis; Renin; Tuberculosis, Renal	1971
Suppressed renin response in unilaterally nephrectomized subjects. Klinische Wochenschrift, 1972, Jan-15, Volume: 50, Issue:2 Topics: Adult; Angiotensin II; Creatinine; Female; Furosemide; Humans; Hypertension, Renal; Kidney; Kidney Diseases; Male; Middle Aged; Nephrectomy; Potassium; Renin; Sodium; Time Factors; Urea	1972
[Preeminence of intravenous urography in the detection of surgically curable renovascular hypertension]. Annales de medecine interne, 1971, Volume: 122, Issue:11 Topics: Angiography; Angiotensin II; Humans; Hypertension, Renal; Kidney Diseases; Radioisotope Renography; Renal Artery Obstruction; Renin; Urography	1971
[The Bartter syndrome and the pseudo-Bartter syndrome]. Munchener medizinische Wochenschrift (1950), 1972, Apr-07, Volume: 114, Issue:14 Topics: Adult; Alkalosis; Angiotensin II; Biopsy; Diagnosis, Differential; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Male; Middle Aged; Renin; Sodium Chloride; Syndrome	1972
Diagnostic improvement with angiotensin in renal angiography. Radiology, 1972, Volume: 105, Issue:1 Topics: Abscess; Angiotensin II; Contrast Media; Female; Femoral Artery; Glomerulonephritis; Humans; Hydronephrosis; Injections, Intra-Arterial; Kidney Diseases; Kidney Diseases, Cystic; Kidney Neoplasms; Kidney Pelvis; Male; Nephrosclerosis; Radiography; Renal Artery; Tuberculosis, Renal	1972
Angiotensin II plasma levels in hypertensive patients. Acta medica Scandinavica, 1972, Volume: 192, Issue:6 Topics: Adenoma; Adrenal Gland Neoplasms; Angiotensin II; Female; Furosemide; Humans; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Hypertension, Renal; Iodine Isotopes; Kidney Diseases; Posture; Radioimmunoassay; Renal Artery Obstruction; Renal Veins; Stimulation, Chemical	1972
Assay of plasma renin activity using commercially available reagents. Clinical biochemistry, 1972, Volume: 5, Issue:4 Topics: Angiotensin II; Binding Sites, Antibody; Blood Proteins; Charcoal; Dialysis; Dimercaprol; Drug Stability; Edetic Acid; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hypertension; Hypertension, Renal; Indicators and Reagents; Iodine Isotopes; Kidney Diseases; Kidney Transplantation; Peptides; Quinolines; Radioimmunoassay; Renin; Sodium; Time Factors; Transplantation, Homologous	1972
A study of the inhibition of the renin-angiotensin system in renal potassium wasting syndromes, including Bartter's syndrome. Helvetica paediatrica acta, 1972, Volume: 27, Issue:5 Topics: Adolescent; Alkalosis; Angiotensin II; Calcium; Child; Child, Preschool; Cystinosis; Female; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Hypophosphatemia, Familial; Juxtaglomerular Apparatus; Kidney Diseases; Male; Potassium; Proteinuria; Renin; Syndrome	1972
Angiotensin I assays. Pennsylvania medicine, 1973, Volume: 76, Issue:1 Topics: Aged; Angiotensin II; Female; Humans; Hypertension; Kidney Diseases; Pregnancy	1973
Possibility that angiotensin resulting from unilateral kidney disease affects contralateral renal function. Nephron, 1971, Volume: 8, Issue:1 Topics: Angiotensin II; Animals; Diuresis; Dogs; Glomerular Filtration Rate; Injections, Intravenous; Kidney; Kidney Diseases; Kidney Function Tests; Models, Biological; Potassium; Regional Blood Flow; Sodium; Water-Electrolyte Balance	1971
Studies on the site of renal salt loss in a patient with Bartter's syndrome. Pediatric research, 1973, Volume: 7, Issue:2 Topics: Adolescent; Adult; Alkalosis; Angiotensin II; Biological Transport, Active; Blood Pressure; Child; Child, Preschool; Chlorothiazide; Glomerular Filtration Rate; Growth Disorders; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Inulin; Juxtaglomerular Apparatus; Kidney Diseases; Kidney Function Tests; Kidney Tubules, Distal; Loop of Henle; Male; Natriuresis; Sodium; Syndrome	1973
Angiotensin II like activity in the plasma of normal subjects and patients with renal hypertension. The Journal of the Association of Physicians of India, 1972, Volume: 20, Issue:5 Topics: Angiotensin II; Animals; Biological Assay; Colon; Humans; Hypertension, Renal; Kidney Diseases; Nephrectomy; Rats	1972
Studies on arterial and renal venous plasma renin activity in hypertensive patients. Acta medica Scandinavica, 1973, Volume: 193, Issue:5 Topics: Adult; Angiotensin II; Antihypertensive Agents; Arteries; Blood Pressure; Female; Heart Rate; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Posture; Renal Veins; Renin	1973
Six year follow-up of a child with Bartter syndrome. American journal of diseases of children (1960), 1973, Volume: 126, Issue:2 Topics: Aldosterone; Alkalosis; Angiotensin II; Biopsy; Blood Pressure; Child, Preschool; Diet Therapy; Female; Follow-Up Studies; Growth Disorders; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney Concentrating Ability; Kidney Diseases; Norepinephrine; Potassium; Renin; Secretory Rate; Sodium Chloride; Spironolactone; Syndrome; Vasopressins	1973
Some observations on the pathogenesis of Bartter's syndrome. The New England journal of medicine, 1973, Nov-08, Volume: 289, Issue:19 Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Juxtaglomerular Apparatus; Kidney; Kidney Diseases; Male; Potassium; Propranolol; Renin; Spironolactone	1973
Bartter's syndrome and erythrocytosis. The American journal of medicine, 1973, Volume: 55, Issue:5 Topics: Adult; Alkalosis; Angiotensin II; Blood Cell Count; Blood Pressure; Erythrocytes; Erythropoiesis; Hematocrit; Hemoglobinometry; Humans; Hyperaldosteronism; Hyperplasia; Hypertrophy; Hypokalemia; Iron; Juxtaglomerular Apparatus; Kidney Diseases; Male; Polycythemia; Potassium; Renin; Reticulocytes; Sodium; Syndrome	1973
[On some aspects of renal tubule physiopathology in childhood]. Minerva pediatrica, 1973, Jul-14, Volume: 25, Issue:25 Topics: Acid-Base Equilibrium; Acidosis, Renal Tubular; Amino Acid Metabolism, Inborn Errors; Amino Acids; Angiotensin II; Biological Transport; Child; Child, Preschool; Cystinuria; Glycine; Hartnup Disease; Humans; Infant; Infant, Newborn; Kidney Diseases; Kidney Tubules; Renal Aminoacidurias; Renal Tubular Transport, Inborn Errors; Sodium	1973
[Franz Volhard--the red and pale high pressure in the modern viewpoint. 1]. Medizinische Klinik, 1973, Oct-05, Volume: 68, Issue:40 Topics: Angiotensin II; Animals; Dogs; Germany; History, 20th Century; History, Modern 1601-; Humans; Hypertension; Kidney Diseases; Rabbits; Renin	1973
Renal ischemia modified by an angiotensin antagonist. Investigative urology, 1974, Volume: 11, Issue:5 Topics: Acute Kidney Injury; Angiotensin II; Animals; Creatinine; Diethylstilbestrol; Female; Heparin; Ischemia; Kidney; Kidney Diseases; Kidney Tubules; Rats; Receptors, Cell Surface	1974
The pressor response to intravenously infused angiotensin II: correlation with plasma renin activity. Clinical science and molecular medicine, 1974, Volume: 46, Issue:2 Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Pressure; Dose-Response Relationship, Drug; Female; Humans; Infusions, Parenteral; Kidney Diseases; Male; Middle Aged; Renin; Stimulation, Chemical	1974
[The Renin-Angiotensin-Aldosterone system in kidney diseases]. Zeitschrift fur Allgemeinmedizin, 1974, Apr-30, Volume: 50, Issue:12 Topics: Aldosterone; Angiotensin II; Humans; Kidney Diseases; Renin; Water-Electrolyte Balance	1974
[Usefulness of several methods of investigation in the diagnosis of renovascular hypertension]. Medicina interna, 1973, Volume: 25, Issue:4 Topics: Adult; Aged; Angiography; Angiotensin II; Aortography; Female; Humans; Hypertension, Renal; Kidney Diseases; Male; Middle Aged; Renal Artery; Renal Artery Obstruction; Renin; Urography	1973
Renin-angiotensin-aldosterone system of a woman with Bartter's syndrome: Juxtaglomerular cell hyperplasia without hypertension. The Journal of urology, 1974, Volume: 112, Issue:3 Topics: Adult; Aldosterone; Angiotensin II; Diet, Sodium-Restricted; Female; Humans; Hyperaldosteronism; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Potassium; Potassium Chloride; Radioisotope Renography; Renin; Sodium; Sodium Chloride; Spironolactone; Syndrome	1974
The relation of plasma renin activity to left ventricular hypertrophy and retinopathy in patients with arterial hypertension. Acta medica Scandinavica, 1974, Volume: 196, Issue:4 Topics: Adolescent; Adult; Aged; Angiotensin II; Cardiomegaly; Heart Ventricles; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Middle Aged; Radioimmunoassay; Renin; Retinal Diseases; Sodium Chloride	1974
Increased cardiovascular reactivity in renal infarction hypertension. Acta physiologica latino americana, 1974, Volume: 24, Issue:2 Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Hypertension, Renal; Infarction; Kidney Diseases; Male; Norepinephrine; Pressoreceptors; Rats; Renin; Time Factors; Tyramine; Vasoconstrictor Agents	1974
Recovery from hepatorenal syndrome after successful orthotopic liver transplantation. Surgical forum, 1973, Volume: 24 Topics: Adult; Angiotensin II; Humans; Kidney Diseases; Liver Diseases; Liver Transplantation; Oliguria; Renin; Sodium; Transplantation, Homologous; Uremia	1973